Tun yaushe ne waɗannan alamun suka kasance?
Kuma duk wani ciwon kirji a cikin mutane na shekarunku ya kamata a bi da shi ta wannan hanyar
Kuma da zazzabi.
Kuma dole ne a duba yawan jininku na cholesterol
Kuma kana da zazzabi a yanzu?
Kuma yanzu kana da wannan ciwon kirji?
Kuma shin kuna da wahalar numfashi?
Kuma za ku iya gaya mini menene sauran alamun da kuke da shi?
Kuma zafin jikinka ya yi yawa
Ina kuma da tari
Ina da sanyi da kuma tari
Kuma a yau na ji zafi sosai a kirji.
Kuma shin lokaci ne mai kyau don jin zafi?
Kuma yana da ciwo a kirji.
Kuma ina ganin ina da zazzabi kadan
Kuma ina so ku gaya mini inda ciwon kirji yake
Kuma sunã da wani zazzabi.
da kuma tarihin ciwon sukari
Kuma ina so in gaya muku cewa ina jin kamar na yi ta yin taƙama a kirji.
Kuma ina so in gaya muku cewa mutane suna ta yi mini tari a kowane lokaci.
Kuma kuna da ciwon kirji
Kuma kun ce wannan shine matsin lamba a kirjinku
Kowa a cikin iyalin yana da matsalar zuciya, cututtukan zuciya, bugun zuciya, yawan cholesterol, hauhawar jini
Akwai wasu alamun cututtuka ko matsalolin da kake gani da ciwon tsoka?
Shin akwai wasu mutane a gidan da suke da irin wannan rashin lafiya?
Shin kana da wasu alamun?
Shin numfashinka yana da kyau?
Kana ci gaba da ciwon kirji?
Domin wannan lokacin na mura ne
Amma bai kamata mu ware ciwon kirji ba, wanda ya shafi zuciya.
Amma matsalar da ta fi muhimmanci yanzu ita ce ciwon kirji.
Amma ina da wahalar numfashi
Amma na san mutane da yawa suna tari a kaina
Amma dole ne mu kula da kowace cuta ta kirji da tsanani.
Amma kana numfashi sosai a yanzu, ko ba haka ba?
Na manta da shi gaba daya saboda wannan ciwon kirji
Kana jin kamar wani yana matsa maka kirji?
Shin har yanzu suna jin numfashi?
Shin suna gunaguni cewa suna da irin wannan rashin lafiya?
Shin kana da wata matsala ta kullum kamar hawan jini ko wani abu makamancin haka?
Shin kana da wasu cututtuka masu tsanani kamar ciwon sukari?
Kana da matsalar numfashi da ciwon kirji?
Kana da hawan jini?
Shin kana da wata matsala ta numfashi tare da shi?
Ka san alamun da ke tattare da shi?
Shin, kun ga hoton?
Ka sha ruwa mai yawa a yau
Duk da haka, ina yin gwajin ciwon sukari.
Duk da haka, bayyanar cututtukan ta daidai suke da na.
Yaya zafin jikinka yake?
Yaya jini yake?
Idan kana da zazzabi mai tsanani
Idan kuna da zazzabi mai zafin jiki na digiri 100 ko fiye
Idan ka ga cewa alamun ka ko kuma matsalolin ka na bukatar karin kulawa
Na ji zazzabi a jiya.
Na kuma ji zazzabi mai tsanani
Na ji zazzabi a jiya.
Ina da ciwo mai tsanani a kirji a nan.
Ina da matsala a numfashi.
Zan aika muku da hoto
Ina jin zafi a kirji a yau
Ina da ciwon kai da zazzabi a yau
Ina ganin wannan shi ne mura.
Ina ganin wannan zazzabi ne mai sauƙi.
Shin yana kama da zama a kan kirjinka?
Ya fara da ciwon kai da zazzabi.
Yana ciwon cikina a tsakiyar kirji.
Yana da zafi a kirji kamar na matsa lamba.
Yana cikin kirji na
Yana tsakiyar ƙirjina
Yana tsakiyar kirji
Na ji zafi a kirji
Ina matukar damuwa da ciwon kirji
Ina so ku gaya mini dalla - dalla game da wannan ciwon kirji
irin su hawan jini ko ciwon sukari
Kamar a tsakiyar kirji
Yanzu za ku iya shan takapirin mai dadi don zazzabi
Yanzu Maryamu, tsawon lokacin da kake da alamun cutar?
Yanzu ka ce kana da ciwon kirji
Wani lokaci ina jin zafi a kirji
To, shin akwai wasu alamun da za su iya sa ka ji kamar ciwo?
Ko kuwa kana jin kamar wani yana zaune a kirjinka?
Yawancin lokaci zafi da tari suna kama da ciwon kai da ciwon tsoka
A tsakiyar ƙirjina
Ka nuna mini hoton da kake ji a ciki
Tun da yake kuna da zazzabi
Shin kana ganin wasu daga cikin wadannan cututtukan suna da alaƙa da yin ciki?
Shin yaranku suna da irin wannan bayyanar?
Ka gaya mini game da ciwon kirjinka
A cikin dare zafin jiki ya ƙaru
zazzabi da na sha a cikin kwanaki biyu da suka gabata
Jiki ya fara ƙaruwa a daren jiya
Ni ne Dr. Porter a Cibiyar Kula da Ayyukan 'Yan Adam a Majami'ar Gaggawa.
Za ka iya gaya mini game da ciwon kirjinka?
Ina jin zafi a kirji a gaban jikina a nan.
Na ji zafi sosai a kirji
Lokacin da na ji ciwon kirji
Yaya za ka ji a kirji?
Yaushe ne ciwon kirji ya fara?
A ina ne ciwon kirjinka yake?
A ina kake jin wannan ciwon kirji?
Kana jin an toshe ka a kirji
Ina so in gaya muku cewa ina da ciwon sukari da dai sauransu.
Ka ce kana da wannan ciwon kirji
Kasancewar cutar coronavirus (COVID-19) a cikin EU / Yankin Tattalin Arzikin Turai da United Kingdom, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Kasuwancin yaduwar cutar coronavirus (COVID-19) na nuna irin wannan yanayin a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Kingdomasar Ingila wanda ke tabbatar da cewa cutar COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe, yayin da take faruwa a matakai daban-daban dangane da ƙasa.
Bisa ga gogewar da aka samu daga Italiya, ya kamata kasashe, asibitoci da kuma cibiyoyin kulawa mai zurfi su kara shirye-shiryen su don karuwar masu cutar COVID-19 da za su bukaci kulawar lafiya, musamman ma ta hanyar kulawa mai zurfi.
A ranar 31 ga Disamba, 2019, an sanar da wani rukuni na masu fama da cutar ta huhu da ba a san su ba, a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka, China ta sanar da cutar Novel Coronavirus, wanda yanzu ake kira da cutar ta Coronavirus ta 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ta haifar da kamuwa da cutar SARS-CoV-2 an sanya ta sunan cutar Coronavirus (COVID-19).
Har zuwa yau, shaidar da aka samu ita ce, kashi 80% na mutanen da ke dauke da COVID-19 suna da rashin lafiya mai sauƙi, wato, tare da ko ba tare da cutar huhu ba, kuma mafi yawansu suna samun sauki.
A cikin kashi 14 cikin dari na shari'o'in, COVID-19 ya zama mafi munin cuta da ke buƙatar shiga asibiti yayin da sauran kashi 6 cikin dari na shari'o'in ke da bayyanar cututtuka masu tsanani da ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da aka kwantar da su asibiti saboda COVID-19 ya kai kusan kashi 4 cikin 100.
A cikin wannan binciken, mun kimanta yanayin yaduwar COVID-19 a kowace ƙasa ta EU / European Economic Area (EU / EEA) da kuma a cikin United Kingdom (UK) kuma mun kwatanta shi da lardin Hubei, China.
Muna kuma kwatanta adadin shari'o'in COVID-19 na yanzu a cikin ƙasashen EU/EEA da Burtaniya tsakanin 31 ga Janairu - 15 ga Maris, 2020 da na Italiya.
Kasashen EU/EEA da UK sun kamu da COVID-19
Bayan China, COVID-19 ya ci gaba da fadada a fannin duniya kuma a halin yanzu, ayyukan COVID-19 a sauran ƙasashe na duniya sun wuce wannan ƙasar.
A ranar 11 ga watan Maris na shekarar 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya bayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na EuroSurveillance 2020, Spiteri et al. an ruwaito farkon lamuran COVID-19 da aka tabbatar a Turai bisa ga ma'anar yanayin WHO.
A cikin EU/EEA, Faransa ta ruwaito farkon shari'o'i uku da aka tabbatar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashen EU/EEA 30 da kuma United Kingdom (UK), tare da shari'o'i 17,750 da mutuwar 1,441 da aka ruwaito daga Italiya kadai tsakanin 31 ga Disamba, 2019 da kuma ranar 31 ga Disamba, 2019 da mutuwar 1,727 da aka ruwaito.
Samun adadin adadin shari'o'in COVID-19 da kuma samun yaduwar yaduwarsu
A Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC), ana sabunta adadin COVID-19 daga kowace ƙasa a kowace rana a karfe 8:00 na safe, kawai daga tushen hukuma kamar su Ma'aikatar Lafiya ta ƙasashe, Hukumar Lafiya ta Kasa da Kasa da WHO.
An yi amfani da wannan bayanan don tantance yanayin COVID-19 a cikin EU/EEA da Burtaniya da kuma kwatanta su da cutar da ke faruwa a Italiya.
A matsayinmu na wakilin yaduwar shari'o'in COVID-19 masu aiki, mun ƙididdige taƙaitaccen yaduwar kwanaki 14 na shari'o'in COVID-19 a cikin kowane EU/EEA ƙasa da Burtaniya, yayin da ake la'akari da tsarin halitta na COVID-19 a cikin lokacin 1 ga Janairu - 15 ga Maris 2020.
Mun kuma nuna jimlar adadin wadanda aka samu a kowace kasa da misalin karfe 8:00 na safe na ranar 15 ga watan Janairu - 15 ga watan Maris 2020 a lokacin da aka samu a kowace kasa da aka samu a lokacin 31 ga watan Janairu - 15 ga watan Maris 2020 a Italiya.
Yanayin COVID-19 a cikin ƙasashen EU/EEA da UK
Yanayin da aka samu na kwanaki 14 na yaduwar yawan adadin shari'o'in COVID-19 a cikin kasashen EU/EEA da UK ya biyo bayan lardin Hubei (China) (Figure 1).
A cikin EU/EEA da kuma a cikin Burtaniya gabaɗaya, jimlar COVID-19 ta fara karuwa a kusa da 21 ga Fabrairu kuma ta karu da sauri a kusa da 28 ga Fabrairu 2020 (supplementary material).
Wannan ya kasance ne saboda yawan adadin wadanda aka samu daga Italiya, amma a duk sauran kasashen EU/EEA da kuma Birtaniya, an samu irin wannan karuwar COVID-19 a cikin tarin yaduwar (supplementary material).
Hoton 2 ya nuna jimlar adadin shari'o'in COVID-19 a cikin EU/EEA da UK a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020 idan aka kwatanta da na Italiya.
Wannan ya nuna cewa a ranar 15 ga watan Maris da karfe 8:00 na safe, sauran kasashe 15 na EU/EEA da kuma Birtaniya sun riga sun ba da rahoton adadin shari'o'i da suka yi kama da na Italiya a makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin wadanda suka kamu da cutar COVID-19 suna karuwa cikin sauri a EU/EEA da Birtaniya.
Hanyoyin da aka lura a cikin yaduwar COVID-19 sun nuna cewa cutar ta kasance tana ƙaruwa a cikin ƙasashe duka.
Wannan duk da cewa akwai bambance-bambance a cikin matakan daban-daban na ƙasashe, bambance-bambance a cikin martani na lafiyar jama'a na ƙasa, da kuma bambance-bambance a cikin ƙayyadaddun ma'anar shari'a da kuma yarjejeniyoyi daban-daban don zaɓar marasa lafiya a cikin ƙasashe waɗanda dole ne a bincika su don tabbatar da COVID-19, gami da kamawa da bincika su.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun ba da rahoton cewa, kashi 10% na marasa lafiya da ke fama da cutar COVID-19 suna bukatar kulawa mai tsanani, kuma kafofin yada labarai sun ba da rahoton cewa asibitoci da wuraren kula da marasa lafiya a wadannan yankuna sun riga sun kai iyakar iyawarsu.
Bayanai na asibiti da/ko shigar da marasa lafiya a cikin ICU na COVID-19 a halin yanzu suna samuwa a matakin EU/EEA don kashi 6% da 1% na shari'o'in, bi da bi (ba a nuna lambobin ba).
Duk da haka, dole ne a tattara su ta hanyar tsari don cika bayanan kulawa na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka ruwaito da yawan mutuwar.
A cikin binciken 2010-11, an lura da bambanci mai girma tsakanin samun gadon kulawa mai zurfi da gadon kulawa na matsakaici a Turai, daga 29.2 a Jamus zuwa 4.2 a Portugal a kowace yawan mutane 100,000.
Wannan yana nufin cewa kasashe na iya samun albarkatu fiye da Italiya (da 12.5 cikin tsauraran kula da gado na matsakaici da kuma kula da mutane 100,000 a shekara ta 2010-11).
Yaduwar asibiti na COVID-19 da ke da alaƙa da 90% na haɗarin haɗarin ƙarfin gadon kulawa mai tsanani tare da kimantawa ga kowace EU/EEA ƙasa da UK ana ba da kwatancen yanayin haɗarin haɗarin haɗari na ECDC akan COVID-19 a cikin sabuntawa ta shida.
Tun da har yanzu akwai mutane da yawa a cikin EU/EEA da wasu yankunan Birtaniya da asibitoci da kuma wuraren kula da marasa lafiya da ke kula da marasa lafiya da ke kula da marasa lafiya da ke kula da marasa lafiya a wasu yankuna na EU/EEA, kuma asibitoci da wuraren kula da marasa lafiya suna kula da marasa lafiya a wasu yankuna na Burtaniya, dole ne a samar da bayanai game da marasa lafiya da wuraren kula da marasa lafiya a matakin Nomenclature of Territorial Units for Statistics 2 (NUTS-2).
Kwarewar da aka samu daga Italiya da kuma halin da ake ciki a sauran ƙasashe ya nuna cewa annobar COVID-19 tana ƙaruwa cikin sauri a cikin EU/EEA da UK.
Kasashe, asibitoci da cibiyoyin kulawa mai zurfi ya kamata su shirya kansu don karuwar adadin masu cutar COVID-19 da ke buƙatar ci gaba da watsawar al'umma na SARS-CoV-2 da kuma kula da lafiya, musamman a yankunan da ke fama da cutar kamar yadda ake yi a Italiya.
Kamar yadda aka nuna a cikin binciken ECDC na kwanan nan, tare da sauya yanayin da ke ragewa zuwa ragewa, ana buƙatar hanzari, da hanzari da kuma zurfin ra'ayi don rage yaduwar SARS-CoV-2, saboda idan ba a aiwatar da shi a kan lokaci ba, ƙila ba za a ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, yarda da kuma daidaita amsar su ba.
Har ila yau, ƙididdigar haɗari mai tsanani ta lissafa matakan kiwon lafiyar jama'a don kawar da tasirin cutar.
Kasashe suna da ƙananan dama don ƙara haɓaka ƙoƙarin sarrafa su da rage matsin lamba akan kiwon lafiya don rage yaduwar SARS-CoV-2.
Idan hakan bai yi nasara ba, zai yi kyau a ga tsarin kula da lafiya na sauran kasashen EU/EEA su fuskanci karuwar marasa lafiya da ke bukatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
A halin yanzu, cutar coronavirus 2019 (COVID-19) ta haifar da cutar ta SARS (SARS) ta haifar da mutuwar mutane sama da 3,000 da kamuwa da cutar ta SARS (SARS) a kasar Sin da sauran wurare a duniya, wanda ya haifar da bala'i ga mutane.
Kamar SARS-CoV, wanda ya haifar da cutar ta SARS a dubban mutane a 2003, SARS-CoV-2 na iya kamuwa da cutar ta bats kuma yana haifar da irin wannan alamun ta hanyar aiki.
Koyaya, COVID-19 yana da ƙananan tsanani da mutuwa fiye da SARS, amma yana da yawa fiye da yaduwa kuma yana shafar maza fiye da tsofaffi da mata fiye da matasa.
A cikin martani ga yawan wallafe -wallafen da ke tasowa game da cututtukan da ke tasowa, wannan labarin yana ƙoƙari ya ba da cikakken bayani game da batun bincike mai sauri.
Za mu hada da ilimin cututtuka, ilimin kimiyyar cutar, ilimin kimiyyar cutar, bincike, magani, tsinkaya da rigakafin cutar.
Duk da cewa akwai tambayoyi da yawa da za a amsa, muna fatan wannan bita zai taimaka wajen fahimtar cutar da ke da lahani da kuma kawar da ita.
Saboda barkewar cutar kwayar cutar, ranar 25 ga Janairu, 2020, bikin bazara ya zama abin tunawa da ba za a iya mantawa da shi ba ga duk mutanen China da aka nemi su zauna a gida don hutu na tsawon lokaci da kuma makonni da yawa bayan haka.
Wannan kwayar cutar tana kama da cutar Coronavirus (CoV) wacce ta haifar da barkewar cutar SARS a shekara ta 2003; saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sake masa suna SARS-CoV-2 kuma ta sake masa suna CoV Disease-19 (COVID-19).
Cutar ta fara ne daga Wuhan, China kuma ta bazu cikin sauri zuwa ko'ina cikin kasar da kuma wasu kasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, an tabbatar da cewa an samu karin shari'o'i 80,000 na COVID-19 tare da fiye da marasa lafiya 40,000 da aka sallama daga asibiti saboda cutar da mutuwar marasa lafiya sama da 3,000.
WHO ta yi gargadin cewa COVID-19 ita ce magabcin mutane na 1 kuma mai yiwuwa ya fi ta'addanci ƙarfi.
A cikin kasa da watanni biyu bayan rahoton farko da aka gabatar a ranar 7 ga Janairu 2020, a cewar PubMed, an buga fiye da labarai 200 kan COVID-19, gami da ilimin kimiyyar cutar, ilimin cututtuka, ilimin kimiyyar cutar, ilimin kimiyyar cutar, bincike, da kuma magani, wanda ya sa an gano jerin kwayoyin cutar ta hanyar warewa daga marasa lafiya da yawa.
Wannan bita yana ƙoƙarin samar da wani abu game da ci gaban bincike a kan sabon da kuma ci gaba da ci gaban fannoni.
A duk lokacin da zai yiwu, za mu yi kokarin kwatanta COVID-19 da sauran cututtukan da ke haifar da SARS da CoV, wato, ciwon huhu na Gabas ta Tsakiya (MERS, 2012).
Za mu tattauna abubuwan da muka koya a kan rigakafi da kuma hasashen cutar, da kuma wasu muhimman tambayoyi.
CoVs sun kasance a matsayin masu cutar da ba ta da cutar ga mutane, tare da haifar da kusan 15% na sanyi na sanyi na yau da kullun 4.
Duk da haka, a wannan karni mun fuskanci cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta CoV a tarihin da aka rubuta na mutane.
Kamar yadda aka nuna a hoto na 1, an fara sanar da Hukumar Lafiya ta Kasa ta Sin daga Wuhan a ranar 31 ga Disamba, 2019 game da tarin mutanen da ke fama da cutar ta huhu, wanda asalinsa ba a sani ba.
Bayan kwana bakwai, an fitar da jerin abubuwan da suka shafi cutar.
An samu rahoton mutuwar farko daga Wuhan a ranar 15 ga Janairu, 2020.
A lokacin, cutar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe masu kewaye.
A ranar 20 ga watan Janairu, an samu rahoton kamuwa da cuta a tsakanin masu ba da kiwon lafiya, wanda ya nuna yiwuwar yaduwar mutum zuwa mutum.
A ranar 23 ga Janairu, an rufe birnin Wuhan tare da rufe dukkan hanyoyin zirga -zirgar jama'a.
A cikin binciken farko na asibiti kan cutar a ranar 24 ga Janairu, an ruwaito cewa daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar abincin teku ta Wuhan, wanda aka ɗauka farkon farkon kamuwa da cutar daga asalin dabba.
A ranar 30 ga watan Janairu, WHO ta bayyana barkewar cutar a matsayin bala'in kiwon lafiya a duniya.
A lokacin da aka ba da rahoton, cutar ta riga ta bazu a duk faɗin China da kuma wasu ƙasashe 50 a duniya (Figure 2.2).
Yayin da yanayin ke kara tsanantawa, har yanzu ana bukatar a tantance yadda za a kai ga annobar.
A cikin binciken da aka gudanar a kan marasa lafiya 8,866 da suka hada da mutane 4,021 da suka kamu da cutar COVID-19 a ranar 11 ga Fabrairu, 2020, an gabatar da karin bayani game da annobar ta hanyar: https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Mutane na kowane zamani sun kamu da SARS-CoV-2, amma sun fi yawa daga shekaru 30 zuwa 65.
Kimanin rabin masu kamuwa da cutar (47.7%) sun kasance sama da shekaru 50, kadan a karkashin shekaru 20 kuma mutane 14 ne kawai suka kamu da cutar a karkashin shekaru 10.
Maza sun fi kamuwa da SARS-CoV-2 (0.27/100,000) fiye da mata (0.31/100,000).
COVID-19 ya bazu ne a cikin garken da ke kusa da shi, musamman a Hubei.
COVID-19 ya ɗauki matsakaici na kwanaki 5 (2-9) daga farkon zuwa ganewar asali.
Matsakaicin lokacin incuba ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga farko zuwa mutuwa ya kai kwanaki 9.5 (4.8-13).
Yawan haihuwa na asali (R0) 3.77 (95% CI:3.51-4.05) ne, kuma daidaitaccen R0 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu da sauri kafin 23 ga Janairu, 2020, wanda ya dace da yawan zirga -zirgar da ke gudana a kasar Sin kafin bazara.
Mutuwar marasa lafiya da aka tabbatar da cutar ta kasance 1.44% (95% CI: 1.10-1.86%) da kuma daidaitaccen mutuwar marasa lafiya duka 3.06% (95% CI: 2.02-4.59%).
Babban manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥60) da matsanancin cutar huhu.
CoVs wani nau'i ne na manyan kwayoyin cuta masu dauke da RNA guda daya.
Ana iya rarraba su zuwa ƙarni huɗu, wato, alpha, beta, gamma da delta wanda aka sani da alpha da beta-CoVs don kamuwa da mutum.
S membrane tip yana haɗuwa da glycoprotein, SARS-CoV da MERS-CoV zuwa ga enzymes 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) masu karɓar angiotensin-transforming enzymes, bi da bi, kuma ya haɗu da membrane.
RNA na kwayar cuta ya zama ba a saki a cikin tantanin halitta; bayan kwayar cuta ta kwayar cuta, membrane ya samar da glycoproteins da nucleocapside proteins tare da RNA na kwayar cuta, wanda daga baya ya shiga cikin plasma membrane don sakin kwayar cuta.
An sanar da farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 sabon nau'in beta-CoV ne wanda aka gano a cikin samfurori 10 da aka tattara daga kasuwar abincin teku ta Hunan, Wuhan, inda cutar ta fara.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV ta hanyar kwayoyin halitta.
Ta hanyar watsawar electron microscope, an gano SARS -CoV-2 a cikin sassan da ba su da ƙarfi na sararin samaniya na mutum.
An gano mai karɓa ga mutum ACE2, SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana haɗuwa da mutum ACE2 tare da rauni fiye da SARS-CoV wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan cututtuka masu tsanani a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2, ko kuma kof3b na iya samar da ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar
Orf3b na SARS-CoV-2 na iya taka rawa wajen kamuwa da cutar ta hanyar kwayar cuta kuma yana iya hana bayyanar IFNβ; ko da yake orf8 ba shi da wani sanannen yanki ko dalili na aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun ba da rahoton cryo-EM tsarin cikakken tsawon mutum ACE2 a ƙuduri na 2.9 Å a cakuda shi da mai ɗaukar amino acid B0AT1.
Sun gano cewa an tsara cakuda, wanda ya ƙunshi abubuwa masu kyauta da kuma rufewa, a matsayin dimer kuma cakuda ACE2-B0AT1 na iya haɗa sunadarai biyu na S wanda ke ba da shaida ga ganowa da kamuwa da cutar CoV.
B0AT1, na iya zama manufa ta magani ga gwajin magani don hana kamuwa da cutar SARS-CoV-2.
Abubuwan da ke cikin nutsuwa da kuma na tsakiya
An san cewa SARS -CoV da MERS -CoV sun samo asali ne daga bats kuma an watsa su zuwa mutane ta hanyar cats da camels, bi da bi.
Ta hanyar kwatanta SARS-CoV-2 da sauran CoVs, an gano cewa bats ne ainihin abincin SARS-CoV-2 saboda sabon cutar ta yi daidai da kashi 96% na CoVs biyu na SARS-kamar bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san abin da abincin tsaka - tsaki ya taimaka wajen wucewa ta hanyar cutar ta hanyar hana mutum kamuwa da cutar ba kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, et al., sun gabatar da maciji a matsayin mai ɗaukar kwayar cutar daga bats zuwa mutum wanda ya ƙunshi sake haɗuwa iri ɗaya da furotin S.
A cewar wani binciken, masu bincike a Guangzhou, China sun nuna cewa pangolin - mai tsawon saurin magana, mai cin naman kaza mai cin nama mai suna SARS-CoV-2 da kuma CoV da aka samu a pangolin - zai iya zama matsakaiciyar abinci mai gina jiki na SARS-CoV-2 bisa ga daidaito na kwayoyin halitta na 99%.
Duk da haka, bambancin bambanci na 1% a cikin dukkanin kwayoyin halittar halittu biyu har yanzu yana da banbanci; saboda haka, ana jiran sakamako mai mahimmanci don tabbatar da hujja (Figure (Figure 33)
Abubuwan da ke tattare da SARS-CoV-2 ba a sani ba tukuna.
SARS-CoV da MERS-CoV na iya rayuwa har zuwa kwanaki 5 a cikin yanayi mai bushe na yanayi na tsawon awanni 48 da ƙasa da 20 °C da kuma a cikin yanayin zafi na 40%-50%.
SARS-CoV-2 na iya samun irin wannan fasalin.
An ruwaito cewa SARS-CoV-2, yana da matukar damuwa ga hasken ultraviolet na tsawon minti 30 a 56 °C; Ethers, 75% ethanol, chlorine-containing disinfectants, parasitic acid, chloroform da sauran fatty solvents na iya kashe cutar yadda ya kamata, amma ba chlorhexidine ba.
Dukan mutane ba su da ƙarfi ga SARS-CoV-2 kuma saboda haka suna da haɗari ga ƙwayoyin cuta.
Babu wani bincike mai zurfi da aka bayar a halin yanzu game da amsawar rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ne kawai ga binciken da aka yi a baya akan sauran CoVs, musamman SARS-CoV da MERS-CoV (Figure 4.4).
A yadda aka saba, bayan cutar ta shiga cikin abinci mai gina jiki, ana fara gano ta ta ta ta hanyar tsarin rigakafin jiki na abinci mai gina jiki daga masu karɓar ganowa (PRR) na samfurin, ciki har da masu karɓar nau'in C-type lectin-like receptors, toll-like receptors (TLRs), NOD-like receptors (NLRs), da RIG-I-like receptors (RLs).
Ta hanyoyi daban -daban, cutar ta haifar da bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta guje wa amsawar rigakafi.
Ba da daɗewa ba, an daidaita tsarin rigakafi don yaƙi da cutar.
Kwayoyin T, ciki har da CD4+ da CD8+ T, suna taka muhimmiyar rawa wajen karewa.
CD4+ T cells suna motsa B cells su samar da rigakafi na musamman ga kwayar cutar kuma CD8+ T cells suna kashe kwayar cutar kai tsaye.
T-helper cells suna samar da pro - inflammatory cytokine don taimakawa kwayoyin da ke karewa.
Koyaya, CoV na iya hana T cell aiki ta hanyar kashe T cells.
Hakanan ana buƙatar rigakafin rigakafi, gami da kari da rigakafi kamar C3a da C5a don yaƙar kamuwa da cutar.
Alal misali, rigakafin da aka ware daga mai haƙuri da ya warke ya hana cutar ta MERS-CoV.
A gefe guda kuma, yawan magungunan rigakafi na jiki na haifar da kwayoyin da ke da 'yanci a gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, har ma da rashin aiki da mutuwa a mafi munin yanayi.
Tsoffin mutane da mata masu ciki da ke da cutar SARS-CoV-2 da ke nuna farkon farawar garke suna da mafi kusantar cutar.
Abu ne na kowa cewa mutanen da suka kamu da cutar ko kuma wadanda ke da aiki guda biyu na rigakafi sun fi kamuwa da cutar fiye da sauran.
Bisa ga binciken farko na mutane 425 a Wuhan, an kiyasta matsakaicin lokacin incuba na SARS-CoV-2 na kwanaki 1-14 ne, mafi yawa kwanaki 3-7.
Koyaya, binciken da aka yi akan shari'o'i 1,099 ya gano cewa matsakaicin lokacin incubation ya kasance kwanaki 3 kuma yana da iyaka daga kwana 0 zuwa 24.
Kamar yadda aka ambata a sama, binciken da aka yi kwanan nan ya nuna cewa lokacin incubacin ya kai kwanaki 4.8 (3.0-7.2) bisa ga yawan mutane 8,866 da suka kamu da cutar.
Yana da matukar mahimmanci ga hukumomin lafiya su daidaita lokacin killacewar da ya dace bisa ga ainihin lokacin incubation kuma don haka su hana mutane masu kamuwa da cutar amma ba su da alamun cutar daga watsawa ga wasu mutane.
A matsayinka na al'ada, mutanen da suka kamu da cutar ko kuma suka kamu da ita suna bukatar zaman kansu na kwanaki 14.
Shin ya kamata a kara tsawon lokacin killacewa zuwa kwanaki 24?
Zazzabi shine babban bayyanar cutar COVID-19 wanda ba shi da alamun bayyanar cututtuka ko wasu alamun kamar tari, rashin numfashi, ciwon tsoka, zazzabi, ciwon kai, ciwon wuya, haushi, zubar da jini, ciwon kirji, kumburi, haushi da kuma kumburi.
Wasu marasa lafiya sun sami wahalar numfashi da/ ko hypoxia mako guda bayan fara cutar.
A cikin matsanancin hali, marasa lafiya sun samu karuwar ci gaban ciwon huhu mai tsanani, tsokoki na tsakiya, rashin cin abinci mai gina jiki da cututtukan cututtukan jiki.
Dole ne a bincika marasa lafiya masu zazzabi da zazzabi da kuma/ko bayyanar cututtukan numfashi don gano cutar a lokaci na farko, koda ba tare da bayyanar cututtukan huhu ba.
A cikin binciken binciken alƙaluma na ƙarshen Disamba 2019, an lura cewa yawan alamun sun kasance 98 ga zazzabi, 76 ga tari, 55% ga wahalar numfashi da 3% ga asarar zuciya; 8% na marasa lafiya sun buƙaci taimakon iska.
An samu irin wannan binciken a cikin binciken biyu na baya-bayan nan na garke da aka samu ta hanyar watsawa daga garken iyali da kuma wanda ba shi da alamun cutar.
A wani kwatanci, binciken binciken adadi na mutane na 2012 ya nuna cewa masu cutar MERS-CoV sun kasance da zazzabi (98%), tari mai bushe (47%) da kuma wahalar numfashi (55%) a matsayin manyan alamomi.
Koyaya, fiye da marasa lafiya na COVID-19, 80% na marasa lafiya sun buƙaci taimakon iska kuma wannan ya dace da cutar MERS da ta fi COVID-19 muni.
An kuma lura da ciwon kumburi (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya da ke fama da cutar MERS.
A cikin marasa lafiya na SARS an lura cewa zazzabi (99%-100%), tari mai bushe (29%-75%), wahalar numfashi (40%-42%), asarar zuciya (20-25%) da kuma ciwon wuya (13-25%) sune manyan alamun bayyanar cututtuka kuma kusan 14%-20% na marasa lafiya suna buƙatar taimakon iska.
Yawan mutuwar COVID-19 ya kai kashi 2 cikin dari a ranar 14 ga Fabrairu, lokacin da aka kai adadin wadanda suka kamu da cutar a duniya zuwa 66,576.
A matsayin kwatankwacin, mutuwar SARS ta kasance 10% na 8,096 na tabbatar da shari'o'in a watan Nuwamba na 2002.
A cikin binciken da aka gudanar a watan Yuni na shekarar 2012, an samu kashi 37 cikin dari na mutane 2,494 da suka mutu a cutar MERS.
Wani binciken da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya fi 6.47 girma tare da 95% amintaccen lokaci (CI) na 5.71-7.23 yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4 kawai.
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, mutuwar da R0 a cikin Table 1.1.
Bayanan da aka ambata sun nuna cewa SARS-CoV-2 yana da damar yadawa fiye da MERS-CoV da SARS-CoV, amma yana da rauni fiye da na baya.
Saboda haka, sarrafa cutar ta SARS-CoV-2 ya fi kalubale fiye da MERS-CoV da SARS-CoV.
A cikin garken, yawanci iyali ɗaya ko kuma ƙungiya ɗaya ko kuma mota kamar jirgin ruwa ne ke farawa.
Yawancin marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da aka shafa ko kuma hulɗa da mutane masu kamuwa da cutar ko marasa lafiya a cikin makonni biyu da suka gabata tun farkon.
Koyaya, an ruwaito cewa mutane na iya ɗaukar kwayar cutar ba tare da alamun bayyanar cututtuka ba har tsawon makonni biyu kuma marasa lafiya da suka warke daga asibiti na iya sake ɗaukar kwayar cutar, wanda ke ba da gargadin tsawaita lokacin killacewa.
A farkon lokaci, yawan farar jini (musamman ƙwayoyin jini) a cikin marasa lafiya na yau da kullum ko ƙananan.
Misali, an gano lymphocenia da kuma karuwa a matakin aminotransference da kuma rashin lafiya a cikin 1,099 marasa lafiya na COVID-19 tare da ƙididdigar ƙwayoyin jini na fararen jini da suka hada da ƙwayoyin jini na 1×109/L.
Wasu marasa lafiya sun sami karuwa a cikin jini na hanta da na tsoka da kuma matakan myoglobin, kuma yawancin marasa lafiya sun sami karuwar sinadarai masu amsa C da kuma ragewar erythrocytes a cikin jini.
A cikin marasa lafiya masu tsanani, an ƙara yawan D - dimers, wani abu da ke haifar da raguwar fibrin a cikin jini, kuma ƙididdigar ƙwayoyin ƙwayoyin ƙwayoyin cuta ta ci gaba da raguwa.
Yawancin marasa lafiya na COVID-19 suna da rashin daidaito a cikin radiography na ƙirjin kuma ana nuna su ta hanyar hotuna masu tabo biyu a cikin huhu ko kuma rashin haske na gilashin ƙasa.
A yawancin lokuta, marasa lafiya suna fama da rashin lafiyar huhu, lalacewar huhu da kuma cutar shan numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, ana yin mummunan rikici a cikin musayar gas saboda kumburi mara kyau, tarin ruwa da ci gaba da fibrosis.
Abubuwan da ke faruwa a cikin nau 'in I da nau 'in II na ƙwayoyin cuta suna rage matakin surface activation kuma suna ƙara matsa lamba a saman farfajiyar, don haka rage ƙarfin huhu da kuma haɗarin dakatar da aikin huhu.
Saboda haka, mafi munin sakamakon radiography na ƙirji galibi yana daidai da mafi munin yanayin cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko kan COVID-19 ya gano yadda cutar ta kashe mutum a cikin huhu, samar da kwayar halittun jini da kuma zubar da kwayar cutar, da kuma kwayoyin halitta masu yawa da suka dace da cututtukan cututtukan cuta da ARDS, da kuma irin na SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar amsa mai jujjuyawar polymerase chain reaction (RT-PCR) ya zama babban ma'auni don ganewar asali na COVID-19.
Duk da haka, saboda yawan rashin adadi mai yawa, wanda zai iya hanzarta annobar, an fara amfani da maganganun asibiti don ganewar asali a China a ranar 13 ga Fabrairu, 2020 (wanda ba ya dogara da RT-PCR kawai).
Haka kuma ya faru da gano SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje -gwajen gwaje -gwaje da binciken radiological yana da mahimmanci da kuma dole ne don yin ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, kungiyar Feng Zheng ta bayyana wata yarjejeniya ta amfani da fasaha ta SHERLOCK mai amfani da CRISPR don gano SARS-CoV-2, wanda ke gano SARS-CoV-2 RNA artificials a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 a microl per input) ba tare da buƙatar wani kayan aiki mai zurfi ba, ta amfani da dipstick.
Idan aka tabbatar da shi a cikin samfurori na asibiti, ana fatan cewa sabuwar fasaha za ta iya ƙara yawan kulawa da sauƙi.
Saboda rashin kwarewa da sabon CoV, likitoci na iya samar da kulawa ta goyan baya ga marasa lafiya na COVID-19 musamman ta hanyar gwada magunguna daban-daban da aka yi amfani da su ko kuma aka gabatar don magance sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta (Table (Table 2).2).
Wadannan magunguna sun hada da maganin rigakafi, maganin rigakafi, steroids, plasmas daga marasa lafiya da suka warke, magani na kasar Sin da kuma magani na yanzu da kuma na gaba tare da taimakon ilimin halayyar mutum.
An kuma ba da shawarar yin amfani da plasma daga marasa lafiya da suka warke don magani.
Kamfanonin magunguna suna cikin gwagwarmaya don samar da rigakafi da alluran rigakafi ga cutar.
SARS-CoV-2 yana fara kai hari ne ga huhu da kuma wasu gabobin da ke nuna ACE2 kamar su tsarin gastrointestinal da koda.
Duk da haka, rashin numfashi da rashin ƙarfi sun kasance babban haɗari ga marasa lafiya kuma manyan dalilai na mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci don kawar da bayyanar cututtuka da ceton rai kuma ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai iska da iska mai iska, dangane da yanayin cutar.
Marasa lafiya da ke fama da cututtukan numfashi masu tsanani suna bukatar taimakon da ake yi na extracorporeal membrane oxygenation (ECMO), da kuma ingantaccen tsarin karkatawa da huhu da ake amfani da shi wajen magance cututtukan zuciya ko kuma rashin numfashi.
Bugu da kari, kula da daidaiton electrolyte, hanawa da kuma magance kamuwa da cuta ta biyu da kuma maganin saurin bugun jini, da kuma kare aikin gabobin jiki masu mahimmanci suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa hadari na cytokine yana haifar da matsanancin amsa na tsarin rigakafi a cikin marasa lafiya na SARS da MERS.
Cytocaine Storm wani nau'i ne na tsarin karuwa wanda ke nuna sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan kwayoyin suna motsa kwayoyin rigakafi su saki kwayoyin da ba su da sinadarin cytokine wanda shine babban dalilin ARDS da rashin cin nasara na kwayoyin halitta.
Ana bukatar rigakafin rigakafi wajen magance tashin cytocaine, musamman a cikin marasa lafiya masu tsanani.
Ana amfani da corticosteroids da tocilizumab, anti-IL6 monoclonal immunosuppressant, don magance cytocaine storm.
Sauran magungunan rigakafi ga sitokinine ya shafi rigakafin T cell-directed immune response, IFN-γ, IL-1, da TNF inhibitors, JAK inhibitors, Blinatumab, suppressors of cytokine signaling 4, da kuma HDAC inhibitors.
Ana amfani da steroid a matsayin mai hana rigakafi a cikin maganin SARS don rage girman lalacewar cutar.
Koyaya, babban adadin steroid bai kasance da amfani ga mummunan lalacewar huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman rashin ƙarfi na jijiyoyi, suna shafar ganewar asali.
Duk da haka, an ba da shawarar yin amfani da tsarin aikin kortisteroid na ɗan gajeren lokaci a ƙananan zuwa matsakaiciyar sashi a cikin marasa lafiya masu cutar COVID-19 masu tsanani.
A lokacin rubuce-rubuce, babu ingantaccen maganin riga-kafi da aka tabbatar.
Duk da haka, an gano cewa yin amfani da Remdesivir, wani nau'in nucleotide a cikin jijiyoyi yana da tasiri a cikin wani mai haƙuri na Amurka na COVID-19.
Remdesivir magani ne na riga - riga na riga - riga wanda Gilead ta haɓaka don maganin cututtukan da aka haifar da ƙwayoyin Ebola da Malburg.
Daga baya, Remdesivir ya nuna yiwuwar hana wasu kwayoyin cutar RNA guda biyu, ciki har da MERS da SARS.
Bisa ga wannan, Gilead ta ba da kayan aiki ga China don yin gwaje -gwaje biyu akan mutane da ke da cutar SARS -CoV-2 kuma sakamakon yana da kyau.
Bugu da ƙari, an ba da shawarar baricitinib, interferon-α, iopinvir/ ritonavir, da ribavirin a matsayin magani mai yiwuwa ga marasa lafiya da ke fama da alamun numfashi mai tsanani.
Maganin tare da iopinavir/ ritonavir na iya haifar da ciwon sukari, haushi, vomiting, cutar hanta da sauran mummunar sakamako.
Dole ne a lura da hulɗar da waɗannan magunguna suke da ita da sauran magunguna da aka yi amfani da su a cikin marasa lafiya.
Samun plasma da kuma rigakafi daga marasa lafiya da suka warke
Akwai dogon tarihi na tattara jini daga marasa lafiya da suka warke daga wani cututtuka masu yaduwa don magance sauran marasa lafiya da ke fama da wannan cuta ko kuma don hana mutane lafiya kamuwa da cutar.
A gaskiya ma, marasa lafiya da suka warke suna da karfin rigakafi a cikin jini dangane da cutar.
Magungunan rigakafi da kwayoyin B ke samarwa don yaki da cututtuka da sauran kwayoyin waje sune immunoglobulins (Ig) kuma suna gano kwayoyin da ba su da alaƙa da kwayoyin cutar kuma suna kashe su kai tsaye.
Bisa ga wannan, an tattara plasma daga jinin wani rukuni na marasa lafiya da suka warke daga COVID-19 kuma an yi amfani da shi a cikin marasa lafiya 10 masu ciwo mai tsanani.
Saurin cutar da kuma cutar da aka samu da kuma ingantaccen oxygen a cikin jini sun inganta cikin sa'o'i 24.
Duk da haka, har sai an samar da takamaiman magunguna, ana buƙatar tabbatarwa da bayani don samar da tsarin don amfani da shi a babban sikelin.
Bugu da ƙari, duk da tasirin magani, dole ne a yi la'akari da wasu lalacewar da ke tattare da plasma.
Alal misali, rigakafi na iya saurin motsa jiki kuma ya haifar da ciwon rashin lafiyar cytokine, wanda zai iya zama mai haɗari ga rayuwa.
Yawan rigakafi a cikin jini yana da ƙananan, kuma ana buƙatar plasma don magance marasa lafiya masu tsanani.
Yana da wuya a ci gaba da samar da rigakafi na musamman da sauri don yaƙar cutar ta duniya.
Saboda haka, yana da mahimmanci kuma ya fi dacewa a ware kwayoyin B daga marasa lafiya da suka warke kuma a gano lambar kwayoyin da ke ba da lambar rigakafi mai tasiri ko kuma a bincika rigakafin da ke da tasiri ga furotin da ake buƙata na cutar.
Ta haka ne za mu iya kara yawan rigakafin jiki.
TCM an yi amfani da ita a kasar Sin na tsawon shekaru don magance cututtuka daban-daban.
Duk da haka, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban -daban a cikin tsari daban -daban dangane da gano cutar bisa ga ka'idodin TCM.
Yawancin ingantattun sinadarai ba a sani ba ko kuma ba su da ma'ana saboda yana da wuya a cire da kuma tabbatar da irin waɗannan sinadarai ko kuma mafi kyawun haɗuwa da su.
A halin yanzu, saboda rashin ingantaccen magani da takamaiman magani ga COVID-19, TCM ya zama ɗayan manyan hanyoyin maye gurbin magani ga marasa lafiya masu sauƙi zuwa matsakaici ko waɗanda suka warke daga matakai masu tsanani.
Misali, an gano cewa kwayar Shu Feng Ji Do da kuma Lian Hua Qing Wen sun yi tasiri wajen magance COVID-19.
A larduna da dama na kasar Sin, kashi 87% na marasa lafiya da ke amfani da TCM, ciki har da Gansu (63.7%), Ninxia (50%), da Hunan (50%) sun ga mafi yawan dawo da farfadowa a cikin maganin COVID-19, yayin da lardin Hubei inda kusan 30% na marasa lafiya na COVID-19 ne kawai suka yi amfani da TCM, ya kasance mafi ƙarancin dawo da farfadowa (13%).
Duk da haka, wannan kwatancen yana da matukar mahimmanci saboda akwai wasu dalilai masu tasiri, kamar yawan marasa lafiya da kuma tsanani da ya kamata a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Bodi Zheng da abokan aiki sun buga wani binciken da ya kwatanta maganin maganin Western Medicine (WM) da kuma maganin WM da TCM.
Sun gano cewa lokacin da ake bukata a koma jiki a cikin WM+TCM ya kasance ƙasa da lokacin da ake bukata a koma jiki a cikin WM+TCM kawai.
Mafi tasiri, yawan rashin lafiyar cutar ta WM+TCM (mai tsanani zuwa mai tsanani) ya kasance ƙasa da yawa (7.4% vs. 46.2%) fiye da na WM kawai, kuma yawan mutuwa ya kasance ƙasa da na WM+TCM kawai (8.8% vs. 39%) fiye da na WM kawai.
Duk da haka, har yanzu ana jiran ƙarin gwaji mai kyau a cikin manyan cibiyoyi don inganci da aminci na TCM.
Hakanan zai zama da ban sha'awa a gano tsarin ayyuka da kuma bayyana ingantattun sassan TCM ko haɗuwa da su idan ya yiwu.
Masu cutar COVID-19 da ake zargi ko kuma suka tabbatar da su suna fuskantar tsoro mai yawa game da cutar mai yaduwa da kisa kuma waɗanda aka killace su ma suna fuskantar rashin tausayi, kadaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, rashin oxygenation da tari, da kuma illa ga magani kamar rashin barci da ake samu ta hanyar corticosteroids, na iya haifar da rashin jin daɗi da kuma ciwon zuciya.
A farkon barkewar cutar SARS, an ruwaito cututtukan tunani da dama, ciki har da ci gaba da damuwa, rashin jin daɗi, tashin hankali, tashin hankali, alamun tunani, kuka, har ma da kashe kansa.
Neman takamaiman lamba da killace mutane a matsayin wani ɓangare na amsawar lafiyar jama'a game da barkewar COVID-19 na iya sa mutane su kasance cikin nutsuwa da nutsuwa game da tasirin cutar taɓawa, killacewa da kuma lalata a kan iyalansu da abokansu.
Saboda haka, dole ne a samar da kulawar lafiyar kwakwalwa ga marasa lafiya da masu cutar COVID-19, da wadanda ake zargi da su da kuma wadanda suka shiga hulɗa da su, da kuma jama'a.
Tallafi na tunani ya kamata ya haɗa da kafa ƙungiyoyin kula da lafiyar hankali na fannoni da yawa, sadarwa mai kyau tare da ci gaba da ingantaccen sabuntawa game da barkewar cutar SARS-CoV-2 da kuma shirye-shiryen magani, da kuma amfani da na'urorin lantarki da aikace-aikacen ƙwararru don guje wa kusanci da juna.
Ana buƙatar allurar rigakafi mai tasiri don hana hanyar watsawa daga ƙwayoyin cuta da kuma masu ƙarancin ƙwayoyin cuta zuwa ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta daga mutane masu kamuwa da cutar kuma galibi suna ba da ƙarin maganin rigakafi don hana cutar ta zama sananne.
An yi ƙoƙari don haɓaka alluran rigakafi na S-protein don samar da rigakafi mai tsawo da ƙarfi ga SARS-CoV.
An tantance alluran rigakafi masu rai a cikin samfurin SARS.
Duk da haka, ingancin wadannan rigakafin a cikin tsofaffi da kuma masu ƙalubalen ƙalubalen haɗari da kuma kariya daga kamuwa da cutar cutar ta junotic na wadannan rigakafin rigakafi a cikin tsofaffi har yanzu ana buƙatar tantance su kafin a fara kowane binciken asibiti.
Wannan na iya kasancewa saboda SARS ta ƙare a hankali shekaru 17 da suka gabata kuma ba a sami sabon labari ba tun daga wannan lokacin.
Akasin haka, saboda kasancewar magungunan zoonotic a yankunan da ke fama da cutar, an ci gaba da samun karamin adadin mutane da kuma tarin MERS a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna.
An kirkiro dabarun rigakafin cutar ta MERS ta amfani da kwayoyin cutar marasa aiki, plasmids na DNA, vectors na kwayar cuta, nanoparticles, karamin kwayoyin cutar da kuma subunits na proteins masu sake haɗawa, wasu kuma an kimanta su a cikin samfurin dabba.
Samar da wani magani mai lafiya da inganci ga mutanen da ba su da rigakafi yana da matukar muhimmanci da kuma muhimmanci wajen sarrafa annobar.
Duk da haka, yana da wuya a shawo kan matsalar saboda dogon lokaci (watau watanni 18) da kuma motsin motsin CoVs a cikin samar da rigakafi.
A matsayin sabon cuta, COVID-19 kwanan nan ya fara bayyana dukkanin hanyoyin bincikensa a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya na iya warkewa a hankali ba tare da alamun wasu cututtuka ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da yawan kamuwa da cutar da mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, yana da mahimmanci ga hukumomin kiwon lafiya su kirkiro samfurin bincike don su fifita ayyukan su, musamman a yankunan da ke da iyakantaccen albarkatu.
Dangane da binciken asibiti da aka samu zuwa yanzu, waɗannan dalilai masu zuwa na iya shafar ko kuma suna da alaƙa da gano cutar a cikin marasa lafiya na COVID-19 (Table (Table 33):
Shekara: Shekara ita ce mafi muhimmanci wajen gano cutar SARS, kamar yadda yake a COVID-19.
A cikin binciken da aka yi na mutane 8,866 da suka kamu da cutar COVID-19 an gano cewa sun kasance tsakanin shekaru 30 zuwa 65, kuma 47.7% na marasa lafiya sun kasance sama da shekaru 50, kamar yadda aka bayyana a sama.
Marasa lafiya da ke bukatar kulawa mai zurfi sun fi fuskantar rashin lafiya da rikitarwa da ke tattare da su kuma sun fi tsufa fiye da waɗanda ba su da irin wannan buƙata (51 vs. 66 a matsakaiciyar shekaru), wanda ke nuna cewa shekaru suna da mahimmanci a matsayin abin da ke haifar da sakamakon sakamakon COVID-19 ga marasa lafiya.
Jima'i: Maza sun fi mata kamuwa da SARS-CoV-2 (0.31/100,000 vs. 0.27/100,000), kamar yadda aka ambata a sama.
Rashin lafiya da rikitarwa: Marasa lafiya da ke bukatar kulawa mai zurfi suna da mafi kusantar shan wahala daga mummunan rauni na zuciya da rashin lafiya.
Hakanan cututtukan zuciya sune manyan dalilan mutuwar marasa lafiya na SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya haɗuwa da collagenosites masu kyau na ACE2 wanda zai iya haifar da ciwon hanta a cikin marasa lafiya na COVID-19.
Yana da kyau a lura cewa shekaru da cututtukan da ke tattare da su suna da alaƙa sosai kuma suna iya tsoma baki da juna.
Binciken Lab na Musamman: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsanani na ciwo ko lalacewar ƙwayoyin halitta kuma an gabatar da shi a matsayin mai yiwuwa sanarwa ga cutar, amsa ga magani da kuma warkewa a ƙarshe.
An kuma gabatar da batun danganta matakan CRP da tsanani da kuma ganewar asali na COVID-19.
Bugu da ƙari, karuwar lactate hydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatinine kinase (CK) na iya taimakawa wajen kimanta sakamakon.
Wadannan enzymes suna bayyana a wurare da yawa a cikin gabobin jiki, musamman a zuciya da hanta, kuma suna samun 'yanci lokacin lalacewar nama.
Saboda haka, suna nuna alamun cututtukan zuciya ko hanta.
Babban alamun asibiti: Radiography na kirji da kuma ci gaban cututtukan asibiti tare da sauran matsaloli dole ne a yi la'akari da su don hango sakamakon COVID-19 da kuma rikitarwa.
Amfani da Steroids: Kamar yadda aka ambata a sama, masu ba da steroid suna da rigakafi waɗanda aka yi amfani da su a matsayin magungunan haɗin gwiwa a cikin cututtuka masu yaduwa don rage yawan lalacewar lalacewa.
Tun da aka yi amfani da karamin sashi na corticosteroid a cikin marasa lafiya masu fama da cutar SARS, mutane da yawa da suka tsira sun sha wahala daga rashin ƙarfi na rayuwa da rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroid a cikin ƙananan allurai da kuma gajeren lokaci a cikin marasa lafiya na COVID-19.
Rashin hankali: Kamar yadda aka ambata a sama, yawancin marasa lafiya sun sha wahala daga matsanancin damuwa yayin barkewar COVID-19, saboda sun jimre tsawon lokacin killacewa da matsanancin rashin tabbas kuma sun shaida mutuwar dangi da abokan marasa lafiya.
Yana da matukar muhimmanci a ba da shawara ta tunani da kuma goyon baya na dogon lokaci don taimakawa wadannan mutane su kwance daga damuwa da komawa ga rayuwarsu ta yau da kullun.
A cewar binciken ilimin kididdiga da aka yi zuwa yanzu, COVID-19 yana nuna halaye daban-daban na cutar daga SARS.
Baya ga yin kwayar cutar a cikin hanyar numfashi ta ƙasa, SARS-CoV-2 na iya yin kwayar cutar cikin hanyar numfashi ta sama yadda ya kamata kuma ba ya haifar da bayyanar cututtuka masu sauƙi ko babu alamun cutar a farkon matakin kamuwa da cutar kamar sauran CoVs da ke haifar da sanyi.
Saboda haka, marasa lafiya masu kamuwa da cutar na iya haifar da ƙalubale mai yawa a cikin sarrafa cutar tare da samar da ƙarancin adadin kwayar cutar yayin ayyukan yau da kullun a farkon matakin ko lokacin incuba.
Koyaya, an yi imanin cewa SARS-CoV ya kamu ne lokacin da marasa lafiya suka yi rashin lafiya sosai, yayin da yawancin watsawar ba su faru ba a farkon matakin.
Saboda haka, cutar COVID-19 ta yanzu ta fi ta SARS tsanani kuma ta fi wuya a sarrafa.
A halin yanzu, ana ci gaba da manyan ƙoƙari a China, gami da kulle-kulle a Wuhan da garuruwan da ke kusa da shi da kuma ci gaba da killace kusan dukkanin jama'a, da fatan hana yaduwar SARS-CoV-2.
Duk da cewa wadannan matakan suna lalata tattalin arziki da sauran yankunan kasar, adadin sabbin masu kamuwa da cutar yana raguwa, wanda ke nuna cewa annobar ta tashi.
Mafi kyawun hasashen shine cewa cutar za ta ƙare a ƙarshen Maris kuma matakin saukarwa zai ɗauki watanni 3-4.
Amma, wasu masana ba su da irin wannan tabbacin.
Paul Hunter, et al., ya yi hasashen cewa COVID-19 wanda ya fi SARS yawa, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., ta kafa samfurin don hango sakamakon annobar kuma ta nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Kungiyar Kanada ta ruwaito cewa an gano SARS-CoV-2 a cikin duka tsakiyar turbinate da kuma wuyan wuyan marasa lafiya da suka warke kuma suka bar asibiti makonni 2 da suka gabata wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama mai maimaitawa kamar cutar mura.
Duk da haka, kasar Sin ta samu alamun da za su ba da tabbaci dangane da ƙarancin adadin sabbin shari'o'i, wanda ke nuna cewa dabarun da ake amfani da su a yanzu suna iya aiki.
Da farko an yi hasashen cewa za a samu mutum miliyan daya da mutuwar Ebola da ta kai rabin miliyan.
Duk da haka, ta hanyar tsauraran matakan killacewa da keɓewa, an samu nasarar sarrafa cutar.
Kamar SARS-CoV, yana yiwuwa SARS-CoV-2 ya raunana cikin kamuwa da cuta kuma a ƙarshe ya ƙare ko ya zama ƙananan ƙwayoyin cuta masu haɗari tare da mutum.
Ga kwatancen COVID-19 da SARS da MERS (Hoto 55)
SARS-CoV-2 yana da matukar yaduwa ta hanyar tari ko cizon sauro da kuma wataƙila kai tsaye ta hanyar tuntuɓar kayan da suka kamu da cutar.
An gano cutar a cikin fitsari, wanda kuma ya haifar da sabon yiwuwar watsawa daga cikin fitsari zuwa bakin.
Wani binciken da aka yi kwanan nan na mutane 138 ya nuna cewa kashi 41 cikin 100 na mutane, ciki har da marasa lafiya 17 da suka riga sun kamu da wasu cututtuka da kuma masu ba da kulawa ta kiwon lafiya 40, sun kasance sakamakon kamuwa da cutar ta asibiti.
Saboda haka, dole ne a yi taka tsantsan sosai don kare mutane, musamman ma masu ba da kiwon lafiya, masu aikin zamantakewa, 'yan uwa, abokan aiki da kuma waɗanda ke kusa da su a cikin haɗuwa da marasa lafiya ko waɗanda ke da cutar.
Launi na farko na kariya da za a iya amfani da shi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska; amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (series # 1860s) yana taimakawa wajen sarrafa yaduwar cutar.
Masks na fuska na tiyata suna hana saukad da ruwa daga wanda ke da cutar daga iska ko mannewa a saman abubuwa, daga inda zasu iya shiga wasu.
Duk da haka, tare da kawai 5% na virions da za a iya wucewa gaba ɗaya, kawai N95 (series # 1860s) masks ne kawai za su iya hana ƙananan virions daga 10 zuwa 80 nm daga numfashi; SARS-CoV-2 yana kama da SARS-CoV a cikin girman kuma duka suna da kusan 85 nm.
Tun da ƙwayoyin za su iya wucewa da masks biyar na tiyata da aka sanya a saman ɗaya, masu ba da kula da lafiya da ke da kai tsaye tare da marasa lafiya dole ne su sa masks na N95 (series # 1860s), ba masks na tiyata ba.
Baya ga abin rufe fuska, masu ba da kiwon lafiya ya kamata su sa rigunan keɓewa da suka dace don rage haɗuwa da ƙwayoyin cuta.
Kwayar cutar na iya kamuwa da mutum ta hanyar idanunsa.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2, duk da cewa ya sa abin rufe fuska na N95; yana yiwuwa cutar ta shiga cikin jiki ta idanunsa masu sa ido.
Saboda haka, masu ba da kulawa ta kiwon lafiya ya kamata su sa rigar fuska ko tabarau masu tsabta yayin aiki tare da marasa lafiya.
A yankunan da aka shafa ko kuma waɗanda za su iya shafawa, ana ba da shawarar da kowa ya wanke hannayensa da sabulu mai hana kamuwa da cuta fiye da yadda aka saba, ya yi ƙoƙari ya zauna a gida don yin zaman kansa, kuma ya iyakance haɗuwa da waɗanda suka kamu da cutar.
Ana ganin cewa mutum yana da nisa mai kyau na ƙafa uku don ya guje wa mai haƙuri.
Waɗannan ayyukan suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zo a matsayin sabon cutar ga ɗan adam, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, saboda kamanceceniya da SARS-CoV, ya kamata ya yi wa China babban hankali dangane da zurfin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙ
Duk da haka, har zuwa 19 ga Janairu, 2020, Daraktan Cibiyar Kula da Cututtuka ta Wuhan ya ta'azantar da 'yan ƙasa da cewa ƙarancin kamuwa da kwayar cutar Novel da iyakanceccen haifuwa daga mutum zuwa mutum kuma babu matsala a hana da iyakance cutar.
Wannan sakon ya sa jama 'a su daina jin tsoro, musamman ma a lokacin da dukan ƙasar ke shirin bikin bazara kuma lokaci ya yi da za a rage cutar zuwa ƙarami a Wuhan.
Hukumomin kula da cututtuka a kasar Sin na iya koyon darasi daga wannan kuma su yi gagarumin cigaba a nan gaba.
Misali, wadannan hukumomi dole ne su (1) yi taka tsantsan sosai yayin yin sanarwa ga jama'a saboda kowane kalma tana da mahimmanci ga 'yan ƙasa kuma tana iya canza ra'ayinsu da yanke shawara; (2) su kasance masu saurin fahimta da karɓa ga bayanan da ba a saba gani ba daga asibitoci maimakon jiran sanarwar yau da kullun daga likitoci ko hukumomi; (3) su kasance masu ƙuntatawa don iyakance yiwuwar annobar a farkon matakin maimakon ƙoƙarin ta'aziyya ga jama'a; da kuma (4) su fitar da ayyuka masu mahimmanci da inganci da yawa don haɓaka wayar da kan jama'a game da annobar, da kuma bincika da inganta tsarin amsawar jama'a lokaci-lokaci.
COVID-19 wanda aka samo asali ne daga kwayar cutar SARS-CoV-2 ya fara barkewa a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu a duk faɗin China da kuma wasu ƙasashe 50 a duniya a lokacin da nake rubutu.
Tun da yake cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, barkewar COVID-19 ta nuna cewa SARS na faruwa akai-akai.
Duk da haka, akwai wasu bambance -bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci don rage cutar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa da maza fiye da mata, kuma tsanani da mutuwar tsofaffi sun fi na matasa.
Yawan mutuwar SARS ya fi na COVID-19 girma (10.91% vs. 1.44%).
COVID-19 marasa lafiya suna watsa kwayar cutar koda kuwa ba su da alamun cutar yayin da marasa lafiya na SARS galibi suna yin hakan lokacin da suke da mummunan rashin lafiya, wanda ke haifar da wahalar iyakance yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana a sannu a sannu dalilin da yasa SARS-CoV-2 ke yaduwa da sauri da kuma yaduwa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mai ƙyama a cikin wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke za su iya sake samun cutar.
Wadannan binciken sun kara hadarin yaduwar cutar sosai.
Duk da irin wannan ci gaban da aka samu a bincike kan COVID-19, har yanzu akwai wasu manyan lamura da za a warware, wadanda su ne:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano kamanceceniya ta 96 cikin dari tsakanin SARS-CoV-2 da CoVs biyu kamar SARS-bat, har yanzu ba za mu iya kammala cewa SARS-CoV-2 ya fito ne daga bats ba.
Abinci na asali, ka yi tunanin wane nau'in dabba ne ya kasance matsakaici wajen watsa cutar daga gizo - ciki zuwa mutum?
Ba tare da gano amsar # 1 da # 2 ba, ba za mu iya dakatar da watsa shirye -shiryenmu yadda ya kamata ba kuma cutar za ta iya sake faruwa a kowane lokaci.
Ko da yake kwayoyin halittar kwayoyin halitta da gwaje -gwajen halittu sun nuna cewa SARS -CoV-2 yana da alaƙa da ACE2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin iska kuma ta sami canji na cututtuka?
Shin kwayar cutar tana ɗaure kwayoyin ACE2 a wasu gabobin jiki?
Idan ba a ba da amsoshin waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da magani mai inganci ba.
Har yaushe za a ci gaba da cutar?
Ta yaya kwayoyin cutar ke samo asali yayin da ake watsa su zuwa mutane?
Shin zai zama annoba ta duniya, ko kuma zai kasance a hankali kamar SARS ko kuma zai ci gaba da kasancewa a lokaci-lokaci kamar mura?
Wannan yana da muhimmanci, amma yana iya ɗaukar lokaci kafin a sami amsoshin tambayoyin da aka ambata a sama da kuma wasu.
Duk da haka, duk abin da ya faru, ba mu da wani zaɓi sai dai mu dakatar da annobar da sauri kuma mu dawo da rayuwarmu zuwa yanayin da ya dace.
Halitta ta asali na kwayar cutar korona
Ta hanyar canji da kuma daidaitawa, an samo asali a cikin dubban shekaru na coronavirus (CoVs) da kuma abubuwan da ke gina jiki (ciki har da mutane).
Kafin 2003, an san akwai mutum biyu masu cutar sankara (HCoVs) wadanda ke haifar da cutar sanyi.
Fashewar cutar SARS da MERS sun nuna mummunan hali da cutar HCoV ta haifar da mummunan yanayi.
Yunƙurin SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake kawo CoVs a fili kuma ya ba mu mamaki da ƙarancin kamuwa da cutar fiye da SARS-CoV 'yar'uwarta.
Cutar HCoV cuta ce ta dabbobi kuma fahimtar asalin dabbobi na HCoVs zai taimaka mana.
Yawancin HCoVs sun samo asali ne daga bats, wanda ba su da cutar.
Akwai kuma wasu bayanai game da abubuwan da ke cikin HCoVs.
Gano dabba yana da tasiri kai tsaye a cikin rigakafin cututtukan mutum.
Binciken hulɗar CoV-nutrient a cikin dabbobi na iya ba da mahimman bayanai game da kamuwa da cutar CoV a cikin mutane.
A cikin wannan bita, muna gabatar da wani bayyani na bayanan yanzu game da HCoVs bakwai, tare da mayar da hankali kan tarihin binciken da aka samo asali da kuma watsawa ta hanyar dabbobi.
Abu mai mahimmanci, muna kwatanta HCoVs daban -daban kuma muna ganin bambance -bambance daga yanayin ci gaban kwayoyin halitta da kuma sake tsara kwayoyin halitta.
Ana tattauna cutar COVID-19 a cikin wannan hangen nesa na cutar ta yanzu.
Bugu da kari, an kuma nuna bukatar sauya abinci mai gina jiki da kuma tasirin ci gaban cutar a kan yadda cutar take da tsanani.
Kwayoyin cutar Corona (CoVs) na cikin iyalin Coronaviridae wanda ya hada da kungiyoyin kwayar RNA masu dauke da inganci, masu dauke da cutar, wadanda ke da nau'i daya.
Ana kiran wadannan kwayoyin da suka ba da mafaka ga mafi girma a cikin kwayoyin RNA, masu nauyin 26 zuwa 32 kilobes, CoVs saboda yanayin da ke ƙarƙashin lantarki.
A tsarin tsarin, CoVs suna da nau'in kwayoyin halitta marasa sashi waɗanda suke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na genomes suna da manyan manyan manyan tsarin karantawa (ORF1a da ORF1b) waɗanda ke canzawa zuwa pp1a da pp1ab replicase polyproteins.
Ana ci gaba da sarrafa polyprotein don samar da furotin 16 da ba na tsari ba, wanda ake kira nsp1~16.
Sauran kwayoyin halitta suna da ORFs don furotin na tsarin, ciki har da spike (S), envelope (E), membrane (M) da nucleoproteins (N).
Hakanan ana sanya wasu furotin masu taimakawa na musamman ta hanyar tsarin zuriya daban -daban na CoVs.
Dangane da bambancin a cikin jerin sunadarai, CoV an rarraba shi zuwa ƙarni huɗu (Alpha-CoV, Beta-CoV, Gamma-CoV da Delta-CoV), daga cikinsu beta-CoVs ne mafi yawa a cikin ƙarni na HCoVs kuma an rarraba shi zuwa zuriya huɗu (A, B, C da D).
Shaidar ta nuna cewa bats da amphibians sune tushen asalin asalin alfanun alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune manyan kwayoyin gamma-CoVs da delta-CoVs.
A cikin dubban shekaru, CoVs sun ci gaba da shawo kan matsalolin jinsin kuma sun fito a matsayin wasu muhimman cututtukan mutum.
Har zuwa yau, an san mutum bakwai na CoVs (HCoVs).
Daga cikinsu akwai HCoV-229E da HCoV-NL63 alpha-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, mawuyacin cututtukan numfashi mai tsanani (SARS-CoV), Coronavirus na numfashi mai tsanani na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da saukin bayyanar cututtuka kamar sanyi da/ko asarar zuciya.
Akasin haka, SARS-CoV, MERS-CoV da sabon gano SARS-CoV-2, suna da matukar cutarwa, suna haifar da kamuwa da cutar ta hanyar hanyar numfashi mai tsanani a cikin marasa lafiya da yawa tare da haɗarin haɗari mai tsanani na numfashi (ARDS) da bayyanar hyperpneumatic.
An gano nau'in HCoV-229E na farko, B814, daga cikin hanci na marasa lafiya masu sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an tattara ƙarin bayani ta hanyar nazarin zurfi game da HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun da ke iyakance kansu.
A gaskiya ma, tun kafin barkewar cutar SARS, an yarda da shi sosai cewa kamuwa da cutar HCoVs ba ta da lahani.
Cutar SARS da ta barke a shekarar 2003 tare da mutuwar mutane sama da 8000 tare da kusan kashi 10 cikin dari na rashin lafiya, tana daya daga cikin cututtukan da suka fi halakarwa a tarihin zamani.
Shekaru goma bayan haka, cutar ta MERS ta haifar da annobar da ta ci gaba a yankin Larabawa, tare da yaduwar cutar a wasu wurare a duniya.
2019 Novel HCoV (2019-nCoV), wanda aka sake suna SARS-CoV-2, shine mai haifar da cutar ta cutar coronavirus 2019 (COVID-19) wanda ya haifar da mutuwar mutane 3,120 da kamuwa da cutar fiye da 91,000 a ranar 3 ga Maris, 2020.
An yi gargadi kuma duniya ta shirya don annobar SARS-CoV-2 mai zuwa.
Dukkanin HCoVs bakwai na asali ne daga dabbobi, daga bats, ratsan ko dabbobi.
Akwai shaidu da yawa da suka goyi bayan ci gaba na HCoVs daga bats, wanda ke nuna cewa ƙwayoyin cuta sun dace da su kuma ba su da cutarwa, amma suna nuna bambancin kwayoyin halitta sosai.
Cutar COVID-19 ta kawo manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da kuma dabi'a ga kasar Sin da kuma duniya.
Gano asalin dabbobi na HCoVs yana ba da tsari don fahimtar tarihin halitta, ƙarfin motsawa da abubuwan da ke tattare da lalata jinsuna.
Zai iya jagorantar ko kuma samar da wadatar da ke cikin SARS-CoV-2 don gano ko kuma samun damar samun kwayoyin halitta masu tasowa, masu matsakaici da masu haɓaka tare da tasiri mai mahimmanci a hana yaduwar gaba.
A cikin wannan bita, mun gabatar da wani bayani game da asalin dabbobi, watsawa tsakanin jinsuna da kuma kamuwa da cutar HCoVs.
Musamman, muna haskakawa da tattauna batun gama gari cewa kwayoyin halittar HCoVs ba su da cutarwa a cikin abubuwan da ke cikin ƙwayoyin halitta, amma suna zama masu cutarwa bayan watsa su cikin sabon abincin.
Za mu kuma sake nazarin yanayin ci gaban HCoV wanda ke haifar da karuwa a cikin kamuwa da cuta tare da rage yawan kamuwa da cuta.
A cikin wannan hangen nesa, ana kuma tattauna sakamakon barkewar cutar SARS-CoV-2 da ke gudana.
An gano cewa akwai cutar ta dabba tun daga ƙarshen shekarun 1930.
Kafin HCoV-229E, wanda aka fara warewa ta hanyar zubar da hanci na marasa lafiya masu kamuwa da cutar sanyi, an ware CoVs daban -daban daga dabbobi masu kamuwa da cutar, gami da turkey, beraye, shanu, alade, cats da karnuka.
An gano HCoVs bakwai a cikin shekarun da suka gabata.
Ga taƙaitaccen taƙaitaccen tarihin gano HCoV (Table 1) zai zama mai bayani da ilimi.
An fara gano nau'in HCoV-229E a shekara ta 1966 daga cikin masu shan numfashi da ke dauke da cutar ta sama, wanda daga baya ya dace da girma a cikin layukan tantanin halitta na huhu na WI-38.
A cikin marasa lafiya da ke dauke da cutar HCoV-229E, an lura da alamun sanyi, ciki har da ciwon kai, cizon sauro, rashin lafiya da kuma rashin jin daɗi a cikin 10 ~ 20% na lokuta, tare da zazzabi da tari.
Daga baya a 1967, an gano HCoV-OC43 ta hanyar yin amfani da kwayoyin halitta a kwakwalwar da ke shan madara.
HCoV-OC43 na kama da HCoV-229E wanda ba a iya ganewa da shi ba, wanda ba a iya ganewa da shi ba, wanda ba a iya ganewa da shi ba, wanda ba a iya ganewa da shi ba.
HCoV-229E da HCoV-OC43 sun bazu ko'ina cikin duniya kuma suna iya kamuwa da su a cikin hunturu tare da yanayin zafi.
Yawanci, ci gaban waɗannan ƙwayoyin biyu ba ya wuce mako guda, bayan haka ana samun rashin lafiya na kusan makonni 2.
A cewar wani binciken da aka gudanar da masu aikin sa kai na mutum, mutane masu lafiya da ke dauke da cutar HCoV-229E sun kamu da sanyi mai sauki.
Wasu marasa lafiya da ke da rashin ƙarfi suna da cututtukan ƙananan numfashi masu tsanani.
SARS wanda aka fi sani da cutar pneumonia atypical, shine cutar ta farko da aka rubuta sosai a tarihin ɗan adam wanda ya haifar da HCoV kuma abin da ya haifar da shi shine HCoV na uku da aka gano, SARS-CoV.
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
An samu kamuwa da cutar ta SARS a kasashe da nahiyoyi da dama, inda aka samu mutum 774 da suka mutu, inda aka samu mutum 8,096.
Baya ga wadanda suka fi yawaita, an kiyasta cewa, tare da tsawon ci gaba na kwanaki 4 zuwa 7 da kuma bayyanar cutar ta kwanaki 10 na cutar, ana iya samun karuwar kusan biyu na biyu saboda kowane hali.
Masu kamuwa da SARS-CoV suna fara nuna alamun ciwon tsoka, ciwon kai, zazzabi, rashin lafiya da sanyi, sannan kuma suna nuna wahalar numfashi, tari da kuma rikicewar numfashi a matsayin alamun bayyanar.
Lymphopenia, jarrabawar hanta da kuma karuwa na creatine kinase sune wasu cututtuka na yau da kullum da suka shafi dakin gwaje -gwaje na SARS.
Ana kuma lura da karuwar cutar ta iska, yaduwar kwayoyin epithelial da karuwar macrofaces a cikin marasa lafiya da SARS.
Kimanin kashi 20-30 cikin dari na marasa lafiya suna bukatar kulawa mai zurfi da kuma numfashi na inji.
Baya ga ƙananan hanyoyin numfashi, wasu gabobin ciki har da gastrointestinal tract, hanta da koda, wanda galibi yana da hadari tare da cytokine storm, na iya kamuwa da waɗannan mawuyacin hali, wanda zai iya zama mai haɗari ga marasa lafiya masu rashin ƙarfi.
An fara gano cutar ne ta hanyar nazarin huhu na wani mutum da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an yi kokari sosai wajen bincike kan cutar HCoV.
An ware HCoV-NL63 daga jariri mai wata bakwai a ƙarshen 2004 a Netherlands.
An gano cewa a farkon an samu yaduwar cutar a cikin yara, tsofaffi da marasa lafiya masu fama da cututtukan numfashi.
Cutar sanyi, Contagionitis, zazzabi, da bronchiolitis na kowa ne a cikin cututtuka da HCoV-NL63 ke haifar da su.
Wani bincike na daban ya bayyana cewa an gano wannan kwayar cutar daga hancin wani yaro mai watanni 8 da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, amma a gaskiya ya bazu ko'ina cikin duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7% na cututtukan numfashi na yau da kullun kuma yana da mafi muni a lokacin bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar ta hanyar hanawa, wanda ake kira croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi asibiti a Hong Kong da cutar huhu da bronchiolitis.
Baya ga cutar pneumonia da bronchiolitis da aka samu daga al'umma, an kuma bayyana cewa HCoV-HKU1 yana da alaƙa da mummunan cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 an gano shi a duk duniya yana haifar da cututtukan numfashi masu laushi.
Dukkanin HCoVs hudu na al'umma sun daidaita sosai a cikin mutane kuma suna da ƙarancin yiwuwar canzawa don haifar da cututtuka masu cutarwa, duk da cewa akwai haɗari daga dalilai da ba a sani ba kamar yadda ya faru a cikin wani ƙaramin hali na HCoV-NL63 mai guba, wanda kwanan nan ya haifar da mummunan kamuwa da cutar ta hanyar numfashi a China.
Yawanci, idan wadannan HCoVs sun sami damar watsa su yadda ya kamata kuma su ci gaba da kasancewa cikin mutane, su ma za su zama marasa guba ko masu cutarwa.
An fara gano cutar MERS-CoV a cikin huhu na wani mutum mai shekaru 60 a Saudiyya a shekarar 2012, wanda ya kamu da cutar huhu mai tsanani da kuma rashin aikin koda.
Inda mafi yawan shari'o'in da aka tabbatar da su daga dakin gwaje -gwaje suka fito ne daga Gabas ta Tsakiya, an ruwaito wasu lokuta da aka shigo da su daga kasashen Turai da Tunisia tare da wani yaduwar cutar ta biyu a cikin dangi na kusa.
Na biyu ya faru ne a Koriya ta Kudu a shekarar 2015 inda aka samu mutum 186 da suka kamu da cutar.
Maganin asibiti na MERS wanda ke nuna mummunan cutar huhu mai tsanani ya dace da SARS.
Ba kamar SARS ba, yawancin marasa lafiya da ke da MERS suna samun rashin lafiyar koda mai tsanani, wanda har yanzu ba a lura da shi a cikin MERS ba, a cikin cututtukan da ke faruwa daga HCoV.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun narkewa kamar tari da kumburi.
A ranar 14 ga Fabrairu, 2020, an samu karin lamuran gwaje-gwaje 2500 da aka tabbatar da cutar, tare da yawan mutuwar 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi hallaka mutane.
Daga tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin masu fama da cutar huhu da ke da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar lafiya ta duniya (WHO) ta bayyana barkewar cutar ta hanyar numfashi ta kasa da kasa da ke da matukar damuwa a duniya saboda SARS-CoV-2 kuma ta sanya sunan cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya tare da mutuwar marasa inganci na kashi 3.4%.
Abin lura, a Hubei China, yawan mutuwar mutane ya kai kashi 4.2 cikin dari, yayin da a wajen kasar ya kai kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, wanda ke bayyana a matsayin zazzabi, tari da wahalar numfashi.
Wasu marasa lafiya ma suna fama da cutar asphyxiation.
Nyonya yana daya daga cikin alamun bayyanar cututtuka mafi tsanani kuma yana iya zama mafi girma a matsayin mawuyacin yanayin numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda kamanceceniya na babban nucleotide na 82%, sun zo cikin rassan rassan daban-daban.
SARS-CoV-2 a bayyane yake ba shi da cutarwa, amma ya fi na SARS-CoV da MERS-CoV.
An samu rahoton marasa lafiya marasa alamun cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs shida, kuma aka lura da bambancin, akwai kamanceceniya da bambance -bambance masu ban sha'awa.
Na farko, tsawon lokacin kamuwa da cutar HCoV da kuma tsarin aiki suna da kama.
A wannan yanayin, SARS-CoV-2 ya bi al'amuran sauran HCoVs shida.
Na biyu, cutar ta COVID-19 tana da irin wannan tsanani da HCoVs (HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63) da aka samu daga al'umma hudu.
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye waɗanda galibi ana gani yayin kamuwa da HCoVs na al'umma, gami da wadanda ba na musamman ba, masu sauƙi ko ba tare da alamun bayyanar cututtuka ba.
A gefe guda kuma, ana iya ganin karamin karamin karamin karamin COVID-19 kamar yadda yake a cikin kamuwa da SARS-CoV, duk da cewa rabo ya dan kadan.
Na uku, ana ganin nau'ikan HCoVs da SARS-CoVs na biyu da aka samu daga al'umma a cikin watsa SARS-CoV-2.
A gefe guda, kamuwa da cutar SARS-CoV-2 ya fi kamuwa da cutar HCoVs da aka samu daga al'umma.
A gefe guda kuma, har yanzu ana bukatar a tabbatar da ko cutar SARS-CoV-2 ta ragu bayan ta wuce cikin mutane kamar yadda ta faru a SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurori na fata.
Ko SARS-CoV-2 yana da muhimmiyar rawa a cikin akalla wasu yanayi kamar SARS-CoV, ya kamata a bayyana ta hanyar nazarin gaba.
Yana da ban sha'awa sosai a ga ko SARS-CoV-2 zai iya yin aiki na yanayi kamar yadda HCoVs da aka samu daga al'umma ke yi.
Duk da haka, halaye na SARS-CoV-2 wanda ya hada da kamuwa da cuta, kamuwa da cuta da kuma ci gaba da yaduwa bayan ya shiga cikin mutane zai kasance da tasiri a sakamakon ƙarshe na barkewar COVID-19.
HCoVs da aka samu daga dukkanin al'ummomi huɗu da ke haifar da bayyanar cututtuka masu sauƙi sun daidaita sosai a cikin mutane.
Daga wani ra'ayi, zai iya zama gaskiya cewa mutane sun dace da HCoVs guda hudu.
A wasu kalmomin, dukansu na iya tsira daga cutar HCoV ta dā.
An kawar da HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma waɗanda ke haifar da cututtuka masu tsanani na HCoV.
Don yin hakan, adadi na gyaran gyare - gyare masu hana abubuwan hana abinci mai gina jiki dole ne su yi kwafin HCoVs a cikin mutane zuwa iyakar isa.
A wannan ma'anar, idan SARS-CoV-2 ya ci gaba da yaduwa kuma ya kamu da mutane da yawa, zai iya zama mafi kusantar daidaitawa ga mutane.
Idan aka daidaita shi da kyau, zai yi wuya a hana shi watsawa cikin mutane ta hanyar killacewa ko wasu matakan hana kamuwa da cuta.
A cikin shekaru da dama, CoVs hudu da aka samu daga al'umma suna yadawa cikin al'ummar mutane, suna haifar da sanyi a cikin marasa lafiya marasa ƙarfi.
Wadannan kwayoyin ba sa bukatar dabbobi.
Akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su da kyau a cikin mutane kuma ba za a iya ci gaba da watsa su cikin mutane ba.
Suna bukatar su zauna a cikin aljihunsu kuma su yada su kuma su nemi damar da za su iya samun damar watsa su zuwa ga mutane masu karɓar su ta hanyar ɗaya ko fiye na masu matsakaici da kuma girma.
Halayen SARS-CoV-2 sun yi kama da HCoVs na SARS-CoV/MERS-CoV da kuma HCoVs na Hudu.
Aƙalla a halin yanzu yana da matukar yaduwa kamar HCoVs da aka samo daga al'umma.
Duk da haka, yana da cutar fiye da HCoVs da aka samu daga al'umma kuma yana da cutar ƙasa da SARS-CoV ko MERS-CoV.
Har yanzu dai, za a ga ko za a iya daidaita shi sosai a cikin mutane kuma a watsa shi cikin mutane ba tare da wata ƙuƙwalwa ko kuma wani abu na dabba ba.
Kafin mu tattauna asalin dabbobi na HCoVs, zai taimaka mana sosai mu tattauna ma'anar da kuma halaye na HCoVs na ci gaba, halitta, ƙwayoyin cuta, masu matsakaici da masu haɓaka.
Wani dabba yana da abinci mai gina jiki na HCoV mai ci gaba idan ya ba da mafaka ga wani babban asalinsa tare da babban kamanceceniya a matakin jerin nucleotides.
Kwayar cutar ta asali tana da kyau sosai kuma ba ta da cutarwa a cikin wannan abincin.
Hakazalika, masu gina jiki na HCoV suna ba da mafaka na dogon lokaci.
A cikin duka biyun, abinci yana kamuwa da cutar ta halitta kuma yana da abinci na halitta na HCoV ko kuma asalinsa.
Akasin haka, idan HCoV ya shiga wani sabon abu na matsakaici kafin ko kusa da shi kafin ya shiga cikin mutane, ba zai dace da sabon abu ba kuma zai zama mai cutarwa.
Wannan abincin na tsakiya na iya zama tushen dabba na kamuwa da cutar mutum kuma yana iya zama mai haɓaka abinci ta hanyar barin kwayar cutar ta sake yin kwayar cutar ta ɗan lokaci sannan kuma ta hanyar watsa ta cikin mutum don haɓaka matakin kamuwa da cutar.
Idan HCoV bai iya yin watsawa a cikin abincin tsaka - tsaka ba, zai iya shiga cikin kamuwa da cutar ta ƙarshe.
A gefe guda kuma, HCoVs na iya daidaitawa ga abincin tsaka-tsaki kuma su ci gaba da kasancewa a cikin gida na dogon lokaci.
A wannan yanayin, abincin da ke tsakanin ya zama abincin da ke cikin ƙwayar halitta.
Bayanai na ilimin cututtuka sun nuna cewa alamar SARS na da tarihin hulɗa da dabbobi masu wasa.
Binciken da aka yi na Seroprevalence ya nuna cewa, masu sayar da dabbobi sun fi yawan mutanen da ke da cutar IgG na SARS-CoV fiye da jama'a.
A cikin kasuwannin dabbobi masu rai, an gano masked palm squirrel (Paguama larvae) da rakun kare a matsayin masu jigilar kwayoyin cutar kamar SARS-CoV waɗanda suka yi kama da SARS-CoV.
Wannan ya goyi bayan gaskiyar cewa ba a sake samun rahoton SARS ba bayan an kashe dukkan kayayyakin da aka samu a kasuwa.
Koyaya, an ruwaito cewa mafi yawan maskarar dabbar dabba ta daji ko gona da ba ta haɗuwa da kasuwannin dabbobi ba, sun kasance masu cutar SARS-CoV, wanda ke nuna cewa maskarar dabba ta dabba na iya zama mai tsanani ne kawai a matsayin mai haɓaka abinci mai gina jiki ba a matsayin mai haɓaka halitta na SARS-CoV ba.
Abin lura, tun da kashi 80% na kasuwannin Guangzhou ke da rigakafin SARS-CoV a cikin dabbobi daban-daban, ba za a iya musun yiwuwar cewa wasu nau'ikan ƙananan dabbobi masu shayarwa na iya zama masu haɓaka abinci mai gina jiki na SARS-CoV ba.
Dukkanin waɗannan sun zama abincin ƙarshe na SARS-CoV.
Binciken da aka yi na bin diddigin abinci na dabbobi na SARS-CoV ya nuna wani nau'in cutar CoV mai suna SARS-Rh-BatCoV HKU3, wanda ke da alaƙa da SARS-Rh-BatCoV HKU3, wanda ake samu a cikin fararen fata na Horseshoe.
Wadannan bats suna da kyau ga rigakafin SARS-CoV da kuma tsarin genomic na SARSr-Rh-BatCoV HKU3.
Wadannan da sauran CoVs na Bats suna da kamanceceniya tsakanin kashi 88-92% na nucleotide da SARS-CoV.
Waɗannan binciken sun kafa sabon ra'ayi cewa bats suna da wadatar cututtukan mutum da ke fitowa.
An gano wasu SARS kamar CoVs (SL-CoVs) a cikin bats amma ba a gano wani a matsayin mai rai ba sai WIV1.
An san mutum angiotensin mai canza enzyme 2 (ACE2) a matsayin mai karɓar SARS-CoV.
An nuna WIV1 daga samfurori na fata na fata don amfani da fata, seawater da mutum ACE2 a matsayin mai amfani don shigar da kwayar halitta.
Abin sha'awa, ƙwayar cutar SARS ta warke ta iya kashe WIV1.
Ya zuwa yanzu, WIV1 shine mafi kusantar asalin SARS-CoV a cikin bats, yana da daidaituwa na 95% na nucleotide.
Duk da irin kamanceceniya da ke tsakanin wadannan kwayoyin, ana ganin cewa WIV1 ba shine mafi kusantar cutar SARS-CoV ba kuma bats ba su da mafi kusantar cutar SARS-CoV.
Binciken jinsi ya sanya MERS-CoV cikin rukuni iri ɗaya na CoV-HKU4 da CoV-HKU5 na Bats.
Bats suna amfani da abu daya mai gina jiki, Dippeptidyl peptidase 4 (DPP4) don shigar da cutar CoV-HKU4 da MERS-CoV.
RNA polymerase sequences na RNA na MERS-CoV sun kasance kusa da na bat-beta-CoV da aka gano a Turai da Afirka.
Har yanzu, babu wani MERS-CoV mai rai da aka gano a cikin daji.
MERS-CoV da kuma mafi kusantarsa CoV-HKU25 suna da daidaituwa ta nucleotide ta kashi 87 cikin 100 kawai.
Saboda haka, bats bazai iya zama mafi kusantar ƙwayoyin cuta na MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa kamar yadda yake a kan raƙuman da ke Gabas ta Tsakiya a ƙasashen Afirka da dama, raƙuman da ke da ƙuƙwalwa suna da ƙwayar cutar ta MERS-CoV.
An gano MERS-CoV mai rai, kamar wanda aka samu a cikin mutane, daga hancin kamel mai kumburi, wanda ya nuna cewa kamel yana da ingantaccen abinci mai gina jiki na MERS-CoV.
Yana da mahimmanci kuma cewa raƙuman da aka kamu da su da cutar MERS-CoV a cikin gwaji sun sami ƙwayar cutar da ke da ƙananan alamomi amma da yawa.
Abin lura, raƙuman da ke da cutar ba kawai suna fitar da ƙwayoyin cuta ta hanyar numfashi ba, har ma da hanyar da ke cikin fitsari, wanda shine babban hanyar fitar da ƙwayoyin cuta daga bats.
Duk da haka, tambayoyi har yanzu suna tasowa tunda babu tarihin hulɗa da raƙuma kafin bayyanar bayyanar cututtukan MERS, mai yiwuwa saboda hanyar watsawa daga mutum zuwa mutum ko kuma hanyar watsawa da ba a sani ba wanda ya haɗa da nau'in dabbobi da ke ba da mafaka ga MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na nucleotide kama da CoV RaTG13 daga bats da aka ware daga Rhinofus.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya isa ya tabbatar da alaƙar zuriya.
Wannan yana nufin cewa, bats ba za su iya zama mafi kusanci ga SARS-CoV-2 ba har sai an gano CoVs iri ɗaya na bats a nan gaba.
Wataƙila, masu ciyar da dabbobi na SARS-CoV-2 na Hunan sun kasance daga cikin namomin kaza da aka sayar da su a cikin kasuwar sayar da kayan abincin teku wanda ya danganta da yawancin farkon shari'o'in COVID-19 na alamar cutar ta mutum daga dabbobi masu yuwuwa.
Yawancin binciken da aka yi kwanan nan dangane da matasancin kwayoyin halitta sun nuna cewa, wata ƙungiya ta ƙananan dabbobi masu tasowa masu haɗari da ake kira pangolin (man Javanika) na iya zama mafaka ga SARS-CoV-2 da ke da nasaba da beta-CoVs.
Waɗannan sun yi daidai da kashi 85 zuwa 92% na nucleotide sequence tare da sabon bangolin CoV genome SARS-CoV-2.
Duk da haka, suna da alaƙa da RaTG13 kamar yadda suke da kusan 90% a matakin jerin nucleotides.
Yana cikin sub-descriptions biyu na SARS-CoV-2 iri ɗaya a cikin zuriyar zuriya wanda ɗayan yana da wani yanki mai ɗaurewa (RBD) wanda ya fi kama da SARS-CoV-2 tare da 97.4% amino acid sequence resemblance.
Akasin haka, RBD na SARS-CoV-2 da RaTG13 sun bambanta sosai duk da cewa suna da kamanceceniya da yawa a cikin kwayoyin halitta.
Wani binciken da aka yi a baya na cutar pangolin ya kuma ba da rahoton gano wani rukuni na kwayar cutar ta DNA daga samfurori na huhu, wanda ya yi daidai da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban -daban da kuma sarrafawa ta hannu don samar da jerin kwayoyin halitta masu sashi tare da cikakken tsawon kwayoyin halitta na 86.3%.
Ba za mu iya musun yiwuwar cewa pangolin yana cikin masu ciyar da dabbobi na SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa asalin Pangolin kai tsaye na SARS-CoV-2 saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da pangolin SARS-CoV-2.
Bugu da kari, nisan dake tsakanin SARS-CoV-2 da RaTG13 ya fi na SARS-CoV-2 da kuma bangolin SARS-CoV-2 da suka shafi beta-CoVs.
Har yanzu ba a kafa hanyar ci gaba da SARS-CoV-2 ba a cikin bats, pangolins da sauran masu shayarwa.
Inda aka sami mafi yawan kamanceceniya tsakanin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2 da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da mafi yawan kamanceceniya tsakanin genomes.
Yana da matukar zato cewa babban kamance tsakanin beta-CoVs masu alaƙa da pangolin SARS-CoV-2 da RBDs na SARS-CoV-2 ya haifar da ci gaba mai tsaka-tsaki na zaɓin.
Wani takaddama na daban na goyon bayan sake haɗuwa tsakanin beta-CoV da RaTG13 da ke da alaƙa da pangolin SARS-CoV-2 a cikin nau'in daji na uku.
A matsayin mai motsawa ga ci gaba mai zuwa, sake haɗuwa yana da yawa a cikin beta-CoVs.
Har yanzu ba a san asalin dabba mafi kusa na SARS-CoV-2 ba.
Baya ga HCoVs masu cutarwa, an kuma yi nazarin asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar jinsi ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga CoVs na bats, yayin da an gano HCoV-OC43 da HCoV-HKU1 a cikin mutants.
An ruwaito cewa an lura da kusanci da HCoV-NL63 na CoV na kwayar cutar ARCoV.2 (Applachen Ridge CoV) da aka samu a cikin kwayar cutar ta uku ta Arewacin Amurka.
A gefe guda kuma, HCoV-229E ya danganta da wani kwayar cutar CoV mai suna Hipposideros/GhanaKwam/19/2008, wanda aka samo a Ghana, kodayake camellid ma shine abin da ake zargi da shi.
Don bayyanawa, an taƙaita bayanin da ake samu a yanzu game da asalin dabbobi na sanannun HCoVs a cikin hoto na 1 da kuma tebur na 2.
Nazarin jinsi ya tabbatar da cewa HCoVs sun kasance suna yaduwa a cikin al'ummomi.
Lokacin da HCoV-OC43 ya wuce jinsuna daga dabbobi zuwa mutane a kusa da 1890, an ga annobar kamuwa da cutar numfashi.
Tarihin watsa HCoV-229E a tsakanin jinsuna bai bayyana ba.
An gano Alpha-CoVs na Bats a cikin kusanci da HCoV-229E.
Daga cikinsu akwai Alpha-CoV.
Akwai shaidu da yawa da suka nuna cewa cutar ta kamu da mutane kai tsaye daga kwayar cutar.
Da farko, ba mutane ba ne suka fuskanci bats a cikin yanayin da Alpaca ke rayuwa.
Maimakon haka, mutane suna da dangantaka ta kusa da alpaca.
Na biyu, bats masu alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin bats Alpha-CoV, yayin da Alpaca Alpha-CoV ya haifar da barkewar cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano Alpha-CoV a cikin namun daji ba.
Saboda haka, ba za a iya musun yiwuwar cewa alpacas suna karɓar HCoV-229E-related alpha-CoV daga mutane ba.
A gaskiya, cutar rabies da Ebola da Nipah da kuma cutar Hendra sune ainihin tushen cututtukan mutum.
Saboda haka ba abin mamaki ba ne cewa bats za su iya watsa HCoV-229E kai tsaye zuwa ga mutane.
A madadin haka, inda bats suke da gene pool na alpha-CoVs HCoV-229E, alpacas da raƙuma masu ƙuƙwalwa na iya zama masu matsakaici masu ciyarwa waɗanda ke watsa ƙwayoyin cuta zuwa mutane, kamar yadda lamarin MERS-CoV yake.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga fararen fata zuwa fararen fata da kuma daga fararen fata zuwa mutum.
An san ci gaban MERS-CoV daga bats a farkon ganowa kuma an ƙarfafa shi ta hanyar binciken da aka samu.
A bayyane yake cewa bats suna samar da wadataccen nau'in nau'in kwayar cutar don musayar kwayoyin halitta da kuma watsa su.
Tsawon shekaru, yawan mazauna, kusanci da zamantakewar jama'a da kuma karfin tashi duk sun dace da yanayin da ake bukata don batura su zama masu yada kwayar cutar.
A gefe guda kuma, cutar MERS-CoV ta shiga cikin raƙuman raƙuman tumaki na shekaru da yawa.
Ya yi aiki sosai a cikin waɗannan raƙuman da suka canza daga abinci mai gina jiki na matsakaici zuwa abinci mai gina jiki na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan canjin canji a cikin waɗannan dabbobi.
Wannan cutar tana da haɗari a cikin mutane kuma mutane sun kasance abincin ƙarshe na MERS-CoV saboda ba za a iya ci gaba da watsa ta ba.
Ba kamar yadda raƙuman ke yi wajen watsa cutar MERS-CoV ba, bangolin yana da matsayi daban-daban wajen watsa SARS-CoV-2.
Musamman, pangolin beta-CoVs suna da matukar cutarwa a cikin pangolin.
Suna iya zama abincin ƙarshe na beta-CoVs masu alaƙa da SARS-CoV-2 kamar yadda suke a cikin yanayin SARS-CoV.
Akwai yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane da yawa da za a yarda da su ko kuma a ƙi su a cikin nazarin da za a yi a nan gaba.
Na farko, bats na iya zama masu gina jiki ga kwayar cutar SARS-CoV-2 kamar SARS-CoV-2.
Mutane za su iya raba gidaje na muhalli tare da bats ta hanyar kashewa ko kuma yin hakar ma'adinai.
Na biyu, pangolin na iya kasancewa daga cikin abubuwan da ke kara yawan abincin da SARS-CoV-2 ke ciki.
Mutane suna kamuwa da cutar ta hanyar kashewa da cin nama.
Yana yiwuwa cewa dabbobi masu shayarwa da dama, ciki har da dabbobi masu gida, za su iya kamuwa da SARS-CoV-2.
Ana buƙatar binciken rigakafi a cikin gida da kuma cikin daji.
Na uku, kamar yadda aka ambata a sama, SARS-CoV-2 na iya sake haɗuwa da daidaitawa a cikin nau'in na uku wanda ya yi hulɗa da bats da pangolin.
Har yanzu ana binciken asalin dabba na SARS-CoV-2.
Baya ga nau'ikan abinci na dabbobi, manyan abubuwa uku masu mahimmanci game da cutar suna da mahimmanci wajen sauƙaƙe ƙetare nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'
Na farko, suna da yawan canjin da ya fi girma a cikin RNA.
Idan aka kwatanta da sauran kwayoyin RNA guda ɗaya, ana iya ganin ƙimar canjin CoV mai matsakaici zuwa mafi girma, tare da matsakaiciyar canji na ~ 10-4 sauyawa a kowace shekara zuwa 2 a kowace wuri, dangane da matakin daidaitawar CoV a cikin sabbin abinci.
CoVs suna dauke da exoribonucleases masu karantawa, wanda lalacewa na iya haifar da matsananciyar canji da lalata ko kuma rage rayuwarsu.
Abin sha'awa, ana ganin cewa remdesivir, analog na nucleotide, yana hana kwayar cutar ta CoV ta hanyar wannan exoribonuclease da RNA-based RNA polymerization.
Remdesivir yana daya daga cikin mafi kyawun wakilai masu tsayayya da SARS-CoV-2 da aka bincika a cikin gwajin asibiti.
Duk da haka, yawan canjin CoVs ya ninka na abinci mai gina jiki sau miliyan daya.
Bugu da ƙari, yawan canjin canji yana da yawa idan ba a daidaita CoVs da kyau ga abincin ba.
Idan aka kwatanta da SARS-CoV tare da babban canjin canji, SARS-CoV-2 yana da ƙananan canji, wanda ke nuna babban matakin daidaitawa a cikin mutane.
Wataƙila, an riga an daidaita shi zuwa wani abinci mai gina jiki kusa da mutane.
Tare da SARS-CoV-2, wannan ya shafi MERS-CoV wanda ya dace sosai a cikin raƙuman raƙuman.
A ka'idar, ba shi yiwuwa cewa yaduwar kwayoyin halitta za su sa rigakafi da maganin rigakafi da SARS-CoV-2 su daina aiki da sauri.
Na biyu, RNA mai girma a cikin CoV yana sanya ƙarin filastik a kan canjin genome don canjin da sake haɗuwa, yana ƙara yiwuwar ci gaban haɗin kai na cikin jinsuna, wanda ke da fa'ida ga fitowar sabon CoVs idan yanayi ya dace.
Wannan yana da goyan bayan tsarin budewa na musamman da kuma ayyukan furotin da aka yi wa lamba a ƙarshen 3 na genome.
Na uku, CoVs suna canza samfurin su ta hanyar bazuwar a cikin kwafin RNA ta hanyar hanyar zaɓin kwafin kwafin.
A cikin abincin da ke aiki a matsayin mahaɗan haɗuwa, sauye -sauyen fiber yakan faru ne a lokacin rubutun CoV RNA.
RNA mai tsawonsa iri daya da kuma na subijinomi, za su iya sake haɗuwa su samar da sabon CoVs.
An gano shaidar jinsi na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43 da kuma CoVs na dabba kamar bats SL-CoV da bats CoV-HKU9.
Hadin gwiwar ƙwayar cuta-mai gina jiki dangane da watsawa
Baya ga abubuwan da aka ambata a sama, hulɗar da ke tsakanin kwayoyin cuta da abinci mai gina jiki, wani muhimmin abu ne da ke shafar watsawa ta cikin kwayoyin.
A nan, ana ganin sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda ya nuna shaidar zaɓin mai kyau a yayin abubuwan da ke faruwa na watsawa.
Dangane da kwatancen bincike na masu karɓa tsakanin mutane da kuma SARS-CoVs na teku, SARS-CoV an yi la'akari da shi yana daidaitawa cikin sauri a cikin abinci mai gina jiki daban-daban, musamman tare da canji akan RBD na S Protein.
A cikin wani nau'i na CoV, RBD yana hulɗa da ƙwayar ƙwayar cuta kuma yana zaɓa ta hanyar amsawar rigakafin abinci mai gina jiki tare da tsanani.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 akan sashi na S1 wanda ke haɗuwa da ɗan adam ACE2 da kuma abokan hulɗarsa don shiga cikin kwayar cutar.
RBD na SARS-CoV na iya gano masu karɓar ACE2 na dabbobi daban -daban, gami da bats, seawats, ratsan da kuma raccoon karnuka, wanda ke haifar da watsa kwayar cutar ta cikin gida.
A zahiri, an gano amino acid 6 kawai a cikin RBD daban da na mutum da na kwayar cuta, kuma 4 daga cikinsu suna cikin asalin da aka ɗaure da kwayar cuta don hulɗa da ACE2 mai kwakwalwa.
RBD na SARS-CoV na sewed yana dauke da mutations K479N da S487T wanda zai iya kara karfin hulɗar spike protein da mutum ACE2 grah.
A wasu kalmomi, waɗannan amino acid biyu na iya zama masu mahimmanci wajen daidaitawa ga kwayar cutar a cikin mutane.
Yana da mahimmanci cewa SARS-CoV-2 yana da ƙwayar halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S sun nuna cewa kamanceceniya na S na proteins tare da ACE2 na mutum na iya canzawa.
A gaskiya ma, binciken Cryo-EM ya nuna cewa an yi amfani da wannan ƙarin sau 10 zuwa 20 fiye da yadda aka yi amfani da su a tsakanin kwayoyin halitta na mutum ACE2 da SARS-CoV S.
Zai kuma zama da sha'awa a tantance ko za a buƙaci wani abokin tarayya don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 ma yana da alaƙa da ACE2, amma daga wani ɓangare na S.
Akwai wasu nau'ikan HCoVs da yawa, kamar aminopeptide N don HCoV-229E, da 9-O-acetylated silica acid don HCoV-OC43.
Hakanan zasu iya zama masu alhakin nasarar daidaita CoVs zuwa mutane bayan watsa su ta hanyar dabbobi daga abincin su.
Sakamakon watsa HCoVs a cikin kwayoyin halitta yana sarrafawa ta hanyar abubuwan da ke rage yawan abinci mai gina jiki da kuma abubuwan da ke hanawa, ban da kwayar halitta.
Bambancin waɗannan furotin na abinci mai gina jiki tsakanin mutane da kuma na halitta na HCoVs, kamar su bats, raƙuma da ƙwai da kuma flies na iya hana watsawa tsakanin jinsuna.
Don samun nasarar watsa HCoVs a cikin jinsuna, dole ne abubuwan da ke tattare da abinci mai gina jiki su kasance masu ƙuntatawa da kuma abubuwan da ke hana abinci mai gina jiki su koma baya.
A wannan yanayin, akwai sauran abubuwa da za a iya ganowa da kuma bayyana masu ƙayyadewar kwayoyin a wannan muhimmin yanki na hulɗar ƙwayar cuta.
Yin amfani da sabuwar fasahar CRISPR na iya kawo sakamako mai kyau ta hanyar bincike mai zurfi na kwayoyin halitta na SARS-CoV-2 da kuma abubuwan da ke hana su.
Tashin sabon HCoVs: Komawa zuwa asali
Bambancin bambamcin CoVs na samar da dama ga tashin sabbin HCoVs.
A wannan ma'anar, bats suna aiki ne a matsayin kwayoyin halitta na CoVs, HCoVs.
Bugu da ƙari, HCoV yana ci gaba ne saboda saurin canji da kuma sake haɗuwa ta hanyar kwayoyin halitta kuma yana aiki da matakai biyu masu mahimmanci a cikin wannan tsari.
Alal misali, ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙ
A cikin sinadarai masu taimakawa SARS-CoV, ORF8 an gano shi yana da mahimmanci wajen daidaitawa a cikin mutane, tun lokacin da aka ware ƙwayoyin cuta masu alaƙa da SARS-CoV, amma an gano su suna yin coding ga sinadarai masu yawa na ORF8.
An gano mutuwar nucleotide 29 na SARS-CoVs a cikin jinsunan da aka ware a farkon annobar mutum.
Wannan kawarwa tana karya ORF8 zuwa ORF8a da ORF8b kuma ana ganin shi mutation ne mai dacewa wanda ke inganta canzawar sel.
Bugu da kari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa da zuriyar alpha da gamma-CoVs, wanda ya gano adadi mai yawa na ƙananan yankunan sake haɗuwa a cikin RNA-based RNA polymerases.
An kuma gano wuraren sake haɗuwa a cikin sassan nsp9, mafi yawa nsp10, da nsp14.
Hakazalika, an lura cewa cutar ta MERS-CoV ta sami abubuwan da suka faru na sake haɗuwa tsakanin zuriya daban -daban, wanda ya faru a cikin raƙuman raƙuman ruwa a Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan da suka faru na sake haɗuwa a cikin sauran HCoVs, inda HCoVs ke sake haɗuwa da sauran CoVs na dabba a cikin kwayoyin halitta na su.
Ya kamata kuma a lura cewa zabin na wucin gadi na iya haifar da canje -canje marasa ganganci a cikin kwayoyin halitta na kwayar cuta, mai yiwuwa saboda ƙwayoyin cuta masu ƙuntatawa, kamar su tsarin rigakafin abinci mai gina jiki.
Misali na irin wannan tasirin shine asarar ORF4 mai tsawon rai a cikin nau'in HCoV-229E na asali saboda ɓacewar nucleotide biyu.
Duk da yake ana iya ganin ORF4 mara kyau a cikin ƙwayoyin cuta da na raƙumi masu alaƙa da HCoV-229E, Alpha-CoV yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da canji.
A ƙarshe amma ba mafi mahimmanci ba, ci gaban sabon HCoVs a hankali yana faruwa ne ta hanyar matsin lamba daga zaɓuɓɓuka a cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Ba a gano alamun bayyanar cututtuka ba ko kuma alamu masu sauƙi ne kawai lokacin da aka kamu da CoVs a bats wanda ke nuna daidaitawa tsakanin CoVs da bats.
Da alama bats sun daidaita sosai ga CoVs a tsarin da kuma jiki.
Alal misali, rashin inganci a cikin kunnawar amsa mai karfafawa a cikin bats yana rage cutar da CoVs ke haifarwa.
Bugu da ƙari, ana hana aikin halitta mai cutarwa a cikin bats saboda rage matakan bayyanawa na kwayoyin halitta masu cutarwa masu karɓar NKG2/CD94 da kuma daidaitaccen kwayar halitta mai mahimmanci na Kwayoyin Category I.
Bugu da kari, karuwar adadin kwayoyin oxygen (ROS) da ake samu daga ayyukan da ake samu na batsa na iya hana kwayar cutar CoV kuma yana shafar karatun shaida ta hanyar exoribonucleases, don haka yana ba da matsin lamba don samar da nau'in kwayar cutar mai cutarwa sosai a lokacin da ta shiga cikin sabon abinci mai gina jiki.
Hakanan za a iya samar da nau'ikan CoV masu cutarwa ta hanyar sake haɗuwa, wanda zai haifar da sabon furotin ko fasalin furotin don daidaitaccen abinci mai gina jiki.
Saboda haka, ba abin mamaki bane cewa a cikin shekaru biyu da suka gabata, an samu sabbin HCoVs guda uku.
CoVs ba su da cutarwa a cikin ƙwayoyin cuta kamar bats da camels ko kuma suna haifar da bayyanar cututtuka.
Suna yin kwafi da ƙarfi ba tare da nuna ƙarfin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Wannan shi ne asirin dalilin da ya sa ake ganin masu dauke da cutar marasa bayyanar cututtuka da kuma dalilin da ya sa mutane suke kamuwa da cutar mai tsanani.
Alamun cututtuka masu tsanani, galibi suna faruwa ne saboda amsawar rigakafi da kuma wuce gona da iri na cytokine, wanda idan ya fi ƙarfin amsawar rigakafi, zai haifar da mummunan lalacewar huhu.
A akasin haka, a cikin masu dauke da cutar marasa bayyanar cututtuka, maganin rigakafi ya bambanta da na CoV.
Hanyar da ta dace na hana rigakafin zai iya samun sakamako mai kyau a maganin SARS-CoV-2.
Maganin Interferon yana da ƙarfi musamman a cikin bats.
Saboda haka, gudanar da Interferon Type I a cikin mutane ya kamata ya zama mai amfani aƙalla a farkon matakin kamuwa da SARS-CoV-2.
Bugu da ƙari, NLRP3 inflamesum activation a bats yana da lahani.
Da wannan hujja, hana NLRP3 inflammasome tare da MCC950 na iya zama da amfani a cikin maganin COVID-19.
Yadawar SARS-CoV-2 ya bi wannan jigo na kowa wanda ya haifar da SARS-CoV da MERS-CoV.
Inda ake ganin 95% na nucleotide kamanceceniya na bats beta-CoV da SARS-CoV, akwai kuma 96% na nucleotide kamanceceniya na bats-CoV da SARS-CoV-2.
Duk da yake an ga seawats da sauran dabbobi suna ba da mafaka ga ƙwayoyin cuta kamar SARS-CoV a cikin kasuwanni, ba a gano mafi kusa ba na SARS-CoV-2 na matsakaici.
An gano ban mamaki irin su pangolin beta-CoVs daga SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗayan abubuwan abinci na tsaka-tsaki ko kuma bangolin beta-CoVs na iya ba da gudummawa ga ɓangarorin gene a cikin sigar ƙarshe ta SARS-CoV-2.
Duk da cewa tambayoyi sun kasance, babu wata hujja da ta nuna cewa SARS-CoV-2 ta kasance da gangan ko kuma ta hanyar mutum.
CoVs sun kasance cikin tattaunawa saboda barkewar cutar SARS-CoV-2.
Nazarin CoVs a cikin bats da sauran dabbobi ya kawo canji mai yawa a fahimtarmu game da ƙwayoyin dabbobi na HCoVs a cikin asali na dabbobi da kuma daidaitaccen watsawa.
Shaidar da ke bayyane ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sune asalin ƙuƙwalwa kuma ana watsa su zuwa mutane ta hanyar abubuwan abinci na tsaka - tsaka.
Ganin cewa kamuwa da SARS-CoV ya samo asali ne daga hulɗa tsakanin mutane da seawats a cikin kasuwanni, rufe kasuwannin ruwa da kashe seawats a can ya kamata ya kawo ƙarshen cutar SARS.
Saboda wannan dalili, dole ne a cire pangolin daga kasuwar taro don hana yaduwar dabbobi saboda gano wasu zuriya na pangolin beta-CoVs da ke kusa da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 yana watsawa ga mutane ta hanyar pangolin da sauran masu shayarwa kuma yadda za a bayyana shi a cikin binciken gaba.
A gefe guda kuma, cutar MERS-CoV ta shiga cikin raƙuman raƙuman tumaki na shekaru da yawa.
Wadannan raƙuman suna da mahimmanci ga hanyar sufuri ga mazauna yankin, kuma suna da babbar hanyar samun nama, madara, fata da kayayyakin ulu.
Suna da yawa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a yi watsi da dukkan raƙuman don sarrafa MERS ba kamar yadda aka yi a kasuwannin dabbobin daji na kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Ya kamata a dauki hanya mai zurfi don samar da alluran rigakafi masu tasiri ga camels akan MERS-CoV tare da sauran matakan hana kamuwa da cuta don hana barkewar cutar ta MERS.
Tun da ba mu iya kawar da wadannan ƙwayoyin ba, za a iya samun sababbin nau'ikan kwayoyin halitta don haifar da barkewar cutar.
CWs masu yawa suna yawo a cikin namun daji.
Musamman, CoVs na bats masu iyawar dabbobi sun bambanta sosai.
Yana yiwuwa a samu ci gaba da sake haɗuwa da waɗannan CoVs na dabbobi, don samar da sababbin CoVs waɗanda za su zama masu yaduwa da kuma / ko kisa ga mutane a nan gaba.
Don rage hulɗa tsakanin mutane da dabbobi, dole ne a yi watsi da al'adun cin dabbobi a wasu yankuna na China.
Tare da gwajin SARS, MERS da COVID-19, ya kamata a yi shiri da kuma tsara yadda za a amsa.
A gaskiya, yawancin ƙwayoyin cuta sun kasance a duniya na dogon lokaci.
Suna zama a cikin gidajensu na halitta har sai sun sami damar yin yaduwa.
Ko da yake bats suna da halaye da yawa da ke taimakawa wajen yaduwar ƙwayoyin cuta, idan aka koya wa mutane su guji bats za a iya rage yiwuwar mutane su sadu da su da sauran jinsunan daji.
Don samun kyakkyawar fahimtar yanayin halittu na CoVs da kuma abubuwan da ke cikin su, ana buƙatar ci gaba da saka idanu kan masu shayarwa wanda zai zama da amfani wajen hana yaduwar mutum daga dabbobi da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar ta dabbobi ita ce ta nisantar mutane daga yanayin rayuwar kwayoyin halitta na ƙwayoyin dabbobi.
Har yanzu akwai wasu sassan da suka ɓace daga cikin ƙwayar cutar SARS-CoV-2.
Na farko, idan bats suna watsa cutar SARS-CoV-2 zuwa pangolin, zai zama da ban sha'awa ganin a wace yanayi bats da pangolins zasu iya raba gidaje iri ɗaya.
Na biyu, idan bats suna taka rawa kai tsaye wajen watsawa, to, dole ne a tantance yadda mutane ke samun hulɗa da bats.
Na uku, idan akwai mai shayarwa na uku da ke aiki a matsayin ainihin abincin tsaka - tsaka, to ya kamata a bayyana yadda yake shafar jinsunan daban -daban, ciki har da mutane, bats da pangolins.
A ƙarshe, tun da yake dabbobi masu shayarwa da yawa, ciki har da dabbobi masu gida, na iya zama masu karɓa ga SARS-CoV-2, dole ne a yi bincike da gwaji na kamuwa da cutar.
Ko dai tsuntsaye ne, ko pangolin ko wani dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kuma wasu kwayoyin halitta masu kama da su za a gano su a cikin abubuwan da suke ciyarwa na halitta a nan gaba.
Ci gaba da bincike a wannan yanki zai bayyana hanyoyin ci gaba na SARS-CoV-2 a cikin dabbobi tare da mahimman tasiri a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Dole ne a sabunta ka'idodin asibiti na "masu zargin" da "masu tabbatar da" COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagororin saurin tuntuɓar don ganewa da kuma magance kamuwa da cutar Coronavirus (2019-nCoV) ta 2019 kuma wannan jagorar ta samar da ƙwarewarmu da kuma daidaitaccen mahallin don magance cutar a duniya.
Koyaya, cutar Coronavirus 2019 (COVID-19) sabuwar cuta ce, basirarmu da iliminmu suna ƙaruwa a hankali dangane da binciken bincike na yanzu da kuma kwarewar aikin asibiti; saboda haka, ana sabunta dabarun bincike da magani akai-akai.
A cikin wannan wasiƙar, mun amsa wata tsokaci kan jagororinmu kuma mun samar da sabbin ka'idodin asibiti na "masu sharhi" da "masu tabbatarwa" daidai da sabon jagororin bincike da magani na COVID-19 (haɓaka ta bakwai) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na 2019, an samu barkewar cutar Coronavirus (2019-nCoV) ta 2019 wanda yanzu aka sanya wa sunan cutar Coronavirus Disease 2019 (COVID-19) kuma an sanya wa cutar sunan cutar ta Coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don yaki da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawarwari masu sauri waɗanda aka buga akan layi a cikin Nazarin Likitanci na Soja a ranar 06 ga Fabrairu 2020.
Tun lokacin da aka buga shi, ya sami babban kulawa.
Duk da haka, lura cewa COVID-19 sabon cuta ne, basirarmu da iliminmu suna karuwa a hankali bisa ga binciken bincike na yanzu da kuma kwarewar aikin asibiti; saboda haka, ana sabunta dabarun bincike da magani akai-akai.
Misali, a total, an fitar da juzu'i bakwai tare da wasu canje -canje na asali a cikin wasu mahallin a cikin jagororin da Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin ya fitar don ganewa da magance COVID-19 (http://www.nhc.gov.cn/) tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020.
Yanzu da Zhou et al. suka yi tsokaci a kan jagorarmu, sun gabatar da wata sanarwa mai sauki dangane da kwarewarsu ta asibiti.
Ayyukansa sun kara sabbin hujjoji ga jagororinmu kuma sun ba da mahimman bayanai ga wannan annobar a duniya.
Muna goyon bayan muhimmin aikin da suka yi kuma muna gode musu.
Duk da haka, aikin su yana buƙatar sabuntawa daidai da sabuwar jagororin bincike da magani don COVID-19 (na bakwai na gwaji) da kuma binciken da aka yi kwanan nan.
A cewar bugu na bakwai (3 ga Maris, 2020), don gudanar da cikakken bincike don tabbatar da abin da ake zargi, ana buƙatar haɗa kowane abu na tarihin annobar tare da abubuwa biyu na maganganun asibiti, ko kuma cika abubuwa uku na maganganun asibiti idan babu tarihin annobar da aka bayyana:
Tarihin annobar: (1) Tarihin tafiya ko zama a Wuhan City da yankunan da ke kusa da shi, ko kuma wasu al'ummomin da aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin hulɗa da shari'o'in SARS-CoV-2 masu yaduwa (tare da gwajin kwayar nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya da ke da zazzabi ko alamun numfashi daga Wuhan City da kewaye da su, ko kuma wasu al'ummomin da aka ruwaito COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa da rukuni na mutane da aka tabbatar da cutar (ƙananan lokuta ≥ 2 na zazzabi da/ko alamun numfashi a cikin makonni 2 a cikin ƙananan yankuna kamar gida, ofis, aji na makaranta, da sauransu).
Bayanan asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da bayyanar cututtuka na COVID-19; (3) yawan adadin fararen kwayar jini yana nuna al'ada, raguwa ko raguwar lymphocytes a farkon farkon matakin.
Dole ne a tabbatar da wani abu da ake zargi da cutar ko kuma wani abu na shaidar cutar da ke tattare da: (1) gwajin PCR na ainihi na SARS-CoV-2 ya tabbata; (2) allurar kwayar cuta ta nuna babban daidaituwa da sanannun kwayar cuta na coronavirus; (3) gwajin jini na SARS-CoV-2 ya tabbatar da IgM mai hana cutar da IgG mai hana cutar; ko kuma SARS-CoV-2-mai hana cutar IgG ya canza daga mai hana cutar zuwa mai kyau, ko kuma ya kara lafiya sau 4 a lokacin gwaji fiye da a lokacin gwaji na gaggawa.
Mun ga cewa an kara gwajin PCR na ainihi don nucleic acid a cikin tsarin numfashi ko kuma a cikin samfurori na jini a cikin na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara da gano cututtukan jini a cikin na hudu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan an kara da shaidar cutar a cikin na bakwai.
Waɗannan canje -canje sun dogara ne akan aikin da masu bincike ke ci gaba da yi, wanda ke gano samfurori na tsarin numfashi, gami da samfurin nucleic acid mai kyau don ganewar asali mai sauri, da kuma samfurin jini, wanda ya haɓaka wadatar samfurori daban -daban, da kuma tallafawa kawo sakamako mai kyau na rigakafi zuwa ƙa'idodin tabbatarwa.
Bugu da ƙari, akwai shaidu da yawa da ke tunatar da mu mu yi hankali da marasa lafiya marasa alamun bayyanar cututtuka da na rashin lafiya.
Saboda haka, ya kamata a sabunta jadawalin kwararar Zhou et al. domin sun rarraba mutumin da ba shi da alamun asibiti a matsayin "ƙananan haɗari".
Ana buƙatar tabbatar da tsarin a cikin ƙarin gwaji da nazarin asibiti.
A ƙarshe, muna fatan cewa za a sami ƙarin hujjoji kai tsaye kuma mu gayyaci masu karatu su ba da ra'ayoyinsu.
Don gano "abubuwan da ake zargi" da "abubuwan da aka tabbatar", muna ba da shawarar gano da kuma bin sabon jagororin ƙasashen gida.
Har ila yau, ƙungiyarmu za ta sabunta jagororin ta lokaci - lokaci don ba da taimako.
An samu sabbin mutuwar mutum biyar daga COVID-19 a Bangladesh, wanda ya kasance mafi girma a cikin rana daya
Jiya, Bangladesh ta tabbatar da wasu mutuwar biyar daga COVID-19 a rana.
Wannan shi ne mafi yawan adadin mutuwar da aka samu a rana daya.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton adadin adadin mutane da suka kamu da cutar, wanda ya haɗa da mutane 114 da suka kamu da cutar da kuma mutane 33 da suka warke daga cutar yayin da suke gida.
A total an samu mutuwar mutane 17 a wannan lokacin.
A wani taron yada labarai na yanar gizo, Dokta Mirzadi Sabrina Flora, darektan IEDCR, ta bayyana cewa, maza hudu da mace daya sun mutu.
A cewar Dr. Mirzadi, biyu daga cikin marasa lafiya sun wuce shekaru 60, biyu daga cikin shekaru 51 zuwa 60 da kuma daya daga cikin shekaru 41 zuwa 50.
Ya kuma bayyana cewa, biyu daga cikin wadanda suka mutu sun kasance 'yan garin Dhaka.
Hukumar lafiya ta duniya (WHO) ta bayyana COVID-19 a matsayin annobar duniya a ranar 11 ga Maris.
Wani jami'in asibitin ya shaida wa wani gida da ke kula da labarai, Anadolu Agency cewa sunan wanda ya mutu shine Jalal Safur Rahman wanda shi ne darektan hukumar yaki da cin hanci da rashawa ta bangal, kuma ana kula da shi a asibitin Kuwait Matri.
A cikin sanarwar bidiyo ta yanar gizo a ranar Asabar, Ministan Sufuri da Sassan Hanyar Bangladesh, Ubaydul Qadar, ya bayyana cewa, za a dakatar da zirga -zirgar tituna har zuwa ranar Asabar mai zuwa fiye da yadda aka shirya.
Wannan dokar hana zirga -zirgar jama 'a ta fara ne a ranar 26 ga watan Maris kuma za ta kare ne a ranar Asabar, 4 ga watan Afrilu.
Ba a hana safarar kayayyakin kiwon lafiya, man fetur da abinci ba.
An samu farkon kamuwa da cutar COVID-19 a Bangladesh a cikin mutane biyu da matar daya daga cikinsu da suka dawo daga Italiya a ranar 8 ga Maris.
A ranar 19 ga watan Maris, dukansu uku sun warke.
An samu kamuwa da cutar SARS-CoV-2 a duniya fiye da miliyan daya
Bayanai daga Jami'ar Johns Hopkins sun nuna cewa a ranar Alhamis, jimlar adadin kamuwa da cutar SARS-CoV-2 a duniya ta zarce miliyan daya.
Ana danganta cutar COVID-19 da mutuwar mutane akalla 52,000.
A ranar da aka wuce wannan adadin, an samu rahoton kamuwa da cutar ta farko a Malawi da kuma mutuwar farko da aka samu a Zambia.
Koriya ta Arewa ta ce har zuwa ranar Alhamis ta kasance cikin wasu kasashe da har yanzu ba su da cutar korona.
Har zuwa jiya, WHO ta ba da rahoton 10,51,635 da aka tabbatar da cutar, gami da 79,332 da aka samu a cikin sa'o'i 24 kafin 10am (0800 UTC) na tsakiyar Turai a ranar 4 ga Afrilu.
An samu karin mutane miliyan biyu da dubu arba'in da hudu da suka kamu da cutar korona a Amurka, kuma hakan ya haifar da mutuwar mutane 5,900.
Labarin CBS News ya ruwaito cewa, a ranar Laraba, an samu mutuwar mutane sama da 1,000 a Amurka sakamakon kamuwa da cutar korona.
Kasashen duniya sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya kara dokar kulle a birnin har zuwa ranar 1 ga watan Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa har zuwa 30 ga Afrilu, Rasha za ta ci gaba da samun albashi ba tare da ta shiga aiki ba.
Majalisar dokokin Portugal ta amince da tsawaita dokar ta baci ta kasa har kwana 15; ta amince da wannan takarda da kuri'u 215, da 'yan majalisa goma suka kasance a wajen, kuma daya ya yi kuri'a a kan ta.
Saudiyya ta sanya dokar hana fita na tsawon sa'o'i 24 a cikin biranen Makka da Madina; kafin haka dokar hana fita ta kasance daga karfe 3 na rana zuwa 6 na safe.
Thailand ta shirya yin dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike Durain ya sanar da cewa an kara dokar zama a gida a jihar har zuwa 1 ga Mayu.
A Ostiraliya, shaguna sun rage yawan takardun wanka da za a iya saya a lokaci guda
A daren Lahadi da Asabar, shaguna na Australiya, Woolworths da Coles sun rage yawan takardun wanka da za a iya saya a duk shagunan su a duk faɗin ƙasar zuwa biyu da ɗaya, a jere.
ALDI ta kuma sanya dokar tanadi guda daya a ranar Litinin.
An sanya waɗannan iyakokin a matsayin saƙonni a shafukan rajista da kuma shafukan Facebook na jerin.
An ruwaito cewa masu siye suna yin siye tare don yanayin da ake buƙatar ware kansu saboda tsoron COVID-19.
A ranar Laraba, kamfanin Woolworths ya rage yawan sayen takardar wanka don isar da gida zuwa fakiti daya a kowane tsari.
Kafin wadannan canje -canje, Woolworths da Coles sun sanya dokar hana sayen kaya hudu a lokaci guda a ranar 4 da 5 ga Maris, bi da bi.
Coles ya bayyana a cikin sanarwarsa ta 8 ga Maris cewa duk da dokar hana amfani da kayayyakin hudu, har yanzu akwai kantuna da yawa da ke rasa kaya cikin awa daya bayan bayarwa, inda ALDI ta bayyana bukatar da ba a taba gani ba a wani shafin Facebook a ranar Talata.
Wani mai magana da yawun kamfanin Woolworths ya ce, tallace -tallace sun yi tashin hankali a makon da ya gabata.
Kayan Costco da ke Canberra ma sun rage adadin kayayyaki zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarni ga manyan masu samar da kayayyaki kuma ya ƙara yawan isar da kayayyaki. Woolworths ya ba da umarni na ƙarin jari, yayin da ALDI ta tattara jari don samar da ranar Laraba ta musamman da aka riga aka tsara.
Russell Zimmerman, shugaban zartarwa na kungiyar 'yan kasuwa ta Australiya, ya ce, "Ka yi kokarin kara yawan kayayyakin sayar da kaya, amma yana da wuya a yi hakan saboda takunkumin da majalisar yankin ta kafa a kan lokaci na isar da kaya.
A halin da ake ciki, yayin da masu samarwa ke kokarin biyan bukatar kuma adadin masu samar da kayayyaki na musamman ya ragu, ana sa ran Russell zai samu karin kudin samarwa.
A ranar Talata ALDI ta sanar da cewa bayan an saki hannun jari kafin lokaci, wasu shagunan ba za su iya gudanar da bikin ranar Laraba ba.
Wani rahoto daga News.com.au ya bayyana cewa, wani masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, Dakta Gary Mortimer, ya ce, shaguna suna cike da kayayyaki a kowace dare.
Ya ce, takardar bayan gida abu ne mai nauyi, saboda haka ba za a iya samun adadi mai yawa ba, sannan kuma, idan aka sayar da dukkan kayayyakin, sai a bar manyan ɗakunan ajiya a baya, wanda zai sa a ji ƙarancin kuma ya zama mai tsanani.
A cewar ABC News, Russell Zimmerman, Coles da Woolworths sun yi tunanin cewa idan an samu wadataccen kaya a kan shiryayye, kuma ana iya sayen kayayyaki kamar takarda ta gida da kuma masu tsabtace jiki, za a iya rage yawan damuwa.
Wanda ya kirkiro takardar bayan gida da aka sake amfani da ita, mai suna Who Gives a Crap, ya ce a ranar Laraba cewa ya rasa kayayyakin da ake amfani da su.
Kamar yadda News.com.au ta ruwaito, kamfanin Kinberly - Clark, mai samar da kayan wanka na Klynex, da kuma kamfanin Solaris Paper, masu samar da kayan wanka sun ce suna aiki 24/7 don ci gaba da samarwa.
Wani shafin yanar gizon Domain.com ya ruwaito cewa a Melbourne, inda ake yin ƙananan gwanjo fiye da dā saboda masu siye da suke yin hutu a ranar hutu ta ranar ma'aikata, wasu masu sayar da dukiya suna ba da takardar wanka kyauta ga masu neman farko a cikin gwanjo.
A ranar Alhamis na jaridar NT News, da Darwin ya wallafa, an saka shafi takwas a ciki don a yanke shi kuma a yi amfani da shi a matsayin takardar gidan wanka.
Wani rahoto na ABC Australia na 3 ga Maris ya nuna cewa, da farko, ba su son yin haramtacciyar sayayya ba; a cikin rahoton sun ce ba su da wani shiri na yin haramtacciyar sayayya.
Russell Zimmerman ya kara da cewa akwai bukatar kayayyaki da yawa, ciki har da masks, sanitizers, dryware, handwashes da kuma flour.
Hakazalika, a waje da Australia, an sanya iyakar fakitin 12 na takarda biyu a kan sayen takarda na toilet na Andres a cikin babban kanti na Burtaniya na Okado a ranar Lahadi da yamma.
Hukumar lafiya ta duniya ta bayyana COVID-19 a matsayin annobar duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana barkewar cutar COVID-19 a matsayin annobar duniya.
Ko da yake kalmar "matsananci" tana nufin kawai yadda cutar ta yadu, ba yadda hatsarin da take fuskanta ba, WHO ta tattauna bukatar ta motsa gwamnatoci su dauki mataki.
Dukkanin kasashe na iya canza hanyar wannan annobar ta duniya.
Idan kasar ta amsa, za ta gano cutar, ta bi da marasa lafiya, ta ware su, ta gano su, ta haɗa su, in ji Tedros Adnanom Gebrazis, Darakta Janar na WHO.
Muna matukar damuwa da matakan damuwa da kuma rashin aiki.
A cewar Dr. Tom Freuden, tsohon darektan cibiyoyin kula da cututtuka na Amurka, wannan annoba ce ta duniya.
A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce babu wani kwayar cutar numfashi da aka gano sai dai cutar mura ta hanyar ci gaba da yaduwar duniya.
Gabraysis ya bayyana irin wannan ra'ayi lokacin da ya ce, "Ba mu taɓa ganin annobar duniya ta haifar da cutar coronavirus ba.
Ya kara da cewa, "Kuma mun ga ba a taba ganin wata annoba ta duniya da za a iya sarrafa ta a lokaci guda ba.
Wannan sabon matsayin annobar ta duniya, an ba da shi ne bayan WHO ta yanke shawarar bayyana dokar ta baci ta kiwon lafiya ta duniya a cikin Janairu.
Dokta Anthony Fochi, shugaban cibiyar kula da cututtuka na cututtuka da cututtuka na Amurka, ya ce game da barkewar cutar, "Abin da ya fi muhimmanci shi ne, za ta kara muni".
A cewar Associated Press, a ranar Alhamis, a duniya akwai akalla shari'o'i 126,000 na COVID-19 kuma sun haifar da mutuwar sama da 4,600.
201920 Cutar Coronaviruses ta zama annoba mai gudana ta cutar Coronavirus Disease 2019 (COVID-19) wanda ya haifar da cutar ta Coronavirus ta 2019 (SARS-CoV-2) mai tsanani ta hanyar cutar ta numfashi mai tsanani.
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, wanda aka ayyana a matsayin dokar ta baci ta kiwon lafiya ta duniya a ranar 30 ga Janairu, 2020 kuma aka ayyana shi a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210 da yankuna, wanda ya haifar da kusan mutuwar 97,000.
Mutane kusan 364,000 sun warke.
A kasar Sin, an kiyasta mutuwar mutum da kashi 4 cikin dari, yayin da a duniya, ta kasance tsakanin kashi 13.04 cikin dari a Algeria da 0.08 cikin dari a New Zealand.
Alamun bayyanar cututtuka sun hada da zazzabi, tari da numfashi.
Abubuwan rikitarwa na iya haɗawa da cutar huhu da kuma rikicin numfashi mai tsanani.
Lokaci daga bayyanar cutar zuwa bayyanar cututtuka yana ɗaukar kimanin kwanaki biyar, amma zai iya ɗaukar kwanaki biyu zuwa goma sha huɗu.
Babu maganin rigakafi ko maganin riga - riga na musamman da aka sani.
Maganin farko shine magani na asali da taimako. Abubuwan da ake ba da shawara na rigakafi sun haɗa da: wanke hannu, rufe bakinka idan ka yi tari, nisantar da kai daga wasu mutane da kuma saka idanu da keɓe kai ga waɗanda ake zaton suna da cutar.
Hukumomi a duk faɗin duniya sun amsa ta hanyar aiwatar da takunkumin tafiye -tafiye, killacewa, dokar hana fita, kula da haɗarin aiki da kuma rufe wuraren aiki.
Wannan annobar ta haifar da mummunan rikici na zamantakewa da tattalin arziki a duniya, ta haifar da jinkirta ko soke ayyukan wasanni, addini, siyasa da al'adu, kuma mutane suna yin sayayya cikin firgita saboda raguwar wadatar kayayyaki.
Makarantun da jami'o'i a kasashe 193 sun rufe a kasa ko kuma a gida, wanda ya shafi kusan kashi 99.4 cikin dari na yawan daliban duniya.
Labaran karya game da cutar sun bazu a kan layi, kuma akwai rashin jin daɗin cin zarafi da nuna bambanci ga mutanen Sin, wasu mutanen da ke da asalin Asiya ta Gabas da Kudu maso Gabas da kuma wasu da ke da launi, da kuma wasu daga yankunan da suka fi yawan kamuwa da cutar.
Rashin tafiye -tafiye da kuma rufe masana'antu masu nauyi sun rage gurɓataccen iska da kuma fitar da carbon.
Hukumomin lafiya a Wuhan (babban birnin lardin Hubei) na kasar Sin sun bayar da rahoton karuwar cutar pneumonia a ranar 31 ga watan Disamba na shekarar 2019 da aka samu sanadiyyar wasu dalilai da ba a san su ba, kuma an fara bincike a farkon watan Janairu na shekarar 2020.
Yawancin cututtukan sun kasance da alaƙa da kasuwar sayar da kayan teku na Hunan kuma saboda haka ana ɗaukar cutar da asalin dabba.
An gano sabon kwayar cutar da ke haifar da barkewar cutar da ake kira SARS-CoV-2, wanda ke da alaƙa da kwayar cutar coronavirus, kwayar cutar pangolin da SARS-CoV. An gano cewa mutum na farko da aka sani da alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba a nuna alaƙa da wannan mutumin da ke cikin rukunin kasuwar nama na baya ba.
Kashi biyu bisa uku na farkon rukunin shari'o'in da aka ruwaito a watan Disamba na 2019 sun kasance suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris na shekarar 2020, wani rahoton da ba a tabbatar ba na South China Morning Post ya bayyana cewa, wani lamari ya faru ne da wani mutum mai shekaru 55 daga lardin Hubei a ranar 17 ga watan Nuwamba na shekarar 2019, wanda zai iya zama farkon lamari. A ranar 26 ga watan Fabrairu na shekarar 2020, WHO ta ruwaito cewa, da ake samun raguwar sabbin shari'o'i a kasar Sin, sai da a kasar Italiya, Iran da Koriya ta Kudu suka karu da sauri, inda adadin sabbin shari'o'i a wajen kasar Sin ya wuce adadin sabbin shari'o'in a kasar Sin a karon farko.
Akwai yiwuwar samun rahotanni kadan na cutar, musamman a cikin mutanen da ke da alamun bayyanar cututtuka.
A ranar 26 ga watan Fabrairu, an samu rahoton ƙananan lamuran a cikin matasa, daga cikinsu, mutane masu shekaru 19 da ƙasa da haka sun kai kashi 2.4% na adadin masu cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Wallens, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su buƙaci kamuwa da cutar kafin su sami rigakafin rukuni mai tasiri.
Maganganu suna nufin yawan mutanen da aka gwada COVID-19, kuma bisa ga tsarin hukuma wanda aka tabbatar da gwajin su tabbatacce.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawanta, kuma ƙasashe da dama kamar Italiya, Netherlands, Spain da Switzerland suna da manufofin hukuma na kada su gwada mutanen da ke da alamun cutar kawai.
Wani binciken da aka wallafa a ranar 16 ga watan Maris ya gano cewa a kasar Sin, har zuwa 23 ga watan Janairu, kimanin kashi 86 cikin dari na kamuwa da cutar COVID-19 ba a gano su ba, kuma wadannan kamuwa da cutar da ba a rubuta ba su kasance tushen kamuwa da cutar ga kashi 79 cikin dari na shari'o'in da aka rubuta.
Wani bincike na kididdiga da aka wallafa a ranar 30 ga watan Maris ya nuna cewa adadin mutanen da suka kamu da cutar a Italiya ya fi yawan wadanda aka ruwaito.
Matsayin farko na asali na haihuwa (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani binciken da cibiyar kula da cututtuka ta Amurka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da suka kamu da COVID-19 sun warke.
A cikin wadanda ba su warke ba, lokacin da suka samu bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, wanda ya fi kowacce kwanaki 14.
A ranar 10 ga Afrilu, 2020, COVID-19 ya yi sanadiyar mutuwar kusan mutane 97,000.
A kasar Sin, a ranar 5 ga watan Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin mutanen da suka wuce shekaru 60, kuma kashi 75% na shari'o'in sun kasance suna da yanayin kiwon lafiya na riga-kafi ciki har da cututtukan zuciya da ciwon sukari.
Yawan mutuwar da COVID-19 ta yi na iya zama mafi girma, saboda ba za a iya haɗa da waɗanda suka mutu ba tare da gwaji ba kamar a gida, a cikin gidajen jinya, da sauransu.
Bayanai na bangare na Italiya sun gano cewa adadin mutuwar da aka samu a lokacin annobar ya ninka na COVID sau 4-5 fiye da na hukuma.
Wani kakakin Cibiyar Kula da Cututtuka ta Amurka (CDC) ya yarda "Mun san cewa an yi hasashen [da ake cewa yawan mutuwar]", wata sanarwa da aka tallafa ta ta hanyar bayanan kwatanci da aka ƙididdige a cikin Amurka. Irin wannan hasashen yana faruwa ne a cikin annobar, kamar yadda ya faru a cikin annobar 2009 H1N1 swine flu.
Mutuwar farko a waje da China ta fara ne a Philippines a ranar 1 ga Fabrairu, kuma mutuwar farko a waje da Asiya a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, an samu mutuwar sama da goma sha biyu a kasashen waje, wato, Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, an samu rahoton mutuwar a cikin kasashe da yankuna sama da arba'in a kowace nahiya sai dai Antarctica. Ana amfani da matakan da yawa don tantance yawan mutuwar.
Wadannan lambobi sun bambanta ta hanyar yanki da lokaci, kuma yawan gwaji, ingancin tsarin kula da lafiya, zaɓin magani, lokacin da aka fara yaduwar, da kuma halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya suna shafar su.
Bisa ga bayanan jami'ar Johns Hopkins, adadin mutuwar da aka samu a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan lambar tana canzawa ta hanyar yankin.
A China, an kiyasta cewa adadin mutuwar ya ragu daga kashi 17.3% (ga wadanda alamun suka fara daga 1 zuwa 10 ga Janairu 2020) zuwa kashi 0.7% (ga wadanda alamun suka fara bayan 1 ga Fabrairu 2020). Sauran matakan sun haɗa da mutuwar shari'a (CFR), wanda ke nuna yawan mutanen da aka gano su mutu daga cutar, da kuma mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (masu ganowa da marasa ganowa) da suka mutu.
Wadannan kididdigar ba su da lokaci kuma suna bin wani yanki na al'umma daga kamuwa da cuta zuwa warkewar cutar.
Yawancin masana ilimi sun yi ƙoƙari su ƙidaya waɗannan lambobin don yawan jama 'a.
Cibiyar Nazarin Kimiyya ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar ta kasance tsakanin kashi 0.1 zuwa 0.39 cikin dari.
Babban kimantawar wannan iyaka ya dace da sakamakon binciken kididdiga wanda ya bincika tasirin gwajin a kan gwajin COVID-19 na farko a cikin Jamus da kuma kimantawar CFR.
WHO ta ce za a iya sarrafa cutar.
Tsawon da kuma lokacin da ya faru ba a san shi ba kuma zai iya bambanta daga wuri zuwa wuri.
"Idan aka bar cutar ba tare da an hana ta ba, cutar ta kamuwa da cuta kullum tana daidaitawa kuma idan babu wadataccen abinci mai gina jiki don cutar, sai ta fara raguwa", in ji Mackie Bonney na Jami'ar Jihar Penn.
Amma, a yanzu, ba za mu iya yin tunanin lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhang Nanshang, ya yi jayayya cewa "za a iya kawo karshen wannan a watan Yuni" idan dukkan kasashe suka bi shawarar WHO kan matakan hana yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucherski na Makarantar Lafiya da Lafiya ta Yammacin Duniya ya ce SARS-CoV-2 "mai yiwuwa zai kasance cikin yaduwar shekara guda ko biyu".
A cewar wani binciken da aka gudanar daga Kwalejin Imperial karkashin jagorancin Neil Ferguson, ana bukatar nisan jiki da sauran matakan "har sai an samu allurar rigakafi (mai yiwuwa: watanni 18 ko fiye)".
"Ina ganin ba zai yiwu ba a kawar da cutar korona gaba daya, domin tana da sauƙin yaduwa", in ji William Sheffner na Jami'ar Vanderbilt, "kuma tana iya zama "rashin yanayi, wanda ke dawowa kowace shekara".
Rashin dawowa zai dogara ne akan iyakar rigakafin rukuni da kuma canjin canji.
Alamun COVID-19 na iya zama marasa ƙayyadaddun yanayi kuma waɗanda ke da cutar na iya zama marasa ƙayyadaddun lokaci.
Abubuwa biyu da suka fi kowa a cikin bayyanar cututtuka sune zazzabi (88%) da kuma tari (68%).
Alamomin da ba su da yawa sun haɗa da: gajiya, numfashi mai ƙyama (kaffa), rashin jin ƙanshi, numfashi mai ƙyama, ciwon tsoka da naƙoƙi, ciwon wuya, ciwon kai, sanyi, zagi, hawan jini, asphyxiation, asphyxiation ko nausy.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta lissafa alamun gaggawa a matsayin wahalar numfashi, ciwon kirji ko matsa lamba, tashin hankali na kwatsam, wahalar farkawa, da kuma fuska ko lebe mai launin shuɗi; ana ba da shawarar kula da gaggawa na likita idan waɗannan alamun sun bayyana. Ci gaban cutar na iya haifar da mummunan cutar huhu, mawuyacin yanayin numfashi, sepsis, bugun jini na septic, da mutuwa.
Wasu daga cikin mutanen da suka kamu da cutar na iya zama marasa lokaci, ba su da alamun ganewar asali, amma sakamakon gwajin ya tabbatar da kamuwa da cutar, saboda haka masu bincike sun ba da shawarar cewa ya kamata a lura da mutane da suka yi kusa da mutanen da suka kamu da cutar da aka tabbatar da su kuma a bincika su sosai don kawar da kamuwa da cutar.
A cikin kasar Sin, ana kiyasta cewa adadin da ake samu a lokacin da aka yi magana da shi ya kai kashi 44 cikin 100.
Matsayin bayyanar cututtuka na yau da kullun (lokacin da ya kasance tsakanin kamuwa da cuta da farkon bayyanar cututtuka) yana daga kwana ɗaya zuwa 14; yana da kwanaki biyar. Misali na rashin tabbas, ƙididdigar kashi na mutanen da ke da COVID-19, waɗanda suka rasa ƙanshi, sun kasance 30% da farko kuma daga baya sun ragu zuwa 15%.
Har yanzu ana gano wasu bayanai game da yadda cutar ke yaduwa.
Ana ganin cewa cutar tana yaduwa ne ta hanyar saukad da da ke faruwa a lokacin da aka yi kusa da shi da kuma lokacin da ake tari, yin tari ko magana; lokacin da aka yi kusa da shi a cikin mita 1 zuwa 2 (mita 3 zuwa 6).
Bincike ya nuna cewa tari daga tsalle daga mita 4.5 zuwa mita 8.2 zuwa 27.
Wasu sun bayar da shawarar cewa za a iya watsa kwayar cutar ta hanyar ƙananan saukad da ke faruwa yayin magana wanda ke kasancewa a cikin iska na tsawon lokaci. Hakanan ana iya haifar da saukad da numfashi yayin barin numfashi, gami da lokacin magana, kodayake ƙwayoyin cuta ba su da iska.
Saukad da za su iya shiga bakin ko hancin mutanen da ke kusa ko kuma su iya shiga huhu ta hanyar numfashi.
Wasu hanyoyin magani kamar su hange da kuma cututtukan zuciya da huhu (CPR) na iya haifar da rage numfashi kuma don haka ya haifar da yaduwar iska.
Yana iya yaduwa idan mutum ya taɓa wani shafi mai cutarwa, har da fata, sannan ya taɓa idanunsa, hanci ko bakinsa.
Ko da yake akwai damuwa cewa zai iya yaduwa ta hanyar fitsari, ana ganin cewa haɗarinsa ba shi da yawa.
Gwamnatin kasar Sin ta yi watsi da yiwuwar watsa SARS-CoV-2 ta hanyar magana da baki. Kwayar cutar tana da matukar yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya yin watsawa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane sun samu gwajin cutar a kwanaki uku kafin bayyanar cututtuka, wanda ya nuna cewa ana iya samun kamuwa da cutar kafin bayyanar cututtuka masu mahimmanci.
Rahotanni kaɗan ne kawai na lokuta masu ban mamaki da aka tabbatar a cikin dakin gwaje -gwaje, amma an gano wasu ƙasashe da ke watsawa ba tare da lokaci ba yayin binciken ganowa.
A cewar Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC), ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Wannan kwayar cutar tana rayuwa a farfajiya na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano cewa cutar tana iya ganowa a kan filastik (polypropylene) da karfe 304, har zuwa kwana ɗaya a kan kwali, har zuwa sa'o'i hudu a kan tagulla.
Koyaya, yana bambanta dangane da zafi da zafin jiki. Gwajin dabbobin gida da sauran dabbobi sun tabbatar da COVID-19.
Babu wata hujja da ta nuna cewa cutar za ta iya wucewa daga dabbobi zuwa mutane, ko da yake hukumomin Burtaniya sun ba da shawarar wanke hannuwanku bayan sun haɗu da dabbobi, kamar yadda ake yi bayan sun haɗu da wasu farfajiyar da mutum mai kamuwa da cutar ya taɓa.
Cutar tafin numfashi mai tsanani Coronavirus 2 (SARS-CoV-2) wani sabon kwayar cuta ce, wacce aka fara ware daga mutane uku da ke fama da cutar huhu da ke tattare da cutar tafin numfashi a Wuhan.
Ana samun dukkan halaye na kwayar cutar SARS-CoV-2 a cikin kwayoyin coronaviruses masu alaƙa da ke cikin yanayi. A waje da jikin mutum, kwayar cutar ta mutu ta hanyar sabulu na gida, wanda ke lalata murfin kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa kwayar cutar ta zoological ne.
Nazarin kwayoyin halitta ya nuna cewa kwayar cutar ta kasance daga cikin rukunin kwayoyin cutar betacoronavirus, subgenic sarbecovirus (warjin B) tare da nau'ikan kwayoyin halitta biyu na bats.
Wannan ya yi daidai da kashi 96 cikin 100 na sauran bat-babble masu dauke da cutar Corona (BatCov RaTG13) a matakin dukkanin kwayoyin halitta.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa bambanci tsakanin bangolin zuwa ƙwayoyin cuta da kuma ƙwayoyin cuta daga mutane zuwa wasu sassan jerin kwayoyin halitta na amino acid guda ɗaya ne kawai.
A cikin kwatancen da aka yi na dukan genomes, an gano yawan kwayoyin halitta na yau da kullum tsakanin cutar pandolyn coronavirus da SARS-CoV-2 da ya kai kashi 92 cikin dari, wanda bai isa ya samar da abinci mai gina jiki na tsaka-tsaki ga pandolyn ba.
Ana iya gano kamuwa da cutar ta wucin gadi ta hanyar bayyanar cututtuka, duk da haka tabbatarwa ta ƙarshe ta hanyar jujjuyawar kwayar cutar ta hanyar yin rikodin polymerase chain reaction (rRT-PCR) ko CT images.
Wani binciken da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR da yawa, ko da yake yana da ƙananan ƙwarewa tare da yawancin hotunansa na kama da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
A watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta bada shawarar cewa " kada a yi amfani da CT a matsayin gwaji na farko don gano ko gano COVID-19".
WHO ta wallafa wasu hanyoyin gwajin RNA don SARS-CoV-2, wanda aka fitar da sigar farko a ranar 17 ga Janairu.
Wannan gwajin yana amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR).
Ana iya gwada shi a kan numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin
Sakamakon yakan kasance cikin 'yan sa'o'i ko kwanaki.
Ana yin gwajin ne a kan nasagrasani fashe, amma ana iya amfani da fashe na wuyansa. Yawancin dakunan gwaje -gwaje da kamfanoni suna haɓaka gwajin sirrological wanda ke gano rigakafi.
A ranar 6 ga Afrilu, 2020, babu wani daga cikin wadannan da ya tabbatar da cewa ya isa ya zama daidai don a amince da shi don amfani da shi sosai.
Gwajin sirrological da Cellex ta ci gaba a Amurka an amince da shi ne kawai don amfani da gaggawa ta hanyar dakunan gwaje -gwaje masu inganci.
Abubuwan da ke nuna hoton hoto a kan radiograph da computed tomography (CT) na mutane masu alamun sun hada da rashin daidaituwa na gilashin ƙasa na waje da kuma rashin zubar da huhu.
Kungiyar Radiological ta Italiya tana tattara bayanan bayanan kan layi na duniya na binciken da aka samu na daukar hoto don tabbatar da shari'o'in.
Saboda kama da sauran cututtuka kamar adenovirus, ba tare da tabbaci ta PCR ba, hotunan hoto yana da iyakanceccen keɓancewa wajen gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa ko da yake daukar hoto bai zama na musamman ga kamuwa da cuta ba, yana da sauri kuma yana da mahimmanci, wanda ke ba da shawarar ra'ayinsa a matsayin hanyar bincike a yankunan annobar.
An kirkiro hanyoyin sadarwa na kwakwalwa masu jujjuyawa na ilimin kere-kere don gano siffofin hoto na kwayar cutar tare da radiograph da CT.
Don hana yaduwar cutar, dabarun sun hada da kiyaye tsabtace mutum mai kyau gaba daya, wanke hannu, guje wa taɓa idanu, hanci ko bakinka da hannayensu ba tare da wanke ba, da kuma coughing ko cizon haƙora a cikin wani nama da kuma sanya wannan nama kai tsaye a cikin shara.
Ana ba da shawarar cewa mutanen da suka riga sun kamu da cutar su sa abin rufe fuska a wuraren jama'a.
Ana kuma ba da shawarar matakan nesa na jiki don hana watsawa. Gwamnatoci da yawa sun hana ko kuma ba da shawarar ba da izini ga duk ba dole ba a cikin ƙasashe da yankuna da cutar ta shafa.
Koyaya, cutar ta kai ga watsawa ta al'umma a mafi yawan sassan duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'ummomi, kuma wasu mambobin al'umma ba su san inda suka kamu da cutar ba ko kuma yadda suka kamu. Ana ba da shawarar cewa masu ba da kulawa da ke kula da mutumin da ke da cutar su yi amfani da ƙa'idodin tsaro, matakan tuntuɓar da kuma kare idanu.
Amfani da bayanan wuri na wayoyin hannu ta gwamnatoci don wannan dalili ya haifar da damuwa game da sirrin sirri, wanda Amnesty International da fiye da kungiyoyi 100 suka fitar da wata sanarwa game da iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen hannu daban-daban ko kuma an gabatar da su don amfani da kansu, kuma a ranar 7 ga Afrilu, 2020, fiye da rukuni na masana suna aiki akan hanyoyin da ke da alaƙa da sirri, kamar amfani da Bluetooth don yin rajistar kusanci daga wayar hannu ta mai amfani.
Masu amfani suna karɓar saƙo idan sun kasance a cikin kusanci da wani wanda ya tabbatar da COVID-19. Akwai ra'ayoyi marasa kyau game da hanyoyin hana kamuwa da cuta; misali, rubbing hanci da yin ihu da wanka ba su da tasiri.
Babu allurar COVID-19 da ake samu, duk da haka kungiyoyi da dama suna aiki don samar da allurar.
Don hana yaduwar cutar, ana ba da shawarar yin wanka hannu.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa a kai a kai na akalla na tsawon dakika ashirin, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun zama marasa tsabta; kafin su ci; da kuma bayan sun zubar da hanci, sun yi tari ko sun yi cizon safa.
Wannan shi ne saboda a waje da jikin mutum, ana kashe kwayar ta da sabulu na gida, wanda ke lalata kumfa mai kare ta.
Bugu da kari, CDC ta bada shawarar yin amfani da kayan tsabtace hannu na tushen barasa wanda ya ƙunshi aƙalla kashi 60 cikin dari na giya, lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane da su guji taɓa idanu, hanci ko bakinsu ba tare da wanke hannayensu ba.
Ana iya lalata farfajiyar tare da wasu magunguna da suka hada da 6271% ethanol, 50100% isopropenol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine (a cikin minti daya na fuskar maganin kashe kwayoyin cutar ga farfajiyar bakin karfe).
Sauran magunguna, kamar benzalkonium chloride da chromexydine gluconate, ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan akwai shakka ko tabbaci na COVID a wani ofishi ko wani wuri kamar daycare, to duk wuraren da ake amfani da su kamar ofisoshin, dakunan wanka, wuraren jama'a, na'urorin lantarki da aka raba kamar allunan, allon taɓawa, kebabbo, na'urorin sarrafawa na nesa, da na'urorin ATM da marasa lafiya ke amfani da su, da sauransu, ya kamata a hana su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su juya bakinsu da hancinsu ko kuma su rufe su da wani abu a lokacin da suke tari ko kuma suna yin tsatsa, sannan su kawar da duk wani abu nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska na tiyata ga mutanen da za su iya kamuwa da cutar, saboda saka abin rufe fuska na iya iyakance adadin saukad da numfashi da kuma nesa da za a iya sauka daga magana, cizon yatsa da kuma tari.
WHO ta ba da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
Stephen Griffin, masanin ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
WHO ta ba da shawarar cewa mutane masu lafiya su sa abin rufe fuska ne kawai idan suna cikin haɗari mai yawa, kamar waɗanda ke kula da mutumin da ke da COVID-19, duk da haka sun yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskarsu.
Kasashe da dama sun fara karfafa amfani da abin rufe fuska ga talakawa.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na fuska wanda ba na likita ba ne wanda aka yi da tufafi. China ta ba da shawarar musamman ga mutanen da ke da lafiya na yau da kullun su yi amfani da abin rufe fuska na likita, musamman idan sun zo kusa da wasu mutane (1 m (3 ft) ko ƙasa da haka).
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata yayin amfani da sufuri na jama'a ko kasancewa a wuraren da jama'a ke.
Jami'an lafiya na Thailand na karfafa mutane su sanya fuska a gida kuma su wanke su a kullum.
Jamhuriyar Czech da Slovakia sun haramta fita a wuraren jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da bakinsu.
A ranar 16 ga watan Maris, Vietnam ta nemi kowa ya sa abin rufe fuska a lokacin da ya je wuraren jama'a don kare kansa da kuma wasu.
Gwamnatin Austria ta tilasta wa duk wanda ya shiga kantin sayar da kayayyaki ya sa abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasar su sa abin rufe fuska a lokacin da suka shiga wuraren jama'a.
Tun tsakiyar watan Maris, Taiwan, wanda ke samar da masks miliyan goma a kowace rana, ta tilasta fasinjojin su sa abin rufe fuska a kan jiragen kasa da bas na cikin birane a ranar 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska a lokacin fita, yayin da aka kuma ba da shawarar yin abin rufe fuska na gida ga waɗanda ba za su iya siyan abin rufe fuska ba.
An yi amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Yin nesa da jama'a (wanda ake kira nesa da jiki) ya ƙunshi aikin sarrafa kamuwa da cuta, wanda aka yi niyya don rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin da ake amfani da su sun hada da killace mutane; hana tafiye -tafiye; da kuma rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, ko kuma cibiyoyin cin kasuwa.
Mutum na iya aiwatar da hanyoyin da za su iya yin nesa ta hanyar kasancewa a gida, ta hanyar iyakance tafiya, ta hanyar guje wa wuraren da jama'a ke taro, ta hanyar yin amfani da gaisuwa ba tare da tuntuɓar su ba, da kuma ta hanyar nisantar da kansu daga wasu.
Yawancin gwamnatoci yanzu suna tilasta ko kuma bayar da shawarar yin nesa da jama'a a yankunan da cutar ta shafa.
An rage yawan jama'a da aka ba da shawarar ta hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka daga mutane 250 (idan babu sanannen yaduwar COVID-19 a wani yanki) zuwa mutane 50, sannan kuma daga baya zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta jama'a da suka fi mutane biyu. Manya da tsofaffi da mutanen da ke da cututtukan likita irin su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma lalacewar tsarin rigakafi suna da haɗarin kamuwa da cututtuka masu tsanani da rikitarwa kuma CDC ta shawarce su da su kasance a gida kamar yadda ya kamata a yankunan da ke da barkewar jama'a. A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "tsarewar zamantakewa" da "tsarewar jiki", don bayyana cewa manufar kasancewa da zamantakewa shine rage yawan saduwa ta zahiri ko kuma ta nesa.
Amfani da kalmar "nesa ta zamantakewa" ya haifar da ma'anar cewa, ya kamata mutane suyi amfani da cikakken keɓewa ta zamantakewa maimakon karfafa su su kasance tare da wasu ta hanyar hanyoyin da za su iya amfani da su. Wasu hukumomi sun fitar da jagororin kiwon lafiya ta jima'i don amfani a lokacin annobar.
Waɗannan sun haɗa da shawarwari don yin jima'i kawai da mutumin da kake zama tare da shi wanda ba shi da cutar ko alamun cutar.
An ba da shawarar a keɓe kai a gida ga mutanen da aka gano suna da COVID-19 da waɗanda ake zargin suna da cutar.
Hukumomin lafiya sun ba da cikakkun umarni don daidaitaccen keɓancewa. Gwamnatoci da yawa sun tilasta ko kuma sun ba da shawarar keɓancewa ga dukan mutanen da ke zaune a yankunan da abin ya shafa.
An fitar da umarnin tsauraran matakan killace kai a cikin kungiyoyin masu haɗari.
An shawarci mutanen da suka iya kasancewa a cikin haɗuwa da wani wanda ya kamu da COVID-19 kuma waɗanda suka ziyarci wata ƙasa ko yanki da ke da yaduwar yaduwa kwanan nan su yi zaman kansu na kwanaki 14 daga lokacin haɗarin ƙarshe.
Dabarun sarrafa annoba shine hana ko hanawa, da kuma shayarwa.
Ana yin rigakafin a farkon fasalin barkewar cutar kuma ana nufin gano mutanen da suka kamu da cutar da kuma aiwatar da wasu matakan sarrafa kamuwa da cuta da rigakafi don hana cutar yaduwa zuwa sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, sai a sauƙaƙe a cikin matakan dakile: ana ɗaukar matakan da za a rage yaduwar da kuma rage tasirinsa a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya haɗa duka matakan hanawa da kuma kawar da cutar a lokaci guda.
Ana buƙatar ƙarin matakan matsananciyar ta'addanci don kawar da cutar ta hanyar rage yawan haihuwa zuwa 1. Wani ɓangare na sarrafa barkewar cutar mai yaduwa shine ƙoƙarin rage matsanancin cutar, wanda aka sani da rage ƙirar cutar.
Wannan yana rage haɗarin karɓar sabis na kiwon lafiya kuma yana ba da ƙarin lokaci don haɓaka alluran rigakafi da magunguna.
Hanyoyin da ba na magani ba da ke iya magance barkewar cutar sun haɗa da matakan rigakafin mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓewa; rufe makarantu da soke taron jama'a da ake nufi don sanya nesa ta jiki; haɗin gwiwar al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan ayyukan; da kuma matakan tsabtace muhalli kamar tsabtace farfajiya. An aiwatar da ayyuka masu tsaurara don hana barkewar cutar a China lokacin da ya bayyana cewa cutar ta kasance mai tsanani, kamar killace birane da sanya tsauraran hanyoyi.
Sauran ƙasashe ma sun ɗauki matakai da yawa don hana yaduwar cutar.
Koriya ta Kudu ta fara bincike mai zurfi da sanya a cikin gida, da kuma yin gargadi game da motsi na masu kamuwa da cutar.
Singapore ta ba da tallafi ga mutanen da suka kamu da cutar da suka yi wa kansu killacewa kuma ta caje wadanda suka kasa yin hakan.
Taiwan ta kara samar da masks na fuska kuma ta hukunta ajiyar kayayyakin kiwon lafiya. Misalai ga Great Britain da Amurka sun nuna cewa manyan kalubale ne a cikin dakile (sake jinkirta yaduwar annobar amma ba a hana ta) da kuma hana (karkatar da ci gaban annobar).
Manufofin dakile mafi kyau na iya rage bukatar kulawa da lafiya ta musamman da kashi biyu bisa uku da kuma mutuwar da aka samu da rabi, amma har yanzu ana kashe daruruwan mutane da kuma lalata tsarin lafiya.
Ana iya ba da fifiko ga dakilewa, amma ana buƙatar kiyaye shi har sai cutar ta bazu cikin yawan mutane (ko har sai an sami allurar rigakafi, idan ta fara), in ba haka ba za a dawo da watsawa cikin sauri daga rashin ƙarfi a cikin matakan.
Matsayi mai tsawo na dakile cutar yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar COVID-19 da aka amince da su, amma ana ci gaba da kokarin ci gaba, gami da gwajin magungunan da ke akwai.
Shan maganin sanyi ba tare da takardar sayan magani ba, shan ruwa, da kuma shakatawa na iya taimakawa wajen rage bayyanar cututtuka.
Dangane da tsanani, ana iya buƙatar maganin oxygen, ruwa na intravenous da taimakon numfashi.
Yin amfani da steroids zai iya jawo sakamako mafi muni.
Ana bincika wasu mahadi da aka riga aka amince da su don magance wasu cututtukan kwayar cutar don amfani dasu a cikin maganin COVID-19.
Wasu "tambayoyi na gargajiya da na gida" na iya taimakawa wajen kawar da bayyanar cututtuka na SARS-CoV-19, a cewar WHO.
Ƙara ƙarfin aiki da daidaita kulawar lafiya don bukatun marasa lafiya na COVID-19 an bayyana shi a matsayin matakin mayar da martani na asali na barkewar cutar ta WHO.
ECDC da WHO na Turai sun fitar da jagororin don canja wurin albarkatu zuwa asibitoci da sabis na kiwon lafiya na farko a matakai da yawa, gami da: mayar da hankali ga ayyukan dakin gwaje-gwaje kan gwajin COVID-19, soke hanyoyin zaɓaɓɓu a duk lokacin da zai yiwu, warewa da keɓe marasa lafiya da ke da cutar COVID-19, da haɓaka ƙarfin kulawa mai tsanani ta hanyar horar da ma'aikata da haɓaka yawan masu iska da gadaje da ke akwai.
Akwai ra'ayoyi da dama game da inda za a iya samun farkon cutar (wanda ake kira marasa lafiya).
An gano farkon sanannen cutar ta Novel Coronavirus a Wuhan, Hubei, China a ranar 1 ga Disamba, 2019.
A cikin wata daya, adadin masu dauke da cutar korona a Hubei ya karu a hankali.
Yawancin su suna da alaƙa da kasuwar sayar da abincin teku na Hunan, wanda aka sayar da dabbobi masu rai, kuma akwai ra'ayi cewa cutar ta fito ne daga ɗayan waɗannan dabbobi; ko kuma, a wasu kalmomin, na dabba ne. An lura da wani rukuni na cutar huhu da ba a san dalilinsa ba a ranar 26 ga Disamba kuma likitan Zhang Jixian ne ya kula da shi a asibitin lardin Hubei, wanda ya sanar da Wuhan Jiangnan CDC a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wata kungiya ta likitoci a Wuhan Central Hospital ta gargadi abokan aikinta game da "Coronavirus kamar SARS".
Da ake zargi da yada jita -jita, 'yan sanda sun yi gargadin likitoci takwas, ciki har da Li Wenliang, kuma wasu likitoci sun yi wa I Fan tsawatawa da dattawan su.
Hukumar Lafiya ta Wuhan ta fitar da sanarwar jama'a a ranar 31 ga watan Disamba kuma ta sanar da WHO.
An sanar da hukumomin lafiya a Wuhan cewa akwai wasu lamuran cutar pneumonia da ba a sani ba, wanda ya haifar da fara binciken a farkon watan Janairu. A lokacin farkon barkewar cutar, adadin mutane ya ninka kusan kowace kwana bakwai da rabi.
A farkon tsakiyar watan Janairu na shekarar 2020, cutar ta bazu zuwa wasu lardunan kasar Sin saboda yawan zirga -zirga da kuma babban tashar sufuri da kuma babbar hanyar jirgin kasa da ke Wuhan saboda sabuwar shekara ta kasar Sin.
A ranar 20 ga watan Janairu, kasar Sin ta samu sabbin mutane 140 a rana guda, ciki har da mutum biyu a Beijing da kuma mutum daya a Shenzhen.
Bayanai na baya sun nuna cewa mutane 6,174 sun riga sun sami cututtukan a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta fi China da Italiya gaba da yawan adadin wadanda aka tabbatar da cutar a duniya. A ranar 9 ga Afrilu, 2020, an samu rahoton sama da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da mutane 364,000 sun warke.
Akwai akalla mutum daya a kasashe da yankuna kusan 200.
Saboda annobar a Turai, kasashe da dama na yankin Schengen sun hana 'yanci da kuma kafa iyakokin iyaka.
Sakamakon haka ya nuna cewa an yi amfani da dokar hana fita ta musamman don hana mutane yin amfani da kayan abinci da kayan abinci da kuma yin amfani da su a cikin gida. A ranar 2 ga watan Afrilu, kusan mutane miliyan 300 a Amurka, ko kusan kashi 90 cikin dari na yawan jama'a, sun shiga cikin wani irin kulle-kulle, fiye da mutane miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun shiga wani irin dokar kulle, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu - kusan kashi daya bisa uku na yawan duniya.
An gano wani mutum da aka fara tabbatar da COVID-19 a Wuhan a ranar 1 ga Disamba, 2019; rahoto mara tabbas ya nuna cewa an fara samun mutum na farko a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya ga wani rukuni na mutane da ke fama da cutar pneumonia da ba a san dalilinsa ba a ranar 26 ga watan Disamba, bayan haka asibitin ya sanar da Wuhan Jiangnan CDC a ranar 27 ga watan Disamba.
A ranar 27 ga watan Disamba na shekarar 2019, an fara gwada kwayoyin halitta na samfurin mai haƙuri wanda ya nuna cewa akwai wani coronavirus kamar SARS.
A ranar 31 ga watan Disamba, Hukumar Lafiya ta Wuhan ta ba da sanarwar jama'a.
An sanar da WHO a wannan rana.
Bayan wannan labari, 'yan sanda a Wuhan sun gargadi likitoci su " yada jita -jita " game da annobar.
Hukumar lafiya ta kasar Sin ta fara da'awar cewa babu "babban shaida" na yaduwar mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na dakile yaduwar cutar, wanda Sakatare Janar na jam'iyyar kwaminis ta kasar Sin, Xi Jinping ya kira "yaƙin jama'a".
An bayyana a matsayin "babban killace a tarihin 'yan adam", a ranar 23 ga Janairu an sanar da yankin kewaye da Wuhan don hana zirga-zirga, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An haramta amfani da motocin sirri a cikin birnin.
An soke bikin Sabuwar Shekara ta kasar Sin (25 ga Janairu) a wurare da dama.
Hukumomi sun kuma sanar da gina asibiti na wucin gadi, asibitin Hosenson, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti, asibitin Lichenson, don kula da ƙarin marasa lafiya.
Baya ga asibitocin da aka gina, kasar Sin ta ma sauya wasu wurare 14 a Wuhan kamar cibiyoyin taro da filayen wasa zuwa asibitocin wucin gadi. A ranar 26 ga Janairu, gwamnati ta kafa wasu matakan hana barkewar COVID-19, ciki har da fitar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a fadin kasar.
Yankunan Hong Kong da Macau sun kafa wasu matakai, musamman ma game da makarantu da jami'o'i.
An kafa matakan aiki na nesa a yankuna da yawa na kasar Sin.
An sanya takunkumin tafiye -tafiye a cikin da wajen Hubei.
An gyara sufuri na jama'a, kuma an rufe gidajen tarihi a duk faɗin China.
An hana zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (sama da rabin yawan jama'a) sun fuskanci wasu nau'ikan takunkumin waje. Bayan barkewar cutar ta shiga matakin ta duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana cutar "zuwa" daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar killace matafiya na kasa da kasa na kwanaki 14 ga duk matafiya na kasa da kasa da suka shiga birnin. A ranar 23 ga Maris, an samu karuwar mutum daya a cikin gida a cikin kwanaki biyar da suka gabata a babban yankin kasar Sin, a wannan misali ta hanyar matafiyi da ke komawa Guangzhou daga Istanbul.
A ranar 24 ga watan Maris na shekarar 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da yaduwar cututtukan da ke yaduwa a gida kuma an daidaita annobar a kasar Sin.
Bayan watanni biyu da dokar ta rufe, an sauƙaƙe takunkumin tafiye-tafiye a Hubei a ranar nan da nan, ban da Wuhan. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shiga masu riƙe da takardar visa ko lasisin zama daga ranar 28 ga Maris, kuma babu wani bayani dalla-dalla game da lokacin da wannan manufar za ta ƙare.
Wadanda suke son shiga kasar Sin dole ne su nemi takardar visa a ofisoshin ofishin jakadancin kasar Sin ko kuma a ofisoshin ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa harkokin kasuwanci da masana'antu su sake budewa a ranar 30 ga watan Maris tare da samar da wani kudade na karfafa tattalin arziki ga harkokin kasuwanci. Majalisar Jiha ta bayyana ranar makoki a ranar 4 ga watan Afrilu, da karfe 10:00 na safe, ta hanyar fara da minti uku na zaman lafiya na kasa, wanda ya kasance a lokacin bikin Qingming, duk da cewa gwamnatin tarayya ta umarci iyalai su yi ta'aziyyar kan layi yayin da suke bin bin bin ka'idodin nisan jiki don kauce wa sabon barkewar COVID-19.
An tabbatar da yaduwar COVID-19 zuwa Koriya ta Kudu daga China a ranar 20 ga Janairu, 2020.
Hukumar kula da lafiyar al'umma ta lura da karuwar adadin wadanda aka tabbatar da su a ranar 20 ga Fabrairu, wanda ya danganta da taron jama'a a cikin Digo, wani sabon motsi na addini wanda aka sani da Babban cocin Yesu Shinchiji.
Shinchijiji masu zuwa daga Wuhan zuwa Daegu sun yi shakkar asalin cutar.
A ranar 22 ga Fabrairu, 1,261 ko kusan 13% na mabiya 9,336 na Ikilisiya sun ba da rahoton alamun cutar. Koriya ta Kudu ta ba da sanarwar mafi girman matakin gargadi a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu karin karin mutane 2,000 da aka tabbatar da cutar a Koriya, wanda ya karu zuwa 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu lokacin da gwaje -gwajen suka tabbatar da cewa sojoji uku sun kamu da cutar.
Shirin da Koriya ta Kudu ta gabatar na tantance yawan mutane don cutar da ware duk wanda ya kamu da cutar da kuma ganowa da killace wadanda suka tuntube su, an ce shi ne mafi girma da kuma mafi kyawun shirin da aka tsara a duniya.
Hanyoyin binciken sun haɗa da tabbatar da alamun bayyanar cututtuka ta hanyar sababbin masu shigowa na duniya ta hanyar aikace -aikacen hannu, hanzarta gwajin cutar tare da sakamakon da aka samu a rana mai zuwa, da haɓaka ƙarfin gwaji don gwada mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu a cikin sarrafa annobar duk da cewa ba a killace biranen baki daya ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a yi masa shari'a, ko kuma sun yaba da martani na Moon, suna da'awar cewa gwamnati ta yi rashin kula da annobar.
A ranar 23 ga watan Maris, an sanar da cewa Koriya ta Kudu tana da karamin adadin wadanda suka kamu da cutar a rana daya a cikin makonni hudu.
A ranar 29 ga watan Maris, an sanar da cewa, daga 1 ga watan Afrilu, za a killace duk sabbin masu shigowa daga kasashen waje na tsawon makonni biyu.
A ranar 1 ga watan Afrilu, kafofin yada labarai sun ruwaito cewa Koriya ta Kudu ta samu buƙatun taimako na gwaji na cutar daga kasashe daban -daban 121.
Iran ta ba da rahoton farkon tabbatar da cutar SARS-CoV-2 a Kom a ranar 19 ga Fabrairu, inda mutane biyu suka mutu a ranar, a cewar Ma'aikatar Lafiya da Ilimin Likita.
Sauran matakan da gwamnati ta sanar sun hada da bukukuwa da sauran al'adu, wasanni da sallah na Juma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da tiriliyan biyar na riyal don magance cutar.
Shugaban kasa Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020, babu wani shiri na killace yankunan da cutar ta shafa kuma za a killace mutane ne kawai.
An sanar da shirin iyakance zirga -zirga tsakanin birane a watan Maris, duk da haka, har zuwa Nuwaros na Farisa, zirga -zirga mai yawa tsakanin birane ya ci gaba.
Har zuwa 16 ga Maris, 2020, wuraren haikalin Shia a Kom sun kasance a buɗe ga mahajjata. A lokacin Fabrairu, Iran ta zama cibiyar watsa kwayar bayan China.
A tsakanin da'awar ɓoye adadin barkewar cutar a Iran, fiye da kasashe goma sun gano cewa sun yi alaƙa da Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa adadin barkewar cutar na iya zama mafi tsanani fiye da 388 da gwamnatin Iran ta yi rikodin zuwa wannan ranar.
An rufe majalisar dokokin Iran a ranar 3 ga watan Maris, lokacin da aka tabbatar da cewa an samu kamuwa da cutar a 23 daga cikin mambobi 290 na majalisar.
A ranar 12 ga watan Maris, Human Rights Watch ta kuma bukaci hukumomin gidan yari na Iran da su saki 'yan kare hakkin bil adama da aka tsare a zaman lafiya don zanga-zangarsu ba tare da wani sharadi ba kuma su saki duk fursunonin da suka cancanci.
Ya ce, cibiyoyin da aka rufe kamar cibiyoyin hanawa suna da mafi girman haɗarin yaduwar cutar, wanda kuma ba shi da isasshen kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda ya kasance mafi yawan mutane da aka samu a kasar tun lokacin da annobar ta fara.
Aƙalla 'yan siyasa da jami'an gwamnati 12 na yanzu ko na baya sun mutu daga cutar a ranar 17 ga Maris.
A ranar 23 ga watan Maris, a Iran ana samun sabbin mutane 50 a kowace awa kuma ana samun sabon mutuwa a kowane minti 10 sakamakon cutar korona.
Wani jami'in WHO ya ce, Iran na iya samun adadin wadanda suka kamu da cutar sau biyar fiye da yadda ake samu a yanzu.
An kuma nuna cewa takunkumin da Amurka ta dauka kan Iran na iya shafar karfin tattalin arzikin kasar wajen amsa cutar.
Babban Kwamishinan Majalisar Dinkin Duniya don Hakkokin Dan Adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da aka gwada wasu 'yan yawon bude ido biyu na kasar Sin a Rome da suka tabbatar da cutar SARS-CoV-2.
Al'amuran sun yi ta kara karuwa, wanda ya sa gwamnatin Italiya ta dakatar da dukkan jiragen da ke tashi da tashi daga China kuma ta ayyana dokar ta baci.
An gano wani rukunin marasa alaƙa na COVID-19 a Lombardy, farawa da 16 da aka tabbatar a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon dokar shari'a don hana barkewar cutar, inda aka killace mutane sama da 50,000 daga 11 garuruwa daban-daban a arewacin Italiya.
"A wuraren da cutar ta bulla, ba za a samar da shiga da fita ba", in ji Firayim Minista Gusep Conte.
An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗannan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, saboda mutuwar 100 a Italiya.
Duk manyan wasannin wasanni, gami da wasannin Serie A, an shirya su ba tare da halartar gani ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dage dukkan wasannin gaba daya na akalla wata daya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai manyan kantuna da kantunan magani. A ranar 6 ga watan Maris, Kwalejin Italiyanci ta Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta wallafa shawarwari kan ɗabi'ar likitanci game da ayyukan da za a iya yi, yarjejeniyar rarraba marasa lafiya masu tsanani.
A ranar 19 ga watan Maris, Italiya ta fi China gaba a duniya a cikin yawan mutuwar da suka shafi cutar coronavirus bayan ta ba da rahoton mutuwar 3,405 daga annobar.
A ranar 22 ga watan Maris, an sanar da cewa Rasha ta tura jiragen saman soja tara zuwa Italiya tare da kayan aikin likita.
A ranar 5 ga watan Afrilu, tare da mafi yawan shari'o'in da suka faru a yankin Lombardy, a Italiya akwai mutane 128,948 da aka tabbatar, 15,887 sun mutu, kuma 21,815 sun warke.
Wani rahoto daga CNN ya nuna cewa haɗuwa da yawan tsofaffin mutanen Italiya da kuma rashin iyawar gwajin cutar a lokacin na iya taimakawa wajen samun babban adadin mutuwar.
Amsar Burtaniya ga cutar ta fara bayyana a matsayin mafi sauki daga cikin kasashen da aka shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta aiwatar da kowane irin nisan jama'a ko matakan killace jama'a a kan 'yan kasar ba.
A sakamakon haka, gwamnati ta fuskanci sukar rashin saurin da ake yi da kuma gaggawa a cikin amsa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da shawarar dakatar da duk balaguron da ba dole ba da kuma saduwa da jama'a, yana ba da shawarar mutane su yi aiki daga gida idan zai yiwu kuma su guji wuraren kamar mashaya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnatin ta sanar da rufe dukkan wuraren nishaɗi kamar mashaya da wuraren motsa jiki da wuri-wuri, da kuma alkawarin biyan ma'aikata har zuwa 80% na albashi har zuwa £2,500 a kowane wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da matakan tsauraran hanyoyin nisan jama'a, ta hana taron mutane fiye da biyu da kuma iyakance tafiya da ayyukan waje zuwa ayyukan da ake ganin dole.
Ba kamar matakan da suka gabata ba, an sanya waɗannan takunkumin ta hanyar bin diddigin da kuma tarwatsa taron.
An ba da umarnin rufe yawancin kasuwancin da aka ɗauka "mafi mahimmanci", gami da manyan kantuna, kantuna, shagunan kayan aiki, tashoshin mai da garages.
A ranar 20 ga watan Janairu, an tabbatar da farkon sanannen lamarin COVID-19 a cikin wani mutum a cikin jihar Pacific Northwest na Washington, wanda ya dawo daga Wuhan a ranar 15 ga watan Janairu.
An kafa rundunar aikin White House Coronavirus a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya ta jama'a, kuma ta haramta shiga matafiya daga kasar Sin.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka - Cibiyar Kula da Lafiya ta Jama'a - ta sanar da cewa ta ci gaba da samar da kayan gwajin ta.
Duk da haka, Amurka ta fara gwajin da jinkiri, wanda ya sa ya yi wuya a fahimci ainihin yadda annobar ta faɗaɗa a lokacin.
Gwajin ya kasance cikin matsala saboda rashin amincewar gwamnatin tarayya ga kayan gwajin da suka lalace da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta hanyar malaman ilimi, kamfanoni da asibitoci) har zuwa karshen Fabrairu, da kuma takunkumin da ke hana mutane cancanta don yin gwaji har zuwa farkon Maris (wanda ya biyo bayan umarnin likita).
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwajin gwaji kasa da 4,000 a Amurka.
A ranar 13 ga watan Maris, jaridar The Atlantic ta ruwaito cewa an yi gwajin kasa da 14,000.
A ranar 22 ga watan Maris, The Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cutar kuma suna da umarnin likita sun jira na sa'o'i ko kwanaki don gwaji". Gwamna J. Insley ya sanar da dokar ta baci bayan an samu mutuwar farko a jihar Washington a Amurka a ranar 29 ga Fabrairu, wani mataki da sauran jihohi suka bi nan da nan.
Makarantun yankin Seattle sun soke darussan a ranar 3 ga Maris kuma har zuwa tsakiyar watan Maris, ana rufe makarantun a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masana ilimin cututtukan cututtuka a Kwalejin Imperial a London ta ba da shawara ga Amurka game da kimanta tasirin sabon coronavirus a ƙasar.
A wannan rana, Shugaba Trump ya sanya hannu kan Dokar Shirye -shiryen Shirye da Amsa na Coronavirus, wanda ya ba da dala biliyan 8.3 a cikin kudade na gaggawa ga hukumomin tarayya don amsawa ga annobar.
Kamfanoni sun sanya takunkumin tafiye -tafiye na ma'aikata, sun soke tarurruka, kuma sun karfafa ma'aikata su yi aiki daga gida.
An soke wasanni da zaman. A ranar 11 ga Maris, mai tasiri daga ranar 13 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye na kwanaki 30 ga yawancin Turai sai dai United Kingdom.
A rana ta gaba, sun faɗaɗa takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga watan Maris, sun ayyana dokar ta baci ta kasa, wanda ya samar da kudade na tarayya don amsawa ga rikicin.
Farawa a ranar 15 ga Maris, kamfanoni da dama sun dakatar da aiki ko rage lokutan aiki a duk fadin Amurka don kokarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a duk jihohi 50 da kuma gundumar Columbia. A ranar 23 ga watan Maris, an ruwaito cewa New York City na da shari'o'in coronavirus 10,700, wanda ya fi yawan adadin a Koriya ta Kudu.
A ranar 25 ga watan Maris, Gwamnan ya ce, ana yin aiki da nisantar zamantakewa, saboda an yi hasashen cewa adadin mutane da suka kamu da cutar zai ninka daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an samu mutum 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu da cutar. A ranar 26 ga watan Maris, Amurka ta samu karin mutane da suka kamu da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya. A ranar 8 ga watan Afrilu, Amurka ta samu mutum 400,335 da suka kamu da cutar, kuma mutane 12,841 sun mutu.
Rahotanni sun bayyana cewa, a ranar 30 ga watan Maris, shugaban Amurka Trump ya yanke shawarar tsawaita ka'idodin nisan jama'a har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin USNS Comfort, wani asibiti mai asibiti mai dakuna kusan 1,000, ya sauka a birnin New York.
A ranar 3 ga watan Afrilu, an yi rikodin mutuwar mutane 884 a Amurka sakamakon cutar coronavirus a cikin sa'o'i 24.
A ranar 3 ga watan Afrilu, adadin masu cutar ya wuce 100,000 a jihar New York. An soki fadar White House don hana saƙonni ta hanyar rage haɗarin da kuma umarci jami'an lafiya da masana kimiyya su daidaita maganganun jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
Trump ya yi amfani da tsarin kula da rikici da ya bambanta da na rashin son kai.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, gami da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da tsarin tafiye-tafiye na iska don yin taswirar bincike da kuma hango ko hasashen yaduwar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar watan Janairu na 2020.
Bayanai daga kungiyar sufuri ta kasa da kasa sun nuna cewa a shekarar 2018 da aka samu, Bangkok, Hong Kong, Tokyo da Taipei sun fi yawan fasinjoji daga Wuhan.
Dubai, Sydney da Melbourne sun kuma kasance sanannun wuraren da za a ziyarta daga Wuhan.
Bali an bayyana ta a matsayin mafi ƙarancin iyawa daga cikin shahararrun biranen 20 mafi shahararrun wurare a cikin shirye-shirye, yayin da biranen Ostiraliya suka kasance mafi ƙarancin iyawa. Ostiraliya ta ba da shirin gaggawa na gaggawa ga sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
A cewarsa, ba a san komai game da COVID-19 ba, kuma cewa Ostiraliya za ta ba da gagarumin ƙarfi ga kula da iyaka da sadarwa a cikin amsa ga annobar.
A ranar 21 ga watan Maris, an ayyana dokar ta baci ta mutum a Australia.
Saboda ingantattun killace zirga -zirgar jama'a a Wuhan da Hubei, ƙasashe da yawa suna shirin fitar da 'yan ƙasarsu da ma'aikatan diflomasiyya daga yankin, galibi ta hanyar jiragen da aka ba da izini ga ƙasarsu, wanda hukumomin Sin suka ba da izini.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand sun kasance na farko da suka yi shirin fitar da 'yan ƙasarsu.
Pakistan ta ce ba za ta fitar da wani dan kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta fitar da wasu 'yan Brazil ko kuma danginta 34 ban da wasu 'yan kasar Sin hudu da kuma dan kasar Indiya.
'Yan ƙasar Poland, China, da Indiya sun sauka daga jirgin zuwa Poland, inda jirgin Brazil ya tashi zuwa Brazil bayan ya tsaya.
An killace 'yan kasar Brazil da suka je Wuhan a wani sansanin soja kusa da Brasilia.
A wannan ranar, an kwashe 'yan kasar Kanada 215 (daga jirgin sama na farko, 176 da na biyu, 39 da gwamnatin Amurka ta ba da izini) daga Wuhan zuwa CFB Trenton kuma an killace su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama na Kanada mai dauke da 'yan kasa 185 ya sauka a CFB Trenton daga Wuhan.
Hukumomin Australia sun kwashe mutane 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da 'Yan Adam ta Kirsimeti Island, wanda aka sake gina a matsayin cibiyar killace mutane, inda suka zauna har tsawon kwanaki 14.
Wani jirgin gudun hijira na New Zealand ya isa Auckland a ranar 5 ga Fabrairu; an killace fasinjojinsa (ciki har da wasu daga Australia da kuma daga yankin Pacific) a wani sansanin soja a Wangaproua, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kori Amurkawa da ke cikin jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga watan Fabrairu, wani jirgin sama ya sauka a Trenton, Ontario dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess.
A farkon watan Maris, gwamnatin Indiya ta fara fitar da 'yan kasar daga Iran. A ranar 14 ga Maris, wani jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta ba da izini ya koma da 'yan kasar Afirka ta Kudu 112.
An yi bincike na asibiti kafin tashi, kuma an bar 'yan Afirka ta Kudu hudu da ke nuna alamun cutar coronavirus don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da suka samu gwajin da ya yi mummunan sakamako ne aka mayar da su.
Sakamakon gwajin ya tabbatar da cewa duk 'yan Afirka ta Kudu ba su da cutar, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji, dukansu suna cikin kulawa mai kyau kuma suna cikin killacewa a cikin Ranch Resort na kwanaki 14.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki a wani bangare saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin daga jami'o'in Amurka sun hada kai don taimakawa wajen aika taimako zuwa sassan kasar Sin da suka kamu da cutar, inda wata kungiya ta hadin gwiwa a yankin Chicago ta aika da masks 50,000 na N95 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don kare "ƙungiyoyin da ke da haɗari a Afirka da Kudancin Asiya" da kuma tallafawa bincike da ƙoƙarin warkar da rigakafi.
InterExxon ta ruwaito cewa gwamnatin Sin ta ba da masks 200,000 ga Philippines a ranar 6 ga Fabrairu, lokacin da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da masks miliyan a Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayayyakin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da kayan aikin kiwon lafiya miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya daban-daban, ciki har da kayan aikin kiwon lafiya 10,000, kuma Amurka ta ba da kayayyakin kiwon lafiya tan 17.8 ga China da kuma alkawarin samun kudi na kudi miliyan 100 don ƙarin taimako ga kasashen da ke fama da cutar.
A watan Maris, kasar Sin da Cuba da kuma Rasha sun tura kayan kiwon lafiya da kwararrun masana zuwa Italiya don taimakawa wajen magance barkewar cutar korona.
Mai kasuwanci Jack Ma ya aika da kayan gwaji miliyan 1.1 da abin rufe fuska miliyan 6, da kuma kayan kariya 60,000 zuwa Addis Ababa, Habasha, don rarraba ta kungiyar Afirka.
Daga bisani, ya aika da kayan gwaji 5,000, da masks na fuska 100,000 da kuma na'urori masu iska biyar zuwa Panama.
Ma ta kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun bayyana damuwarsu game da masks da kayan gwaji da aka yi a kasar Sin.
Misali, Spain ta dawo da kayan gwajin coronavirus 58,000 da kasar Sin ta yi da daidaito na 30% kawai, yayin da Netherlands ta dawo da kayan rufe fuska 600,000 na kasar Sin da suka lalace.
Belgium ta dawo da masks 100,000 da ba su da amfani, wadanda aka yi zaton sun fito ne daga China amma a gaskiya sun fito ne daga Colombia.
A gefe guda kuma, tallafin da kasar Sin ta bayar a Latin Amurka da wasu sassan Afirka na samun karbuwa sosai. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da wani shiri na gaggawa na taimakon kasashen da ke tasowa.
WHO ta yaba da kokarin da hukumomin kasar Sin ke yi wajen sarrafa cutar.
WHO ta yi nuni da bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin kasar Sin da tsare sirri wanda ya hana kokarin hanawa da kuma hanawa, da kuma rikicin da ke faruwa a yanzu inda gwamnatin tarayya ta "bayar da sabuntawa akai-akai domin kauce wa tsoro kafin hutun sabuwar shekara".
A ranar 23 ga watan Janairu, a cikin martani ga hukuncin da hukumomin tsakiya suka yanke na aiwatar da takunkumin sufuri a Wuhan, wakilin WHO Gauden Gallia ya ce yayin da "ba a ba da shawarar da WHO ta yi ba" wannan "yana nuna muhimmin alamar sadaukarwa ga dakile cutar a inda ta fi kasancewa" kuma ya kira ta "ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagar gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagar gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagar gagarumin gagarumin gagar gagarumin gagarumin gagarumin gagarumin gagarumin gagar gagarumin gagarumin gagarumin gagarumin gagar gagarumin gagar gagarumin gagar gagar gagarumin gagarumin gagarumin gagarumin gagarumin gagarumin gagar gagarumin gagarumin gagar gagarumin gagar gagar gagarumin gagarumin gagarumin gagarumin gagar gagarumin gagarumin gagar gagarumin gagarumin gagar gagarumin gagarumin gagar gagar
Darakta Janar na WHO, Tedros Adnanom, ya ce, PHEIC na haifar da "hadarin yaduwar duniya, musamman a ƙasashe masu karamin da matsakaitan kudade ba tare da ingantaccen tsarin kiwon lafiya ba.
A mayar da martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya ce "babu wani dalili na irin wadannan matakan da ke tsoma baki cikin tafiye-tafiye da kasuwanci na kasa da kasa ba tare da dalili ba" kuma "WHO ba ta bada shawarar hana kasuwanci da zirga-zirga".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 don shirya dabarun a cikin ƙasashen da ke da ƙananan kudade, inda ta ambata bukatar taimakawa ƙasashen da "ba su da tsarin gano mutanen da suka kamu da cutar, ko da kuwa ta fito".
Tedros ya kara da cewa, "mu na da karfi ne kawai kamar yadda muke da rauni" kuma ya bukaci al'ummar duniya da su "yi zuba jari a yau ko kuma su biya karin a baya". A ranar 11 ga watan Fabrairu, WHO ta kafa COVID-19 a wani taron manema labarai a matsayin cutar.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da "ba da ikon dukan tsarin Majalisar Dinkin Duniya a cikin martani".
Sakamakon haka ne aka kunna tawagar gudanar da rikicin Majalisar Dinkin Duniya, wadda ta daidaita martani na Majalisar Dinkin Duniya baki daya, wanda a cewar WHO zai "ba su damar mayar da hankali kan mayar da hankali kan lafiyar lafiyar yayin da sauran hukumomi za su iya amfani da kwarewarsu wajen magance tasirin zamantakewa, tattalin arziki da ci gaban da ke tattare da annobar".
A ranar 14 ga Fabrairu, an kunna wata ƙungiya ta WHO da ke jagorantar kasar Sin don ziyarci yankin don ba da gudummawar ƙasa ga masana WHO da na duniya a China, don taimakawa wajen gudanar da gida da kuma gudanar da taro tare da manyan cibiyoyin ƙasa da manyan cibiyoyin ƙasa don tantance "ciwo da kamuwa da cutar" da kuma tantance "samar da ayyukan amsawa a larduna da jihohi, gami da tsarin birane da na karkara", ta hanyar gudanar da bita da taro tare da manyan cibiyoyin ƙasa. A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa zai yiwu "duniya ta yi aiki sosai don shirya don cutar coronavirus", ta ce duk da cewa cutar za ta kasance da wuri a faɗi, amma dole ne ƙasashe su kasance a "mataki ɗaya na kasancewa a shirye".
A cikin martani ga barkewar cutar a Iran, WHO ta aika da wata ƙungiya ta hadin gwiwa don tantance halin da ake ciki. A ranar 28 ga Fabrairu, hukumomin WHO sun ce za a tantance barazanar cutar coronavirus a duniya daga "babba" zuwa "mafi girma", wanda shine mafi girman matakin faɗakarwa da kimanta haɗari.
Mike Ryan, darektan gudanarwa na shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa "wannan gwaji ne na gaskiya ga kowace gwamnati a duniya: lokaci ya yi da za a farka.
Wannan kwayar cutar na iya zuwa kuma kana bukatar ka kasance a shirye", yana mai cewa matakan da za su iya taimaka wa duniya ta kauce wa "a cikin mafi munin hali".
Ryan ya kara da cewa, bayanan da ake samu a yanzu ba su tabbatar wa hukumomin kiwon lafiya na duniya da su bayyana cutar ta duniya ba, yana mai cewa, irin wannan sanarwar za ta nuna "mu na yarda da cewa, kowane mutum a duniya zai fuskanci cutar".
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO "ta damu sosai game da haɗarin yaduwar cutar da haɗarin haɗari da haɗarin rashin aiki". WHO ta fuskanci babbar zargi a matsayin rashin kula da annobar, gami da jinkirin bayyana dokar ta baci ta lafiyar jama'a da kuma rarraba cutar a matsayin annoba.
A ranar 6 ga watan Afrilu, mutane 733,000 ne suka sanya hannu a kan wannan takardar, kuma sun hada da wata takardar neman murabus na Darakta Janar na WHO, Tedros Adonom.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada girmama hakkin kowa a lokacin annobar COVID-19.
Kungiyar ta ce kowa ya cancanci yin amfani da hanyoyin da za su kare ransa kuma wannan alhakin gwamnati ne.
Kungiyar ta jaddada cewa bai kamata a yi amfani da rashin albarkatu ko rashin inshorar lafiya a matsayin hujja ga nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, gami da nakasassu, kungiyoyin 'yan kasa, tsofaffi, wadanda suka yi gudun hijira, marasa gida, wadanda ke rayuwa a cikin matsanancin talauci, wadanda ke zaune a cikin karkara, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana su ba da ke bukatar taimakon gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar al'umma na rikicin COVID-19.
Kungiyar Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Takin Tattarin Takin Tattarin Tattarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin T
Daga manufofi zuwa ƙarfafa tsarin kiwon lafiya da kuma magance tasirin hanawa da hanawa tafiya daga tattalin arzikin duniya, Cibiyar Dijital ta ƙunshi mai bin ka'idojin ƙasa, kuma ana nufin taimaka wa ƙasashe su koya daga juna da kuma ba da gudummawa ga daidaitaccen amsawar duniya ga ƙalubalen coronavirus.
Gwamnatin kasar Sin ta yi ta sukar Amurka da Ministan Birtaniya Michael Gove da kuma dan Shugaban Brazil, Jair Bolsonaro, Eduardo Bolsonaro, kan yadda za su magance annobar da ke barkewa a lardin Hubei na kasar Sin.
An kori gwamnoni da dama na jam'iyyar kwaminis ta kasar Sin (CPC) a matakin larduna don magance matakan killace mutane a tsakiyar kasar Sin, a matsayin alamar rashin jin dadin da jami'an siyasa suka yi game da barkewar cutar a yankunan.
Wasu masu sharhi sun yi imanin cewa wannan matakin na nufin kare Sakatare Janar na jam'iyyar kwaminis ta kasar Sin, Xi Jinping daga fushin jama'a kan barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da wani abin da ya riga ya yarda da barkewar cutar coronavirus da ta fara a Wuhan, a bangaren makirci game da COVID-19 da ke fitowa daga Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta kira coronavirus "Cinese virus" ko "Wuhan virus", inda ta ce "tsarin sarrafawa na China ya juya wani cutar zuwa cutar ta duniya", wanda wasu masu sukar suka yi la'akari da nuna wariyar launin fata da "rashin nasarar gwamnatinsu wajen hana cutar".
Jaridar Daily Beast ta samu wata sakon gwamnatin Amurka, wadda ta nuna rashin amincewar sadarwa da ke da tushe a majalisar tsaro ta kasa, inda aka ambata cewa dabarar ita ce "dukkanin kasar Sin ce.
Ana tambayar mu mu yi kokarin tura wannan sakon ta kowace hanya, ciki har da taron manema labarai da halartar talabijin. "Kayan tallace-tallace kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ta yi na tura tallafi ga kasashen da suka kamu da cutar wani bangare ne na yakin neman zabe don kara tasiri a duniya.
Shugaban harkokin wajen EU, Josep Borrell, ya yi gargadin cewa yana da "dandalin siyasa na duniya wanda ya hada da gwagwarmaya don tasiri ta hanyar juyawa da kuma 'yancin siyasa'".
Borel ya kuma ce "China tana tura sakon da ya dace cewa ba kamar Amurka ba, ita ce mai daukar nauyi da kuma amintacciyar hadin gwiwa".
China ta kuma bukaci Amurka ta cire takunkumi a kan Syria, Venezuela da Iran, inda ta aika da taimakon da ake zargin ta yi wa kasashen biyu.
An dakatar da bayar da masks 100,000 na Jack Ma ga Cuba a ranar 3 ga Afrilu ta hanyar takunkumin Amurka.
An kuma zargi hukumomin Amurka da sauya tallafin da aka yi wa wasu al'umma don su yi wa kasarsu.
Kuma akwai rikice-rikice game da abin rufe fuska tsakanin Jamus, Austria da Switzerland; da sauran ƙasashe kamar Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan masu sanyaya iska da aka yi niyyar kawowa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin gwiwar Tarayyar Turai da Italiya da ke fama da cutar coronavirus.
Jakadan Italiya a Tarayyar Turai Maurizio Massari ya ce "Kasar Sin ce kawai ta amsa a hanya ta biyu.
Hakika, wannan ba kyakkyawan alamar haɗin kai ba ne a Turai".
A ranar 22 ga watan Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya a aika da likitocin soja, na'urorin kashe kwayoyin cuta na musamman da sauran kayan aikin likita zuwa sojojin Rasha.
Jaridar La Stampa ta Italiya ta yi magana game da wani "babban jami'in siyasa" da ba a san shi ba, inda ta ce kashi 80 cikin 100 na taimakon da Rasha ta ba su "ba su da amfani ko kuma ba su yi amfani da Italiya sosai ba".
Wannan majiyar ta zargi Rasha da yin "tabbatar siyasa da siyasa".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi Di Mio, sun musanta rahotannin kafofin watsa labarai kuma sun nuna godiya.
Rasha ta tura kayayyakin kiwon lafiya zuwa Amurka ta jirgin sama mai dauke da kaya.
Kakakin Kremlin Dmitry Peskov ya ce: "Yayin da [Putin] ya ba da taimako ga abokan aikinsa na Amirka, ya yi imanin cewa idan masana'antun Amirka suka ƙara samar da kayan aikin likita da kayan aiki, za su iya biya su idan ya cancanta".
A Jamus, Poland, da kuma Baltic States, za a gudanar da mafi girma NATO yakin motsa jiki, NATO "Defender 2020" soja motsa jiki a low matakin.
Sakatare Janar na Kisan Nukiliya Kate Hudson ya soki aikin Defender 2020: "A cikin rikicin kiwon lafiyar jama'a na yanzu, ba wai kawai yana barazanar rayuwar sojojin Amurka da na kasashen Turai da dama ba, har ma da mazaunan kasashen da suka halarci aikin da suke yi". Gwamnatin Iran ta yi matukar fama da cutar, inda kusan 'yan majalisa biyu suka kamu da cutar da wasu 'yan siyasa goma sha biyar na yanzu ko kuma na baya.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta jama'a ga shugabannin duniya a ranar 14 ga Maris, 2020, yana neman taimako, inda ya ce kasarsa, Iran, tana fama da fama da annobar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka a kan ta. Wannan annobar ta haifar da kiran Amurka ta daidaita manufofin zamantakewa a sauran ƙasashe masu arziki, gami da kula da lafiya ta duniya, kula da yara ta duniya, hutun iyali mai biya, da kuma samun babban matakin kuɗi ga lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen cewa hakan zai iya shafar yiwuwar sake zabar Donald Trump a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta lalace saboda annobar.
Koriya ta Kudu ta soki Japan ta "tabbatar da ita da kuma kokarinta na yin rigakafi" lokacin da Japan ta sanar da cewa za a killace duk wanda ya zo daga Koriya ta Kudu a wuraren da gwamnati ta tsara na tsawon makonni biyu.
A farkon, al'ummar Koriya ta Kudu sun kasance cikin rikici game da yadda Shugaba Moon Jae - in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun da suka yi kira ga a yi wa Moon shari'a, suna da'awar cewa gwamnati ta yi rashin kula da annobar, ko kuma sun yaba da martani.
Wasu masu sharhi sun nuna damuwa cewa hakan zai iya taimaka wa gwamnatoci su karfafa karfin su.
A Hungary, majalisa ta amince da firaminista Viktor Orbán ya yi mulki har abada ta hanyar jefa kuri'a, ta dakatar da majalisa da kuma zaben, kuma ta hukunta wadanda aka gano suna magance cutar da kuma rikicin da kuma yada labaran karya game da gwamnati.
An danganta barkewar cutar ta coronavirus da misalai da yawa na rashin wadata, wanda ya samo asali ne daga amfani da kayan aiki don yaƙar barkewar cutar a duniya, cinikin tsoro, da katsewa a cikin masana'antu da ayyukan kayan aiki.
Hukumar Kula da Abinci da Magunguna ta Amurka ta yi gargadi game da karancin magunguna da na'urorin likita saboda karuwar bukatar masu amfani da kuma tsangwama ga masu samarwa.
An kuma lura da yanayin cin kasuwa mai tsoron gaske a wurare da yawa, wanda ya haifar da rashin kayan masarufi kamar abinci, takarda gidan wanka, da ruwan kwalba, wanda ya haifar da raguwar wadata.
Musamman masana'antar fasaha an yi gargadin su game da jinkirin jigilar kayan lantarki.
A cewar Darakta Janar na WHO, Tedros Adnanom, bukatar kayan tsaro ta mutum ta karu sau 100.
Wannan bukatar ta sa farashin ya karu har zuwa sau ashirin, tare da jinkirin samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Wannan ya haifar da karancin kayan aikin kare lafiyar mutum a duniya, wanda WHO ta yi gargadin cewa zai sa ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba masu sayen Digo sabuwar dama ta sayar da kayayyakin Australiya a kasar Sin.
Wannan aikin ya haifar da karancin kayan abinci ga jarirai a wasu manyan kantuna kuma daga baya gwamnatin Australiya ta haramta shi. Duk da yawan adadin shari'o'in COVID-19 da kuma bukatar abinci mai yawa a yankin Arewacin Italiya da Wuhan, duk yankunan biyu suna guje wa matsanancin karancin abinci.
Matakan da kasar Sin da Italiya suka dauka kan adana kayayyaki masu muhimmanci da kuma cinikin haram sun yi nasara, wanda ya hana matsanancin karancin abinci da aka yi hasashen a Turai da kuma Arewacin Amirka.
Arewacin Italiya ba ta ga raguwar yawan aikin gona ba, amma a cewar wakilan masana'antu farashin zai iya tashi.
An ga ɗakunan abinci masu ɗamara a birnin Wuhan ne kawai na ɗan lokaci, yayin da jami'an gwamnatin China suka saki shagunan shan nama don tabbatar da isasshen abinci ga jama'a.
Irin wannan dokar ta Italiya ta sa ya zama wajibi ga masu samar da abinci su ajiye kayayyaki don irin wannan gaggawa.
Kasashen duniya sun ji rauni a China: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, matakan gwamnati na hana yaduwar cutar, da kuma raguwar tallace-tallace na 20.5% sun yi mummunan rauni ga tattalin arzikin kasar Sin a farkon watanni biyu na shekarar 2020.
Tun da kasar Sin tana da babbar tattalin arziki da cibiyar masana'antu, an yi la'akari da barkewar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agathe Demaris na Cibiyar Ilimin Tattalin Arziki ya yi hasashen cewa kasuwanni za su kasance masu saurin tashi har sai an samu cikakken bayani game da sakamakon da zai iya faruwa.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa sakamakon tattalin arzikin annobar a kan ci gaban duniya zai iya fi karfin annobar SARS ta 2002-2004.
Wani masanin jami'ar Washington a St. Louis ya kiyasta tasirin dala biliyan 300+ a kan sarkar samar da kayayyaki a duniya wanda zai iya wuce shekaru biyu.
Kungiyar kasashen da ke fitar da man fetur (OPEC) ta yi "rashin ƙarfi" bayan da farashin mai ya ragu sosai saboda raguwar bukatar da ake samu daga China.
Kasuwancin jari na duniya ya fadi a ranar 24 ga Fabrairu saboda karuwar adadin shari'o'in COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, saboda damuwa game da barkewar cutar coronavirus, wasu alamun jari na Amurka, gami da NASDAQ-100, S&amp;P 500 Index, Dow Jones Industrial Average, sun ba da rahoton raguwa mafi girma tun daga 2008, inda Dow ya faɗi maki 1,191, wanda shine mafi girma a cikin rana ɗaya bayan rikicin kuɗi na 2007-08.
Dukkanin alamun sun fadi sama da kashi 10 cikin 100 a wannan makon.
A ranar 28 ga watan Fabrairu, kamfanin SCOP Rating GmbH ya tabbatar da cewa kasar Sin tana da cikakken cancanta ta bashi, amma ya ci gaba da yin mummunan zato.
Kashewar hannun jari ya sake raguwa bisa ga fargaba na coronavirus, mafi girma ya faru a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya zama mummunan yanayi.
Masanin tattalin arziki Mohammad Al-Erian ya yaba da matakan gaggawa da manyan bankuna da jihohi suka dauka a kan lokaci.
Babban Bankuna na duniya suna amsawa da sauri fiye da rikicin kudi na 2008.
Yawon shakatawa yana daya daga cikin yankunan da suka fi fama da cutar saboda dokar hana fita, rufe wuraren jama'a ciki har da wuraren jan hankali, hana duk wani tafiya a duniya.
A sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Quants sun soke jiragen saboda karancin bukatar, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya fadi.
Wannan shi ne tasiri mafi girma da aka gani a kan masana'antar jirgin ruwa.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da dama.
Lokaci na annobar ya yi daidai da lokacin babban lokacin tafiya na hutun sabuwar shekara ta kasar Sin, lokacin Chunyuan.
Gwamnatocin ƙasa da na yanki sun soke manyan abubuwan da ke faruwa, gami da bikin Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu da ke rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe wasu abubuwan bikin sabuwar shekara da wuraren yawon bude ido da yawa a Beijing don hana taron jama'a, gami da Forbidden City da kuma bikin haikalin gargajiya.
A cikin 24 daga cikin larduna 31 da karamar hukuma da yankuna a kasar Sin, hukumomi sun kara hutun sabuwar shekara zuwa 10 ga Fabrairu, tare da umarnin da yawancin wuraren aiki kada su sake budewa zuwa wannan ranar.
Waɗannan yankuna suna wakiltar kashi 80 cikin 100 na GDP na ƙasar da kuma kashi 90 cikin 100 na fitarwa.
Hong Kong ta kai matakin mayar da martani ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
A Turai da Latin Amurka, yawon shakatawa na masu sayarwa ya ragu da kashi 40%.
Kasashen Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar kashi 50-60%.
Yawan masu zuwa shagon a watan Maris ya ragu da kashi 33 zuwa 43 bisa dari idan aka kwatanta da watan Fabrairu.
Masu gudanar da shagon duniya sun ɗauki ƙarin matakai, kamar ƙara tsabta, kafa masu duba zafin jiki na masu siyayya, da soke bukukuwa. A cewar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don kimanta Latin Amurka, koma bayan tattalin arziki da annobar ta haifar zai iya jefa mutane miliyan 14 zuwa 22 cikin matsanancin talauci a Latin Amurka waɗanda ba za su kasance cikin yanayin da ba tare da annobar ba.
A cikin watan Janairu da Fabrairun 2020, a lokacin da annobar ta yi zafi a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
A kasar Sin, kimanin ma'aikata masu hijira miliyan 300 ne da ke cikin gidajensu a lardunan cikin gida ko kuma a lardin Hubei. A watan Maris na shekarar 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Rikicin coronavirus na iya haifar da raguwar ayyuka miliyan 47 a Amurka kuma ƙididdigar rashin aikin yi na Bankin Tarayya na St. Louis na iya sauka zuwa 32% . Yawan miliyoyin ma'aikatan da ke ƙaura zuwa Indiya sun rasa aikin yi saboda kulle-kullen (wanda ake biya ta hanyar albashi na yau da kullun). Binciken da aka yi daga Cibiyar Angus Read ya gano cewa kashi 44% na iyalai na Kanada sun sami rashin aikin yi na wani nau'i. Ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da suka shiga kulle-kullen a tsakiyar Maris 2020.
A lokacin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi amfanin rashin aikin yi na wucin gadi kuma ma'aikata miliyan 1 na Birtaniya sun nemi shirin bashi na duniya. Kimanin rabin miliyan kamfanoni a Jamus sun tura ma'aikatansu zuwa makarantu na aiki na gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbet.
Faransa da Birtaniya sun amince da tsarin biyan kuɗin aiki na ɗan gajeren lokaci na Jamus.
Yankin fasahar wasan kwaikwayo da al'adun gargajiya sun shafar cutar sosai, wanda ya shafi ayyukan ƙungiyoyi a duniya da kuma mutane masu aiki da masu aiki da kansu.
Kungiyoyin da ke cikin fannin fasaha da al'adu sun yi ƙoƙari su ci gaba da aikinsu (wanda aka ba da kuɗi ta jama'a) don samar da damar samun al'adun al'adu ga al'umma, kula da lafiyar ma'aikatan su da jama'a da kuma tallafawa masu fasaha a duk inda zai yiwu.
Kamar yadda na Maris 2020, a duk faɗin duniya da kuma a cikin bayanan daban-daban, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu an rufe su har abada tare da soke ko dakatar da nune-nunen su, bukukuwan su da nune-nunen su.
A sakamakon haka, an yi ƙoƙari sosai don samar da ayyuka na madadin ta hanyar dandamali na dijital. Wani sabon cuta da ke saurin ƙaruwa a kwanan nan shine soke ayyukan addini, manyan bukukuwan wasanni, da sauran bukukuwan zamantakewa, kamar bukukuwan kiɗa da taron fasaha da nunin salon.
A cikin wata sanarwa da aka yi a birnin Vatican, an sanar da cewa an soke kallon mako mai tsarki a Roma, wanda ya faru a makon ƙarshe na zaman Kirista na Lent.
Yawancin bishops-ƙungiyoyi sun ba da shawarar dattawa su zauna a gida maimakon halartar taro a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kai tsaye ta kan layi ko talabijin, yayin da wasu ke ba da sabis na drive-in.
A cikin wani labarin da ya nuna cewa a cikin wani labarin da aka rubuta a cikin littafin nan, an rubuta cewa: "A cikin littafin nan, an rubuta cewa: 'Abin da ya faru a cikin wannan labarin, an rubuta shi a cikin littafin nan: 'Abin da ya faru a cikin wannan labarin, an rubuta shi a cikin littafin nan: 'Abin da ya faru a cikin wannan labarin' .
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, kuma daga bisani aka rufe wuraren ibada, yayin da Saudiyya ta haramta shigar da baƙi da baƙi zuwa wuraren ibada a Makka da Madina.
Cutar ta haifar da babbar matsala a cikin kalandar wasanni a duniya tun lokacin yakin duniya na biyu.
Yawancin manyan wasannin wasanni sun soke ko kuma an dakatar da su, gami da gasar zakarun Turai ta 2019, Premier League ta 2019, UEFA Euro 2020, 2019-20 NBA Season, da kuma 2019-20 NHL Season.
Cutar ta rushe shirin gasar Olympics ta bazara ta 2020, wanda aka tsara don farawa a ƙarshen Yuli; kwamitin Olympics na duniya ya sanar a ranar 24 ga Maris cewa za a sake shirya taron "daga 2020 zuwa kwanan wata amma ba daga lokacin bazara na 2021 ba". An rufe gidajen caca da sauran wuraren caca a duniya kuma an dage ko soke wasannin karta na rayuwa.
Wannan ya sa yawancin masu caca suna amfani da hanyar kan layi, wanda ya ba da rahoton ƙaruwa mai yawa a cikin ƙimar sabon sa hannu a shafukan caca na kan layi. Hakanan masana'antar nishaɗi ta sha wahala, tare da ƙungiyoyin kiɗa daban -daban da suka dakatar ko soke kide - kide.
Yawancin manyan gidajen wasan kwaikwayo kamar na Broadway sun dakatar da duk wasan kwaikwayon.
Wasu masu fasaha sun gano hanyoyin ci gaba da aiki da raba su a kan intanet a matsayin madadin ga ayyukan rayuwa na gargajiya, kamar yin raye-raye na wasan kwaikwayo ko "aikin" na yanar gizo don yin wasan kwaikwayo, rarrabawa da kuma tallata aikin su.
A kan layi, yawancin abubuwan da ke tattare da coronavirus na intanet sun bazu a matsayin abin dariya da damuwa a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar nuna bambanci, ƙiyayya da wariyar launin fata ga mutanen da ke da asalin Sin da Gabashin Asiya, da kuma mutanen da ke da wuraren zafi a Turai, Amurka da sauran ƙasashe.
Kasashe da dama, musamman Turai, Gabashin Asiya, Arewacin Amurka da kuma yankin Asiya Pacific sun ga abubuwan tsoro, shakku da kuma rashin jituwa.
Rahotanni daga watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ke iyakance ga China) sun rubuta ra'ayoyin wariyar launin fata na mutanen China a cikin kungiyoyi daban-daban a duniya game da cancantar samun kwayar cutar ko samun hukunci mai kyau.
Wasu ƙasashen Afirka sun ga karuwar rashin amincewar Sin.
Mutane da yawa a Wuhan da Hubei sun ruwaito nuna bambanci bisa ga asalin yankin su.
Akwai taimako na kan layi da kuma na waje ga mutanen China da kuma mutanen da ke yankunan da cutar ta shafa.
Bayan ci gaban annobar a cikin sabbin ƙasashen da ke da zafi, mutanen Italiya, ƙasar Turai ta farko da ta fara fuskantar mummunan annobar COVID-19, na iya fuskantar shakku da ƙiyayya. 'Yan ƙasa daga ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun da'awar hana Sinawa shiga ƙasashensu a ƙoƙarin hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
A kasar Sin da kuma sauran 'yan Asiya a Birtaniya da Amurka sun ruwaito karuwar cin zarafin wariyar launin fata da kuma hare -hare.
Shugaban Amurka Donald Trump ya fuskanci sukar kiransa coronavirus "Cinese virus", wanda masu sukar suka yi la'akari da shi wariyar launin fata da kuma adawa da kasar Sin.
Masu zanga-zangar a Ukraine sun kai hari kan bas din da ke dauke da 'yan Ukraine da kasashen waje da ke gudun hijira daga Wuhan zuwa Novi Sad.
Daliban da ke zuwa daga arewa maso gabashin Indiya, wanda ke da iyaka da China, waɗanda ke karatu a manyan biranen Indiya, an ce sun sha wahala daga cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata Party (BJP) a West Bengal, Dilip Ghosh, ya ce, 'yan kasar Sin sun lalata yanayi kuma saboda haka Allah ya yi musu sakamako.'
Daga bisani, ofishin jakadancin kasar Sin a Kolkata ya ce wannan bayanin "ba daidai ba ne". A kasar Sin, cutar ta karfafa zalunci da wariyar launin fata a kan mazaunan da ba Sinawa ba, inda aka bayyana 'yan kasashen waje a matsayin "ƙazanta na waje" da kuma "ƙazanta".
Wasu jaridu da ke da takardun biyan kuɗi sun cire su don wasu sassan ko duka ɗaukar hoto game da cutar coronavirus.
Yawancin masu wallafa kimiyya sun samar da takardun kimiyya game da annobar tare da buɗewa.
Wasu masana kimiyya sun zaɓi su raba sakamakon su da sauri a kan sabobin preprint kamar bioRxiv.
Cutar da ta taso - Cutar da ta taso ta fitowa, sau da yawa ta samo asali ne daga hanyar yaduwar cutar ko kuma hanyar watsawa
Duniya da cututtuka - Bayani na Duniya da Cutar Cutar
Jerin annoba da annoba - Jerin mutanen da suka mutu saboda cututtukan cututtuka
Cinikin dabbobin daji da cututtukan cututtuka - haɗarin kiwon lafiya da ke tattare da cinikin dabbobin daji na kasashen waje
Gwajin dakin gwaje-gwaje na cutar Coronavirus Disease 2019 (COVID-19) da kuma SARS-CoV-2 da ya danganci ya hada da hanyoyin gano bayyanar cutar da kuma gano rigakafin da aka samar a matsayin martani ga kamuwa da cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin samfurori ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da kamuwa da cuta ta kwanan nan ko ta aiki.
Ana iya amfani da gano rigakafi (aikin jini) don tantancewa da kuma lura da mutane.
Binciken rigakafi ya nuna yawan mutanen da suka kamu da cutar, har da wadanda alamun su suka yi sauki sosai ko kuma wadanda basu da alamun cutar.
Sakamakon wannan bincike zai iya tabbatar da ainihin mutuwar cutar da kuma matakin juriya na mutane.
Saboda karancin bincike, babu wata ƙasa da ta sami tabbataccen bayanai game da yaduwar cutar a cikin mutane har zuwa Maris 2020.
A ranar 23 ga watan Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3 cikin dari na yawanta kuma akwai rashin daidaito sosai game da yawan gwajin da aka yi a ƙasashe daban -daban.
Wannan rashin daidaito na iya shafar yawan mutuwar da aka ba da rahoton, wanda zai iya zama mafi girma a wasu ƙasashe.
Ana iya gwada samfurori na numfashi da aka samu ta hanyoyi daban -daban, gami da samfurori na nasagrasani fae ko bulgams, ta amfani da Real - Time Reverse Transcription Polymerase Chain Reaction (rRT - PCR).
Sakamakon yakan kasance cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya tabbatar da gwajin RT-PCR da aka yi tare da ƙuƙwalwar ƙuƙwalwa a farkon makon cutar.
Daga baya, cutar za ta iya ɓacewa daga cikin makogwaro, yayin da ta ci gaba da girma a cikin huhu.
Ga mutanen da suka kamu da cutar da aka bincika a mako na biyu, za a iya ɗaukar samfurin daga cikin iska ta hanyar catheter mai tsotsa ko kuma a yi amfani da kayan da suka fito daga tari (balgam).
Daya daga cikin farkon gwajin PCR ta amfani da Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) an ci gaba da shi a Charité a Berlin a watan Janairun 2020, kuma ya zama tushen rarraba kayan aikin 250,000 ta WHO.
Kasar Ingila ta kuma ci gaba da samar da kayan gwajin har zuwa 23 ga Janairu 2020. Kamfanin Koriya ta Kudu Koganbiotech ya ci gaba da samar da wani nau'i na bincike, PCR-based SARS-CoV-2 Test Kit (Powercheck Coronavirus) a ranar 28 ga Janairu 2020.
Wannan bincike ya gano "E" gene wanda ake raba shi da dukkan beta coronavirus kuma musamman RdRp gene wanda ake samu a SARS-CoV-2. A China, BGI Group na daya daga cikin kamfanoni na farko da suka samu amincewa don amfani da gaggawa na PCR-based SARS-CoV-2 gwajin kit daga National Medical Products Administration of China. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) suna rarraba 2019-novel coronavirus (2019-nCoV) Real-time RT-PCR diagnostic panel ga dakunan gwaje-gwaje na kiwon lafiya na jama'a ta hanyar International Reagent Resources.
Tsoffin sigogi na kayan gwajin sun sami sakamako mara kyau saboda kuskuren masu aiki a cikin ɗayan binciken kwayoyin halitta guda uku, kuma sun haifar da matsala a cikin gwajin a CDC a Atlanta; wanda ya haifar da matsakaicin samfurin da aka yi nasarar sarrafawa a cikin Fabrairu 2020 gaba ɗaya ƙasa da samfurori 100 a rana.
Gwaje -gwaje da ke amfani da abubuwa biyu ba a tabbatar da su ba har zuwa 28 ga Fabrairu 2020 kuma ba a ba da izinin fara gwajin ga jihohi da kuma gidajen gwaje -gwaje ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin dokar ta baci ta amfani da shi.
Har zuwa 5 ga Maris, 2020, LabCorp ta sanar da samun gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
Quest Diagnostics ta samar da gwajin COVID-19 a duk fadin kasar nan har zuwa 9 ga Maris, 2020.
Babu iyakancewar adadi da aka sanar; dole ne a tattara samfurori da sarrafa su daidai da bukatun CDC.
A Rasha, Cibiyar Nazarin Virology da Biotechnology ta VECTOR ce ta kirkiro da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajista da wannan gwajin. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta ci gaba da gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, an ba da izinin FDA don gwajin da za a iya yi a cikin sa'o'i 3.5 don yin gwaji mai yawa, wanda zai haifar da kusan gwaje -gwaje 4,128 da za a iya yi a cikin sa'o'i 24 daga inji ɗaya.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa ga Laboratories na Abbot (EUA) don yin bincike akan tsarin Abbot na m2000; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermopisher Scientific a baya.
A ranar 21 ga Maris, 2020, Sheffield ta samu EUA daga FDA don bincike wanda ke ɗaukar kusan minti 45.
FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da ba a buƙatar jerin canje -canje na zafin jiki, wannan hanyar na iya samar da sakamako mai kyau a cikin ƙasa da minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka kuma Abbott na son kara samar da su don gwajin 50,000 a kowace rana. A Taiwan ana ci gaba da samar da wani kayan gwaji wanda ke amfani da rigakafin monoclonal wanda ke da alaƙa da ƙwayoyin nucleocapside (N) na kwayar cutar coronavirus, da fatan cewa zai iya samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin cutar mura mai tsanani.
Wani bita na wallafe -wallafe na Maris 2020 ya kammala cewa a farkon lokaci, radiograph na ƙirjin yana da ƙarancin mahimmancin asibiti, yayin da CT [computed tomography] za a iya samun sakamakon kafin bayyanar cututtuka.
Abubuwan da ke cikin CT na musamman sun haɗa da bilateral multilobber ground - glass opesification tare da rarraba ta gefe, asymmetric, da baya.
Yayin da cutar ta ci gaba, tasirin subplural, da kuma hauka da kuma karfafawa na ci gaba.
Nazarin da ya kwatanta PCR da CT a Wuhan, inda cutar ta samo asali a yanzu, ya nuna cewa CT tana da mahimmancin gaske fiye da PCR, duk da cewa ba ta da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran.
Kamar yadda na Maris 2020, Kwalejin Radiology ta Amurka ta bada shawarar cewa kada a yi amfani da CT a matsayin gwaji ko gwajin layi na farko don gano COVID-19. Kamar yadda na Maris 2020, CDC ta bada shawarar PCR don gwajin farko.
Wani ɓangare na maganin rigakafi ga kamuwa da cuta ya ƙunshi samar da rigakafi, gami da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta don tantance rigakafi da ke farawa a cikin mutane a cikin kwanaki 7 ko makamancin haka bayan bayyanar cututtuka da kuma lura da mutane. Ana iya gwada gwaje -gwaje a cikin manyan dakunan gwaje -gwaje (CLT) ko kuma ta hanyar gwajin kulawa (PoCT).
A cikin dakunan gwaje -gwaje da yawa, za a iya yin waɗannan gwaje -gwajen ta hanyar tsarin sarrafa kansa mai ƙarfin gudana mai ƙarfi amma kasancewa a ciki zai dogara da yawan samar da kowace tsarin.
Ana amfani da samfurin jini guda ɗaya don CLT, duk da haka ana iya amfani da jerin samfurori don lura da amsa mai hanawa.
Ana samun jini guda ɗaya daga cikin fata don PoCT.
Ba a buƙatar matakin janyewa na farko don gwaji daban da hanyoyin PCR. A ranar 26 ga Maris, 2020, FDA ta nada raka'a 29 waɗanda ke ba da sanarwar ga Hukumar idan ya cancanta kuma don haka yanzu suna iya rarraba gwajin rigakafin su.
A ƙarshen watan Maris na 2020, EuroImmun Medical Laboratory Diagnostics & Apitope Diagnostics ta sami amincewar Turai don kayan gwajin ta wanda zai iya gano IgG da IgA rigakafi ga ƙwayoyin cuta a cikin samfurin jini.
Yana da ikon gwada daruruwan samfurori a cikin 'yan sa'o'i kaɗan kuma saboda haka yana da sauri fiye da gwajin PCR na gargajiya na RNA na kwayar cuta.
Ana iya gano rigakafin bayan kwanaki 14 bayan fara kamuwa da cuta. A farkon watan Afrilu, Birtaniya ta gano cewa babu wani kayan gwajin rigakafin da suka saya da ya isa amfani da shi.
Hong Kong ta shirya inda marasa lafiya masu shakku za su iya zama a gida, Sashen gaggawa za su samar da bututun samfurin ga mai haƙuri, za su yi ta busa shi kuma su dawo da sakamakon binciken ba da daɗewa ba. NHS ta Burtaniya ta sanar da cewa suna fara shirin yin binciken gida na masu cutar da ake zargi, wanda ke kawar da haɗarin mai haƙuri na kamuwa da wasu idan ya je asibiti ko kuma ya kawar da haɗarin lalata motar asibiti da aka yi amfani da ita.
Cibiyoyin binciken da aka yi ta hanyar motsa jiki sun taimaka wajen yin bincike mafi sauri, mafi girma fiye da kowace ƙasa a Koriya ta Kudu. A Jamus, Ƙungiyar Likitocin Kiwon Lafiya ta Kasa ta Sanar da Lafiya ta Sanarwar ta ce a ranar 2 ga Maris cewa a cikin yanayin asibiti suna da damar yin bincike kusan 12,000 a kowace rana kuma sun yi 10,700 a makon da ya gabata.
Idan likita ya ba da umarnin a yi bincike, asusun inshorar lafiya ne zai biya kuɗin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin bincike 160,000 a mako.
Har zuwa 19 ga Maris, ana ba da gwajin motsa jiki a cikin manyan birane.
Har zuwa 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
Binciken farko na dakin gwaje-gwaje ya lura cewa a kalla a kalla samfurori 483,295 ne aka gwada a mako 12/2020, wanda ya hada da mako 12/2020 kuma samfurori 33,491 (6.9%) sun tabbatar da cewa SARS-CoV-2 ya tabbata. A Isra'ila, masu bincike a asibitin Technion & Rembrandt sun ci gaba da bincike da kuma bincika samfurori daga marasa lafiya 64 a lokaci guda, ta hanyar haɗa samfurori da kuma idan an gano cewa samfurin ya tabbata. A Wuhan, BGI ta fara binciken wani dakin gwaje-gwaje na gaggawa na mita 2000 mai suna "Huo-Yan" (Cinyanci: 火眼, ko "Fire Eye" a Turanci) a ranar 5 ga Fabrairu, 2020, wanda zai iya sarrafa samfurori sama da 10,000 a rana.
Da kuma daukar kwanaki 5 da yin shiri da Wanda ya kafa BGI, Wang Jian, model ya lura cewa idan ba a fara wannan bincike ba, adadin masu cutar a Hubei zai karu da kashi 47% kuma kudin da ake kashewa wajen magance killacewa zai ninka.
Cibiyar binciken Wuhan Laboratory ta yi saurin bin diddigin Hue-yen Laboratories a birnin Shenzhen, Tianjin, Beijing da Shanghai, a cikin birane 12 a duk faɗin kasar Sin.
A ranar 4 ga Maris, 2020, jimlar damar yau da kullun ta kasance gwaje -gwaje 50,000 a kowace rana. Origiami Asse ta ba da tsarin bude tushen da aka nuna wanda zai iya bincika samfurori daga mutane 1122 na marasa lafiya na COVID19 ta amfani da gwaje -gwaje 93. Wadannan tsarin daidaitaccen za a iya gudanar da su a cikin ƙananan dakunan gwaje -gwaje ba tare da buƙatar sarrafa kayan aikin robotic ba.
Kafin watan Maris, rashin isasshen reagent da kuma karancin adadin sun zama matsala a manyan gwaje -gwaje a EU, UK da Amurka.
Wannan ya sa wasu marubuta su gano wasu hanyoyin samfurori da suka hada da dumama samfurori a 98 °C (208 °F) na minti 5 don fitar da RNA genome don ƙarin bincike. A ranar 31 ga Maris, an sanar da cewa United Arab Emirates yanzu tana gwada yawanta don cutar coronavirus fiye da kowace ƙasa a kan mutum, kuma tana kan hanyar ƙara yawan gwajin don isa ga babban yawan jama'a.
Wannan ya faru ne saboda haɗuwa da ikon duba ta hanyar tuki da kuma sayen dakin gwaje -gwaje mai yawa daga Group 42 da BGI (wanda ya dogara da dakin gwaje -gwajen gaggawa na "Huo - Yan" a China).
An gina dakin gwaje -gwaje a cikin kwanaki 14 kuma yana iya yin dubban gwaje -gwajen RT - PCR a kowace rana kuma shine dakin gwaje -gwaje na farko a duniya da ke aiki a irin wannan babban matakin a wajen China.
An kirkiro hanyoyin bincike daban-daban da ke niyya ga sassa daban-daban na bayanan kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta amince da kuma tura tsarin Jamus na samar da kayan aiki don bunkasa kasashe masu karamin kudin shiga da ke da karancin albarkatu.
An buga dokar Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba ta kasance ba har zuwa 28 ga Janairu, wanda ya jinkirta samun gwajin a cikin Amurka. A farkon barkewar cutar akwai matsaloli game da amincin kayan aikin gwaji tsakanin China da Amurka kuma ba su iya samar da isasshen kayan aikin don biyan buƙatun bincike da shawarwari daga masana kiwon lafiya na kasar da na Ostiraliya ba.
Akasin haka, masana sun bayyana cewa samun wadataccen bincike a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta ci gaba da bunkasa ikon yin gwaji a tsawon shekaru, musamman a cikin dakunan gwaje -gwaje na masu zaman kansu.
A ranar 16 ga watan Maris, WHO ta ce, kara yawan shirye-shiryen bincike shine hanya mafi kyau don rage karuwar cutar COVID-19. Babban bukatar bincike saboda yaduwar cutar ya haifar da tara dubban gwaji a cikin dakunan gwaje-gwaje na Amurka masu zaman kansu da kuma samar da magunguna da sinadarai sun zama masu wahala.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton matsalolin daidaito a cikin kayan gwajin ta.
A Amurka, an samu karancin kayan gwajin da CDC ta samar; sai gwamnatin ta kawar da matsalolin da ke hana gudanar da bincike na sirri. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Biogeji Biotechnology Co., Ltd na kasar Sin, amma ta gano cewa sakamakon bai dace ba.
Kamfanin ya bayyana cewa sakamakon da bai dace ba zai iya faruwa ne saboda rashin samun samfurori ko kuma rashin amfani da kayan aikin yadda ya kamata.
Ma'aikatar Spain ta ce za ta cire kayan gwajin da ba daidai ba kuma ta maye gurbin su da wasu kayan gwajin da Shenzhen Biogie ta samar. Kashi 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamako mara kyau.
Firayim Minista Matovič ya ba da shawarar cewa a jefa su cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce, kayan gwajin da Turkiyya ta saya daga China suna da ƙimar kuskure mai yawa kuma ba ta amfani da su ba.
Bayan an gwada, an sanya mutanen da suka samu cutar a cikin killace da kuma gano mutanen da suka samu cutar SARS-CoV-2 sun samu sakamako mai kyau.
A wurin mutuwar farko ta COVID-19 a Italiya, masu bincike da ke aiki a garin Vò na Italiya sun gwada kusan mutane 3,400 sau biyu a cikin kusan kwanaki goma.
Kusan rabin mutanen da suka samu sakamako mai kyau ba su da wata alama, kuma an killace duk wadanda aka gano.
Dakatar da tafiya a wurin da ake zuwa da zuwa ya kawo ƙarshen sabon kamuwa da cuta.
Ta hanyar gano lamba ta hanyar ta'addanci, ta hanyar hana tafiye-tafiye na cikin gida, ta hanyar bincika da killacewa, amma ba tare da tsauraran ƙuntatawa kamar rufe gidajen abinci da shagunan siyarwa ba, annobar cutar coronavirus ta 2020 tana taɓarɓarewa a Singapore a cikin jinkiri fiye da sauran ƙasashe masu tasowa.
An soke wasu shirye-shirye, kuma Singapore ta fara ba da shawara ga mazauna gida daga ranar 28 ga Maris, amma ta sake buɗewa a kan lokaci a ranar 23 ga Maris bayan an yi hutu a makaranta.
Wasu kasashe da dama, kamar Iceland da Koriya ta Kudu sun kuma yi amfani da hanyar gano lamba, hana tafiye-tafiye na cikin gida, bincika da killacewa, amma ta hanyar kulle-kulle mai rauni.
Binciken kididdiga ya nuna cewa kasashen da suka samu karin bincike fiye da wadanda suka mutu, suna da karancin adadin mutuwar, mai yiwuwa saboda kasashen sun fi iya gano wadanda ke da alamun rashin lafiya ko kuma marasa cutar.
WHO ta ba da shawarar cewa kasashen da ba su da damar yin gwaji kuma waɗanda dakunan gwaje -gwaje na kasa da ke da iyakantaccen gogewa kan COVID-19 su aika da samfurori na farko na COVID-19 na farko biyar da na farko na 10 masu cutarwa zuwa ɗayan dakunan gwaje -gwaje na WHO 16 don tabbatarwa.
Daga cikin dakunan gwaje -gwaje 16 da aka yi amfani da su, 7 a Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka da 1 a Ostiraliya.
A cikin jadawalin da ke ƙasa, tsarin binciken ƙasar yana rinjayar kashi 1 cikin 100 na masu gwajin da suka dace.
A wasu kalmomi, a cikin wata ƙasa da ake gwada asibiti ne kawai, yawan masu gwajin zai fi na ƙasar da ake gwada dukkan 'yan ƙasa, ko suna da alamun cutar ko a'a.
Wanke hannu (ko kuma wanke hannu), wanda aka fi sani da tsabtace hannu, aiki ne na wanke hannuwanmu don kawar da ƙasa, man fetur, ƙwayoyin cuta ko wasu abubuwa marasa kyau.
Yin wanka a kai a kai da sabulu a "lokaci na gaggawa" a rana yana hana yaduwar cututtuka da yawa, kamar su asma da hauka, da ke yaduwa ta hanyar fitsari.
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko sanyi na yau da kullum, misali, idan ba su wanke hannuwansu kafin su taɓa idanunsu, hancinsu ko bakinsu (watau, ƙwayar cuta).
Abubuwa biyar masu muhimmanci a rana da ake bukatar wanke hannu da sabulu su ne: kafin da bayan wanka, bayan wanke ko sauya suturar jariri, kafin a ciyar da jariri, kafin a ci abinci, da kuma kafin a shirya abinci ko kuma bayan cin naman alade, kifi ko kaza.
Idan babu ruwa da sabulu, za a iya wanke hannuwanka da toka.
Kafin, a lokacin da kuma bayan da aka shirya abinci.
Kafin ka kula da wani mai ciwo da kuma bayan ka kula da shi.
Bayan an sauya dan jariri ko kuma an wanke shi bayan ya yi amfani da gidan wanka.
Bayan ka zubar da hanci, ka ji tsami ko kuma ka yi cizon sauro.
Bayan shan dabba, naman dabba, ko kuma shan dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace jiki da suka shafi hanyoyin magani.
Yin wanka kafin a ba da magani ko kuma kulawar likita na iya hana ko rage yaduwar cutar.
Babban manufar maganin wanke hannu shine tsabtace masu cutarwa (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cutar) da kuma sunadarai da zasu iya haifar da cutar ko cutar.
Wannan yana da mahimmanci ga waɗanda ke kula da abinci ko kuma waɗanda ke aiki a fannin magani, amma yana da mahimmanci ga jama'a.
Yin wanka hannu yana da fa'idodi masu yawa ga lafiyar jiki, gami da: rage yaduwar cutar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtuka na cutar sankara; rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar jarirai a cikin haihuwar gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa yin amfani da wanka a hannu a cikin yara 'yan ƙasa da shekara biyar zai iya inganta tsawonsu.
A cikin kasashe masu tasowa, sauye - sauye na hali mai sauƙi, kamar fara wanke hannu da sabulu, na iya rage yawan mutuwar jarirai da ke tattare da cututtukan numfashi da kumburi.
Wannan aikin mai sauki zai iya rage yawan mutuwar da ake samu daga wadannan cututtuka da kusan kashi 50.
Hanyoyin da ke inganta wanke hannu na iya rage yawan cututtukan cutar sankara da kusan kashi uku, kuma hakan yana kama da samar da ruwa mai tsabta a yankunan da ba su da isasshen kuɗi.
Kashi 48% na cututtukan asarar hannu na iya kasancewa tare da wanke hannu da sabulu. Wanke hannu da sabulu a matsayin halayyar motsa jiki a gidaje, makarantu da al'ummomi a duniya shine hanya mafi inganci da arha don hana asarar hannu da kuma cututtukan numfashi mai tsanani (ARI).
Wani babban ARI, cutar huhu, wanda ke kashe yara kimanin miliyan 18 a kowace shekara, ita ce babbar sanadin mutuwar yara a karkashin shekara biyar.
Kimanin yara miliyan 35 ne ke mutuwa a kowace shekara saboda cutar sankara da kumburi.
A cewar UNICEF, yin amfani da sabulu don wanke hannu kafin cin abinci da bayan amfani da gidan wanka na iya ceton rayuka fiye da kowane magani ko magani, wanda zai iya rage yawan mutuwar da ke haifar da asarar zuciya zuwa kusan rabin da kuma mutuwar da ke haifar da cututtukan numfashi mai tsanani zuwa kashi ɗaya cikin huɗu.
Ana haɗa hannuwan hannu da sauran matakan tsabtace jiki a matsayin ɓangare na tsarin ruwa, tsaftacewa da tsaftacewa (WASH) shirye -shirye.
Yin wanka na hannu kuma yana kare mutum daga cutar da ke yaduwa ta hanyar kai tsaye.
Wani sakamako mai illa na wanke hannu shi ne, wanke hannu akai -akai zai iya cutar da fata ta hanyar bushewar fata.
Wani bincike na Danish na 2012 ya gano cewa yin wanka sosai na iya haifar da ciwon fata mai saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin
Sau da yawa ana ganin wanke hannu a matsayin wata alama ce ta rashin lafiyar mutum.
Akwai lokatai guda biyar a rana da wanke hannu da sabulu yake da muhimmanci wajen rage yaduwar cutar ta hanyar fitsari: bayan amfani da gidan wanka (shaye-shaye, zubar da fata), bayan wanke hanci (bayan canza layin), kafin ciyar da yaro, kafin cin abinci da kuma kafin/bayan shirya abinci ko cin naman kaza, kifi, ko kaji.
Sauran lokutan da ya kamata a yi amfani da fasaha mai kyau na wanke hannu don hana yaduwar cutar su ne: kafin da bayan an warkar da wani yanke ko rauni; bayan yin tari, tari ko kuma yayyafa hancinka; bayan taɓa dabba ko dabbobi; da kuma bayan taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike a shekarar 2014 ya nuna cewa Saudiyya ce ta fi yawan wanke hannu da sabulu a shekara ta 2015 a kasashe 54; Amurka da kashi 77 cikin 100 a Amurka da kuma kasar Sin da kashi 23 cikin 100 a duniya. Akwai hanyoyin sauya halaye da dama a yanzu don inganta halayyar wanke hannu da sabulu a lokuta masu muhimmanci.
"Sharshen kula da lafiya mai mahimmanci" da Ma'aikatar Ilimi ta Philippines ta aiwatar da shi misali ne na manyan ayyuka don inganta lafiyar yara da ilimi.
Wannan shirin na kasa ya hada da wanke hakora a kullum da kayan kwalliyar fluoride da kuma wanke hannu a kullum da sabulu, da kuma shan maganin rigakafi sau biyu a shekara.
An yi nasarar aiwatar da shi a Indonesia.
Idan aka hada sabulu ko kuma mai tsabtace ruwa a cikin ruwa, za a iya cire kwayoyin daga fata.
Babban aikin sabulu da kuma wankewa shine rage shinge a cikin narkewa, da kuma kara narkewa.
Ruwa shi kaɗai ba shi da kyau a tsabtace fata domin kitse da furotin, waɗanda suke cikin kayan ƙasa na halitta, ba su narke cikin ruwa.
Duk da haka, samun ruwa mai yawa yana taimakawa wajen tsabtace.
Sau da yawa ana amfani da sabulu mai ƙarfi don yin amfani da shi, wanda zai iya haifar da ƙwayoyin cuta daga amfani da shi a baya.
Wasu nazarin da suka duba yadda kwayoyin cuta ke canja wurin su daga sabulu mai karko sun kammala cewa babu yiwuwar canja wurin saboda wankewar kwayoyin da aka yi da safa.
Duk da haka, CDC ta ce "sabunan da ke da kayan aiki masu sauƙi na sauke sabulu a hannayen hannu ba tare da taɓa hannayensu ba sun fi kyau".
An yi wa jama 'a masu kula da lafiyarsu jajircewa da yin amfani da sabulu masu hana kwayar cuta.
Har zuwa yau, babu wata hujja da ta nuna cewa amfani da maganin kashe kwayoyin cuta ko kuma maganin kashe kwayoyin cuta na haifar da kwayoyin halitta masu rigakafin kwayoyin cuta a cikin yanayi.
Koyaya, sabulu masu hana kwayoyin cuta suna ƙunshe da wasu kwayoyin cuta na yau da kullun kamar triclose, wanda ke da jerin sunayen jinsunan kwayoyin da ke hana kwayoyin.
Saboda haka, ko da yake sabulu masu hana kwayoyin cutar ba su haifar da nau'ikan kwayoyin da ba su da maganin rigakafi, ba za su iya zama masu tasiri kamar yadda ake tallata su ba.
Baya ga mai hana ruwa da kuma kare fata, masu tsarawa na iya kasancewa acid (acetic acid, ascorbic acid, lactic acid), benzoic acid mai aiki da ƙwayoyin cuta da sauran masu gyara fata (alverine, bitamin, menthol, kayan shuka). Wani bincike mai zurfi daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu masu sauki, masu dauke da trichlose suna da tasiri kamar sabulu masu amfani da kwayoyin cuta masu dauke da trichlose a cikin rigakafin cututtuka da kuma kawar da kwayoyin cuta daga hannayensu.
Ruwan da ke da zafi sosai don wanke hannu ba shi da zafi sosai don kashe kwayoyin.
A zafin jiki (da digiri 37 na Celsius), kwayoyin cuta suna girma da sauri.
Koyaya, ruwan sabulu mai zafi ya fi tasiri fiye da ruwan sanyi, sabulu don cire man fetur na ƙasa da ƙwayoyin cuta.
Koyaya, sabanin abin da aka sani, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba ya da tasiri a rage adadin kwayoyin cuta a hannayen.
Mai tsabtace hannu ko mai tsabtace hannu shine mai tsabtace hannu mai tsabta tare da tushen ruwa.
A ƙarshen shekarun 1990s da farkon karni na 21, kayan tsabtace hannu marasa ruwa (wanda aka fi sani da rufin hannu mai ƙanshi, rufin hannu mai ƙazantawa ko kuma tsabtace hannu) na shan giya sun fara samun karbuwa.
Yawancin waɗannan isopropyls suna dogara ne akan barasa ko ethanol, wanda aka tsara tare da glycerin a cikin gel (mai polymer na acrylic acid) tare da mai narkewa kamar carbomers (mai polymer na acrylic acid), ko kuma a cikin wani ruwa ko kumfa, don sauƙin amfani da kuma rage tasirin bushewar barasa.
Hanyar da ake amfani da ita ta hanyar hada hydrogen peroxide da tanuna tana kara inganta aikin rigakafin kwayoyin cuta.
Maganin shan giya mai tsabta yana kashe kwayoyin cuta, kwayoyin da ke hana magunguna masu yawa (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (gami da HIV, herpes, RSV, rhinovirus, vaccine, influenza da hepatitis) da kuma cututtukan jiki.
Masu tsabtace ruwa na giya da ke dauke da kashi 70% na barasa suna lalata kwayoyin halitta da kashi 99.97% bayan 30 seconds na amfani (3.5 log reduction, daidai da 35 decibel reduction) da kuma kashi 99.99% zuwa 99.999% bayan minti 1 na amfani (4 zuwa 5 log reduction).
Ana amfani da maganin hana shan magani ko maganin hana shan giya don rufe hannu biyu gaba ɗaya ko kuma su narke.
A gaba da baya da kuma tsakiyar hannayen hannu da kuma dukkan yatsun yatsun hannu ana rubbed su na kimanin dakika 30, har sai ruwa, jelly ko gel sun bushe.
Dole ne a yi wanka sosai ta wajen shafa yatsunsu a hannayen hannu biyu. Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar yin wanka maimakon wanke hannu a maimakon wanke hannu, musamman ma idan hannuwan suna da tsabta.
Ana amfani da waɗannan masu amfani da yawa bisa sauƙin amfani da su da kuma hanzarta kashe kwayoyin cuta; duk da haka, kada a yi amfani da su a matsayin maye gurbin don wanke hannu mai kyau har sai sabulu da ruwa sun ɓace.
Sau da yawa amfani da maganin hana shan giya na iya haifar da fata ta bushe sai dai idan an haɗa da lubricants da/ ko moisturizers na fata a cikin miyagun ƙwayoyi.
Ana iya rage ko kawar da tasirin bushewar giya ta hanyar haɗa glycerine da/ ko wasu lubricants a cikin furotin.
A cikin gwaji na asibiti, an rage yawan zafin jiki da kuma bushewar fata fiye da sabulu ko kuma maganin rigakafi ta hanyar maganin hana shan giya.
Abubuwan da ke haifar da rashin lafiyan da ke haifar da rashin lafiyan da ke tattare da abubuwan da ke cikin giya ko kayan shan giya sune dermatitis, cututtukan urticaria ko rashin jin daɗi.
Ƙananan kusanci don haifar da dermatitis fiye da wanke hannu da sabulu da ruwa ya zama abin sha'awa.
Duk da ingancin su, masu aiki da ba su da ruwa ba ba suna tsabtace kwayoyin halitta da hannu, amma suna hana su ƙwayoyin cuta.
Wannan shine dalilin da ya sa sabulu da ruwa ba su da tasiri sosai wajen hana yaduwar cututtukan hannu, saboda har yanzu ana samun cututtukan hannu.
Ingancin kayan aikin hana shan giya ya dogara da kayan aiki da kuma tsari, kuma a tarihi sun kasance suna da tasiri sosai fiye da giya da kuma kayan shafa.
A kwanan nan, ba kamar giya ba, wanda aka nuna yana rage inganci bayan amfani da shi sau da yawa saboda yiwuwar: ci gaba da mummunan halayen fata, an nuna yana da ci gaba da kuma ƙwayoyin cuta na antibacterial bayan amfani da benzalkonium chloride.
Mutane da yawa a cikin al'ummomin da ba su da kuɗi sosai ba za su iya sayen sabulu kuma su yi amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙasa da kanta na iya zama mafi tasiri fiye da ruwa, amma ba su da tasiri fiye da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko toka ta lalace da kwayoyin halitta, zai iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, toka kuma wakili ne mai kashe kwayoyin halitta domin idan aka yi masa ruwa, zai haifar da narkewar kwayoyin halitta.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu idan babu sabulu.
Daidaitaccen fasaha na wanke hannu da aka ba da shawarar da Cibiyar Kula da Cututtuka ta Amurka ta bayar don hana yaduwar cutar ta ƙunshi matakai masu zuwa:
Ka wanke hannunka da ruwa mai zafi ko sanyi.
Ana ba da shawarar ruwa mai gudana saboda basins da ke da ruwa mai ɗorewa na iya gurɓata, duk da haka yawan zafin ruwa ba shi da mahimmanci.
Ka shafa sabulu a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a hannunka, ka shafa a cikin hannunka, ka shafa a cikin hannunka, ka shafa a cikin hannunka, ka shafa a cikin yatsunansu, ka kuma ka shafa a cikin yatsunansu.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan sun yi amfani da sabulu maimakon ruwa su kaɗai.
Ka yi ta shafawa na akalla dakika 20.
Rashin da ake yi yana haifar da taɓawa, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma yin taɓawa na tsawon lokaci yana haifar da ƙarin ƙwayoyin cuta.
Ka wanke shi a ƙarƙashin ruwa mai gudana.
Yin wanka a cikin tafki na iya sake gurɓata hannayensu.
Ka bushe shi da tawul mai tsabta ko kuma ka bar shi ya bushe a cikin iska.
Hannun da ke da ruwa da kuma rigar hannu suna da sauƙin sake gurɓatawa. Mafi yawan wuraren da aka fi watsi da su sune yatsunsu, wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin kusoshi.
Kayan kwalliya da aka yi da ƙusa da ƙusa za su iya ba da mafaka ga ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da maganin shafawa don hana bushewar hannu; fata mai bushewa na iya cutar da fata wanda zai iya ƙara haɗarin kamuwa da cuta.
A cikin ƙasashen da ke tasowa inda babu ruwa da/ko sabulu, za a iya yin zaɓuɓɓukan da ba su da tsada, idan ya cancanta, don sauƙaƙa wanke hannu, misali, yin amfani da ruwa mai rataye daga matattarar ruwa mai kyau da kuma/ko toka tare da ramuka masu dacewa. A cikin yanayin iyakancewar samar da ruwa (misali makarantu ko yankunan karkara a ƙasashen da ke tasowa), akwai hanyoyin kiyaye ruwa, kamar "tippi-taps"da sauran zaɓuɓɓukan da ba su da tsada.
Tippi-tap wani fasaha ne mai sauki wanda ya hada da amfani da hanci daya, wanda aka yi amfani da shi don zuba ruwa kadan a hannayensu da kuma takalmin sabulu.
Yin bushewa da kyau na hannu wani muhimmin ɓangare ne na tsarin tsabtace hannu, amma akwai wasu muhawara game da yadda za a bushe a cikin gidajen wanka na jama'a.
Yawancin bincike sun nuna cewa, tawul ɗin takarda suna ba da tsabta fiye da na'urorin bushewa na lantarki da ake samu a cikin gidajen wanka da yawa.
A shekara ta 2008, Jami'ar Westminster, London ta gudanar da wani bincike wanda masana'antar takarda ta yi wa kwamitin kula da kayan aiki na Turai, wanda aka yi wa kwamitin kula da kayan aiki na Turai, don kwatanta matakan tsabtace da takarda ta samar, masu bushewa da iska mai zafi da kuma masu bushewa da iska mai iska na zamani.
Bayan wanke hannu da kuma bushewa da iska mai zafi, adadin kwayoyin ya karu da kashi 194% a kan yatsunsu da kuma kashi 254% a hannayen hannu.
Drying tare da jet-air dryer ya kara yawan kwayoyin cuta da kashi 42% a kan yatsunsu da kuma 15% a hannayen hannu.
Bayan wanke hannu da kuma bushewa da tawul ɗin takarda, an rage adadin kwayoyin zuwa 76% a kan matsakanin yatsunsu da kuma 77% a kan hannayen hannu, a matsakaita. Masana kimiyya sun kuma yi gwaje -gwaje don tabbatar da ko kowane irin bushewa yana haifar da iyawar sauran masu amfani da gidan wanka da kuma gurɓata yanayin gidan wanka.
Jirgin sama mai bushewa, wanda ke fitar da iska daga na'ura a kimanin saurin 180 m/s (650 km/h; 400 mph), ya iya tashi da hannu da kuma na'ura daga kwayoyin halitta masu ƙarancin ƙarfi kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Yin amfani da na'urar bushewa ta hannu mai iska mai zafi ya sa microorganisms suka yadu daga na'urar bushewa zuwa mita 0.25.
A shekara ta 2005, wani bincike da kamfanin TÜV Produkt und Umwelt ya yi, ya nuna cewa ba a samu yaduwar kwayoyin halitta a hannu ba.
Bayan an bushe hannu, an lura da canje -canje a cikin ƙididdigar kwayoyin:
Akwai masana 'antun bushewa na hannu daban-daban, kuma an kwatanta bushewa na hannu da na tawul na takarda.
Yin wanka hannu ta amfani da wanke hannu ta amfani da wanke hannu a lokacin tafiya idan babu sabulu da ruwa.
Dole ne a ƙunshe da akalla kashi 60 cikin ɗari na giya a cikin kayan aikin tsabtace hannu na tushen giya.
Bayan dogon lokaci da likitan Hungary Ignaz Semmelweis ya gano (1846), an bukaci yin wanka na hannu bayan an gano tasirinsa wajen hana cutar a cikin asibiti.
Akwai na'urorin lantarki da ke ba da ra'ayoyi don tunatar da ma'aikatan asibiti game da wanke hannu idan sun manta.
A cikin wani binciken, an gano cewa amfani da su ya rage yawan kamuwa da cuta.
Aikin wanke hannu a kalla na tsawon dakika 15, yana yin wanka da ruwa da sabulu ko gel da ya dace, kuma yana shafa kowane ɓangaren hannu.
Dole ne yatsun hannu biyu su yi aiki tare.
Idan akwai shara a ƙarƙashin ƙusa, ana iya amfani da goga mai gashi don cire shi.
Tun da yake kwari suna iya zama a cikin ruwa a hannu, yana da muhimmanci a wanke su da kyau kuma a shafa su da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul ɗin takarda don rufe ruwa (kuma a buɗe duk wani ƙofar fitarwa idan ya cancanta).
Wannan yana hana sake gurɓata hannu daga waɗannan farfajiyar.
Yin wanka a cikin tsarin kula da lafiya yana nufin kawar da kwayoyin cuta masu cutarwa ("kwayoyi") da kuma hana su watsawa.
Rahoton jaridar The New England Journal of Medicine ya ce, a yawancin yanayin kiwon lafiya, rashin wanke hannu ya kasance a matakin da ba a yarda da shi ba, inda likitoci da ma'aikatan jinya da yawa suka manta su wanke hannuwansu a kai a kai kafin su taɓa marasa lafiya, wanda ke haifar da yaduwar kwayoyin cuta.
Wani bincike ya nuna cewa yin wanka da kuma wasu ayyuka masu sauki na iya rage yawan cututtukan jini da ke tattare da jini zuwa catheter da kashi 66 cikin dari.
Ana iya samun jagorar tsabtace hannu ta hannu da aka samo daga ƙungiyar a shafin yanar gizon ta don yin tsokaci ga jama 'a.
Wani bita mai dacewa da aka yi da shi, da Witby da sauransu suka yi.
Idan ana buƙatar yin aiki na bin ƙa'idodi, kayan aikin kasuwanci na iya auna da tabbatar da tsabtace hannu.
Hukumar lafiya ta duniya ta tsara "kashi biyar" na wanke hannu:
Bayan an samu jini/ ruwa na jiki
kafin aikin kashe kwayoyin cutar, kuma
Bayan an kula da mai haƙuri. Ƙara sinadarai masu kashe cututtuka a cikin sabulu (" magani " ko " maganin rigakafi " sabulu) yana ba da ikon kashe kayan wanke hannu.
Domin a 'karye' hannayenka kafin a yi aiki ko a cikin tsarin da ke da kwayoyin da ke da tsayayyar maganin rigakafi, ana iya bukatar yin amfani da irin wannan maganin kafin a yi aiki ko kuma a cikin tsarin da ke da ƙwayoyin da ke da tsayayyar maganin rigakafi. Don a 'karye' hannayenka don aikin tiyata, dole ne a yi amfani da famfo wanda za a iya kunnawa da rufewa ba tare da taɓa hannu ba, wasu wanke na chlorhexidine ko iodine, wanke na disinfectant don bushewa da hannuwan bayan wanke, da kuma wanke na disinfectant brush don tsabtace rufi da kuma wani kayan aikin disinfectant don tsabtace ƙusa.
Dole ne a cire dukan kayan ado.
Wannan tsari yana buƙatar wanke hannuwan hannu da gwiwoyi na tsawon minti 2-6.
Ba a buƙatar yin rubbing na dogon lokaci (minti 10)
A lokacin wankewa, ya kamata a hana ruwa a kan wuyan hannu ya koma hannayensu.
Bayan an gama wanke hannu, ana wanke hannuwan da tufafi marasa ƙwayoyin cuta kuma ana sa rigar tiyata.
Don rage yaduwar kwayoyin cuta, yana da kyau a wanke hannu kafin kuma bayan kula da wani mai rashin lafiya ko kuma a yi amfani da maganin hana hana hana hana cutar hannu.
Don sarrafa kamuwa da cutar Staphylococcal a asibitoci, an gano cewa mafi yawan amfanin wanke hannu ya fito ne daga kashi 20% na wanke hannu, kuma lokacin da yawan wanke hannu ya karu sama da kashi 35%, an sami karamin ƙarin amfanin.
Yin wanka da hannu da sabulu mai laushi yana sa kamuwa da cutar ta kamuwa da kwayoyin cuta ya ninka fiye da sau uku fiye da wanka da sabulu mai hana kamuwa da kwayoyin cuta. Idan aka gwada wanka da hannu da maganin shan giya da aka yi amfani da sabulu mai hana kamuwa da kwayoyin cuta na tsawon minti 30, an gano cewa wanka da hannu da giya ya rage kamuwa da kwayoyin cuta da kashi 26% fiye da wanka da sabulu mai hana kamuwa da kwayoyin cuta.
Amma sabulu da ruwa sun fi tasiri fiye da kayan aikin hannu na tushen barasa wajen rage cutar H1N1 Influenza A da kuma kwayar cutar Clostridium difficile daga hannu. Matakan inganta tsabtace hannu a cikin tsarin kula da lafiya na iya haɗawa da ilmantarwa ga ma'aikata kan wanke hannu, haɓaka wadatar kayan aikin hannu na tushen barasa, da tunatarwa ta rubuce da ta baki ga ma'aikata.
Ana bukatar karin bincike kan ko wane irin wannan tsari ne ya fi tasiri a cikin tsarin kula da lafiya daban -daban.
A kasashe masu tasowa, wanke hannu da sabulu ana ganin shi ne hanya mai araha, mai muhimmanci don samun lafiya mai kyau, har ma da abinci mai gina jiki.
Koyaya, samun halaye na wanke hannu na duniya yana da ƙalubale saboda rashin wadatar ruwa mai inganci, sabulu ko kayan wanke hannu a gidajen mutane, makarantu da wuraren aiki.
Alal misali, a mafi yawan yankunan karkara na Afirka, babu wanka mai tsabta a kowane gida mai zaman kansa ko na jama'a, ko da yake akwai zaɓuɓɓukan da suka fi sauƙi don yin wanka.
Duk da haka, rashin yawan wanke hannu na iya zama sakamakon halin da ake ciki maimakon rashin sabulu ko ruwa.
Ƙarfafawa da tallafawa wanke hannu da sabulu na iya tasiri kan yanke shawara, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu da kuma kawo canji ga halayen mutane na dogon lokaci.
Don yin aiki yadda ya kamata, ana bukatar kulawa da kimantawa.
Wani tsarin nazari na nazarin 70 ya gano cewa hanyoyin da aka yi amfani da su a cikin al'umma suna da tasiri wajen kara yawan wanke hannu a cikin LMICs, yayin da kamfen ɗin tallata zamantakewa ba su da tasiri. Misali don tallata wanke hannu a makarantu shine "Hanyar tauraro uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, masu arha don tabbatar da cewa ɗalibai suna wanke hannu tare da sabulu tare da sauran bukatun tsabtace jiki.
Idan aka samu mafi ƙarancin ma'auni, makarantu za su iya samun taurari daya zuwa uku a jere.
Yin tashoshin wanke hannu na iya zama wani ɓangare na kamfen ɗin tallata wanke hannu wanda aka yi don rage cututtukan cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya misali ne na wani yunkuri na wayar da kan jama'a da ke neman sauya halaye. A sakamakon annobar cutar korona ta 2019-20, UNICEF ta inganta amfani da emojis na wanke hannu.
Wasu karatu sun yi la'akari da jimlar kudin tasiri na wanke hannu a cikin kasashe masu tasowa dangane da rigakafin DALYs.
Duk da haka, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftacewa tsada sosai.
Muhimmancin wanke hannu ga lafiyar mutum - musamman ga mutanen da ke da yanayi mai mahimmanci, kamar uwaye da suka haifi jariri ko a cikin sojoji da aka ji rauni a asibitoci - an fara gano su a tsakiyar karni na 19 ta hanyar masu gabatar da tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, Ba'angilishi wanda shine "kafa aikin jinya na zamani".
A lokacin, mutane da yawa sun gaskata cewa cutar ta kasance ne saboda ƙanshi mai ƙanshi mai suna miyasmus.
A cikin shekarun 1980, barkewar cutar ta abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ƙara inganta tsabtace hannu a matsayin muhimmin hanyar hana yaduwar cutar.
Cutar da aka samu na Swine Flu a shekarar 2009 da kuma annobar COVID-19 a shekarar 2020 sun kara wayar da kan mutane game da muhimmancin wanke hannu da sabulu don kare kansu daga irin wadannan cututtukan cututtuka a kasashe da dama.
Alal misali, an rataye wasu hotunan da ke ɗauke da "daidaicin fasahar wanke hannu" a kusa da wanke hannu a cikin gidajen wanka na jama'a da kuma ofisoshin gwamnati da kuma a tashoshin jiragen sama a Jamus.
"Ku wanke hannuwanku" yana nufin cewa ba ku yarda ku ɗauki alhakin wani abu ko kuma ku yarda cewa kuna da hannu a cikinsa ba.
Wannan ya fito ne daga littafin Matta, inda Pontius Pilate ya ware kansa daga hukuncin da ya yanke na giciye Yesu Kristi, amma ya zama magana da aka yi amfani da ita sosai a wasu al'ummomin Turanci.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari na tsabtace wani abu mai ban mamaki wanda ya nuna laifin da ta aikata da kuma laifin da ta yi wa mijinta.
An kuma gano cewa bayan mutane sun tuna ko kuma sun yi tunani a kan ayyukan da ba su da kyau, suna wanke hannuwansu sau da yawa fiye da wasu, kuma suna ba da ƙarin muhimmanci ga kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba da izinin wanke hannuwansu bayan yin tunani irin wannan, ba su da wataƙila su yi wasu ayyuka na "tsabtace" kamar su aikin sa kai.
Addinai suna ba da shawarar yin wanka a hannu don dalilai na tsabta da na alama. Yin wanka a hannu ba tare da ruwan sabulu ba don wanke hannu yana da wani ɓangare na wanke hannu na yau da kullun da aka bayyana a cikin addinai da yawa, ciki har da Baha'u'llah, Hindu, Tewilah da Netilat Yadayim a cikin Yahudanci, Laobao a cikin Kiristanci, da Wazu a cikin Musulunci. Addinai suna ba da shawarar wanke hannu musamman don samar da tsabta bayan wasu ayyuka.
A Hindu, Yahudanci da Musulunci, wanka hannu bayan yin amfani da gidan wanka wajibi ne.
A addinin Hindu, addinin Buddha, addinin Sikh, addinin Yahudanci da addinin Musulunci, wanke hannu kafin da kuma bayan cin abinci wajibi ne.
Gudanar da haɗarin yaduwar COVID-19 a wurin aiki
Don sarrafa haɗarin yaduwar COVID-19 a wurin aiki, don hana cutar Coronavirus Disease 2019 (COVID-19) aikace -aikacen tsarin tsaro na kasuwanci da kiwon lafiya don sarrafa haɗari.
Yin amfani da hanyar da ta dace don sarrafa haɗarin yaduwar cutar a wurin aiki ya dogara da wurin aiki da aikin da za a yi, wanda ya dogara da kimanta haɗarin tushen haɗari, tsanani na cutar a cikin al'umma, da kuma abubuwan haɗari na ma'aikatan da ke da haɗarin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙarancin haɗari na kasuwanci tare da mutane da sauran abokan aiki, wanda ake ba da shawarar matakan hana kamuwa da cuta na asali, gami da: wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, bin ɗabi'ar numfashi, da tsabtace da kuma lalata yanayin aiki a kai a kai.
Ayyukan da ke da haɗarin haɗari na matsakaici sune waɗanda ke buƙatar yin ma'amala ta atomatik ko kusa da mutanen da ba su san ko suna da wata shakka game da kamuwa da COVID-19 ba, amma waɗanda za su iya kamuwa da cutar saboda watsawar al'umma ko tafiya ta duniya.
Wannan ya hada da ma'aikatan da ke da hulɗa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da wasu tsarin tallace -tallace masu yawa.
Baya ga matakan hana kamuwa da cuta na asali, matakan sarrafa barazanar ga wannan rukunin sun hada da: sadarwa ta hanyar matattarar iska mai inganci, amfani da masu tsaro na sneez, da kuma samar da kayan kariya na mutum don yanayin idan mutum da ke fama da COVID-19 ya fuskanci.
OSHA ta ce ma'aikatan kiwon lafiya da ma'aikatan gidan matattu suna da haɗarin haɗari mai yawa idan sun fuskanci COVID-19 mai kamuwa da cutar ko wanda ake zargi da cutar, kuma wannan haɗarin ya zama haɗari mai yawa idan ma'aikatan suka yi aiki da ayyukan samar da aerosol akan COVID-19 mai kamuwa da cutar ko wanda ake zargi da cutar, ko tattara samfurori ko sarrafa su.
A cikin matakan da suka dace da wadannan ma'aikatan akwai kula da injiniyoyi kamar su Negative Pressure Transmission Chambers da kuma kayan kariya na mutum da suka dace da aiki.
COVID-19 zai iya haifar da tasiri mai yawa a cikin wurin aiki.
Ma'aikata na iya kasancewa a wurin aiki saboda tsoron rashin lafiya, bukatar kula da wasu ko kuma yiwuwar tuntuɓar su.
Abubuwan da ake buƙata, da kuma hanyoyin samun waɗannan abubuwa (kamar rage lokacin buƙata ko sayayya ta hanyar isarwa ko sabis na motsi) na iya canza yanayin kasuwanci dangane da su.
A ƙarshe, za a iya shafar zirga-zirgar kayayyaki daga yankunan da COVID-19 ta yi tasiri sosai. Shirye-shiryen shiri da kuma shirin amsawa ga cutar mai yaduwa za a iya amfani da shi don jagorantar ayyukan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da ayyukan aiki da aiki daban-daban, gami da tushen haɗari, abubuwan haɗari da ke tasowa daga gida da tsarin al'umma, da kuma abubuwan haɗari ga ma'aikatan mutum kamar tsufa ko yanayin rashin lafiya.
Sun kuma bayyana matakan da ake bukata don magance haɗarin da kuma shirye -shiryen gaggawa don yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye -shiryen shiri da kuma amsawa ga cututtukan cututtuka na iya zama batun shawarwari na kasa ko na kasa.
Manufofin mayar da martani ga barkewar cutar sun hada da: rage watsawa tsakanin ma'aikata, kare mutanen da ke da babban haɗarin rikitarwa na kiwon lafiya, kula da ayyukan kasuwanci da rage tasirin illa ga sauran raka'a a cikin jerin abubuwan samar da su.
Matsayin da ake fama da cutar a cikin al'umma da ke da wurin aiki yana shafar yadda ake amsawa.
Tsarin sarrafa haɗari tsari ne wanda aka yi amfani dashi sosai don tsara matakan sarrafa haɗari bisa ga inganci a cikin aminci da lafiya na kasuwanci.
Inda ba za a iya kawar da barazanar COVID-19 ba, akwai ingantattun kayan aikin sarrafawa, sannan na gudanarwa, kuma a ƙarshe na'urorin tsaro na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayyar ma'aikaci ba, kuma wannan na iya zama mafi arha a aiwatar.
Gudanar da gudanarwa shine sauya manufofin aiki ko hanyoyin da ke buƙatar aiki ta hanyar ma'aikaci ko mai aiki.
Ana ganin cewa kayan kare mutum (PPE) ba su da inganci fiye da na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu hulɗa.
Dole ne ma'aikata su zaɓi kowane nau'in PPE bisa ga haɗari, su sanya shi yadda ya kamata (misali, na'urar numfashi), su sa shi koyaushe kuma yadda ya kamata, su duba shi akai-akai, su kula da shi kuma su canza shi kamar yadda ya cancanta, kuma su cire shi yadda ya kamata, su tsabtace shi kuma su adana shi ko su kawar da gurɓataccen abu.
A cewar Hukumar Kula da Lafiya da Lafiya ta Kasuwanci ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙananan haɗari na kasuwanci tare da mutane da sauran abokan aiki.
Abubuwan da ake ba da shawarar don hana kamuwa da cuta ga dukkan wuraren aiki sun haɗa da: wanke hannu akai -akai da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, samar da ɗabi'ar numfashi mai rufe tari da hauka, kayan haushi da kayan shara, shirya masu canzawa ko masu daidaitawa idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aikin wasu, da tsabtace da kuma lalata yanayin aiki a kai a kai.
Ganowa da kuma warewar masu iya kamuwa da cutar a wuraren aiki yana da matukar muhimmanci ga kare ma'aikata, abokan ciniki, baƙi da sauransu.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa ma'aikatan da ke da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
A cewar OSHA, ayyukan da ke da matsakaicin haɗarin haɗari sun haɗa da ayyukan da ke buƙatar maimaitawa ko kusanci da mutane a cikin ƙafa shida (1.8 m), waɗanda ba a san ko suna da tabbacin cewa suna da COVID-19 ba, amma waɗanda za su iya kamuwa da SARS-CoV-2 saboda watsawar jama'a da ke gudana a kusa da wurin aiki, ko kuma saboda mutumin ya yi tafiya ta duniya a cikin wuri mai yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke da hulɗa da jama'a kamar makarantu, yanayin aiki mai yawan jama'a, da wasu tsarin tallace-tallace masu yawa. Waɗannan sun haɗa da shigar da matattarar iska mai inganci a cikin kulawar injiniya don wannan da rukunin haɗari mai yawa, haɓaka ƙimar canji, shigar da shingen jiki kamar masu tsaro na filastik masu tsabta, da shigar da windows na drive-through don sabis na abokin ciniki. Waɗannan sun haɗa da ƙarfafa ma'aikatan marasa lafiya a cikin kulawar gudanarwa don waɗannan da manyan ƙungiyoyin haɗari, sauya tarurruka na gani da ido tare da sadarwar kai tsaye, kafa matakan daidaitawa, hana ba dole ba ne a yi tafiya zuwa wuraren tsabtace jiki don wuraren COVID-19 ko wuraren wanka, haɓaka tsarin tsaro na gaggawa don sadarwar jama'a, da buƙatar haɓaka ƙarancin hanyoyin sadarwa na gaggawa, da buƙatar rage damuwa game da haɗarin aiki na musamman ga waɗannan da manyan ƙungiyoyin haɗari.
Ma'aikatan da ke cikin wannan rukunin haɗari ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, ana yin wasu matakan da suka dace don kare ma'aikatan jirgin sama da sauran fasinjoji: nisantar da mai rashin lafiya da wasu da ƙafa 6, naɗa wani memba na jirgin don ya yi wa mai rashin lafiya hidima, da kuma ba mai rashin lafiya abin rufe fuska ko kuma gaya masa ya rufe bakinsa da hanci da ƙusa idan ya yi tari ko ya yi tsotsa.
Ma'aikatan jirgin su sa sa safofin hannu masu amfani idan suna kula da mai haƙuri ko sun taɓa ruwan jiki ko kuma wataƙila sun kamu da cutar, kuma idan mai haƙuri yana da zazzabi, tari, ko wahalar numfashi, ya kamata ya sa ƙarin kayan kariya na mutum.
Dole ne a zubar da safar hannu da sauran kayan aiki a cikin jaka mai tsabtace jiki, sannan a tsabtace da kuma hana ƙwayoyin cuta daga baya. Don safarar kasuwanci, gami da jiragen ruwa da sauran jiragen ruwa masu jigilar kaya, a cikin kulawar haɗari, dakatar da tafiya idan ya kamu da rashin lafiya da kuma keɓance kansa da kuma sanar da cibiyar likitancin jirgin nan da nan idan wani ya sami zazzabi ko wasu alamun cutar yayin tafiya a jirgin.
A matsayin mai kyau, dole ne a bi likita a cikin ɗakin mai keɓewa. Don makarantu da wuraren kula da jarirai, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko hana cutar idan wani mai kamuwa da cutar ya kasance a cikin makarantar da ba ta da wata hanyar watsawa ta al'umma.
Lokacin da akwai karamin watsawar al'umma, ana iya aiwatar da dabarun nisantar zamantakewa, kamar yin ziyara a yankin, tarurruka da sauran manyan tarurruka kamar soke abinci a cikin horo na jiki ko aji na waƙar ko gidajen cin abinci, ƙara nesa tsakanin tebur, daidaita lokacin isowa da hutu, iyakance baƙi marasa mahimmanci, da amfani da sararin ofis na daban don yara masu alamun cutar kamar mura.
Idan akwai isasshen watsawa a cikin al'ummar gida, ana iya yin la'akari da hutun makaranta na tsawon lokaci ban da dabarun nisantar zamantakewa. Ga ma'aikatan tilasta bin doka da ke gudanar da ayyukan yau da kullun, CDC ta ɗauki haɗarin kiwon lafiya na gaggawa kamar haka.
Jami'an tsaro da ke da alaka da mutanen da suka tabbatar da COVID-19 ko kuma wadanda ake zargi da su, ana ba da shawarar su bi ka'idoji iri ɗaya da na masu aikin likita na gaggawa, tare da kayan aikin kariya na mutum.
Idan akwai kusanci yayin kamawa, ma'aikatan dole ne su tsabtace da kuma hana rigakafin su ta amfani da tsabtace gida ko gogewa kafin su sake amfani da belts da kayan aiki, kuma su bi ka'idodin aiki na yau da kullun don hanawa da kawar da PPE da aka yi amfani da su da kuma hanawa da wanke tufafi.
OSHA ta ce wasu ma'aikatan kiwon lafiya da gidan matattu suna cikin manyan ko kuma manyan matakan haɗarin haɗari.
Ayyukan da ke da haɗarin haɗari sun haɗa da samar da kiwon lafiya, taimakawa, ma'aikatan dakin gwaje -gwaje da sufuri na likita waɗanda suka zo cikin haɗari da sanannun ko waɗanda ake zargi da COVID-19.
Wadannan sun zama masu haɗarin haɗari idan ma'aikata suka yi aiki da samar da aerosol a kan sanannun ko masu zargin COVID-19, tattara samfurori ko sarrafa su.
Ayyukan da ke haifar da aerosol sun haɗa da shigar da bututu, hanyoyin shigar da cuff, bronchoscopy, wasu hanyoyin haƙori da gwaje -gwaje, ko tattara samfurin daga tsatsa.
Ayyukan gidan matattu masu haɗarin haɗari sun haɗa da mutanen da ke shirya jikin mutanen da suka san ko suna da alamun shari'o'in COVID-19 a lokacin mutuwarsu; idan sun bincika gawawwakin, suna da haɗarin haɗari sosai. Ƙarin aikin injiniya don waɗannan rukunin haɗari ya haɗa da ɗakunan keɓewa don sanannun ko masu sharhi na COVID-19, gami da yayin aiwatar da ayyukan samar da aerosol.
A wasu tsarin kula da lafiya da kuma gidan matattu, za a iya samun daidaitattun maganganun cutarwa.
Dole ne a kula da samfurori tare da matakan tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a ware masu zuwa a cikin wuraren jiran aiki daban-daban, dangane da ko suna da cutar COVID-19, ban da sauran PPE, OSHA ta ba da shawarar yin amfani da na'urorin numfashi ga mutanen da ke aiki a cikin ƙafa 6 na waɗanda aka sani ko ake zargi da kamuwa da cutar SARS-CoV-2, da kuma waɗanda ke yin ayyukan da ke haifar da aerosol.
A Amurka, N95 filtering faces respirators ko mafi kyau da NIOSH ta amince da su ya kamata a yi amfani da su a cikin mahallin wani tsari mai zurfi na rigakafin numfashi wanda ya hada da gwajin dacewa, horo da kuma gwajin likita.
Sauran nau'ikan na'urorin numfashi na iya samar da ƙarin tsaro da inganta kwanciyar hankali ga ma'aikata. WHO ba ta ba da shawarar rufewa, saboda COVID-19 cuta ce ta numfashi maimakon ta hanyar ruwan jiki.
WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata kawai ga ma'aikatan binciken a wuraren shiga.
Ga wadanda ke tattara samfurori na numfashi daga marasa lafiya na COVID-19 ba tare da samar da aerosol ba, WHO ta ba da shawarar yin amfani da abin rufe fuska, kwalliyar fuska, da kuma safofin hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin masks na tiyata da N95 ko FFP2 respirator.
Ganin cewa wadatar PPE a duniya ba ta isa ba, WHO ta ba da shawarar rage bukatar PPE ta hanyar telemedicine, ta hanyar hana masu amfani da kayan gani kamar windows masu gaskiya, ta hanyar ba da damar shiga daki tare da mai haƙuri na COVID-19 ɗaya kawai, ta hanyar amfani da PPE da ake buƙata don takamaiman aiki kawai, ta hanyar amfani da na'urar numfashi guda ba tare da cirewa ba yayin kula da marasa lafiya da yawa tare da ganewar asali ɗaya, ta hanyar dubawa da daidaita sarkar samar da PPE, da kuma hana amfani da masks ga mutanen da ke da rashin lafiya.
Mai aikawa: Catherine Meher, Shugaba na Gidauniyar Wikimedia
Aiki: Duk ma'aikatan Wikimedia Foundation
Jigo: [Covid-19] Rage nauyi da shirya don gaba
Ranar watsawa: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Babu haƙƙoƙi
A wannan watan muna fuskantar yanayi mai ban mamaki.
Cutar COVID-19 ta bayyana cewa dukkan mutane a duniya suna da alaƙa da juna da kuma alhakinmu ga juna.
Kalubalen da ke tattare da shi ba su da iyaka a gare mu, amma mun san cewa mafi kyawun amsa da za mu iya bayarwa ya dogara ne da tausayi na duniya, hadin kai, da kuma inganta al'umma, wanda ke cikin wannan ƙungiyar.
Irin wannan abokantaka da muka gani tsakanin abokan aikinmu a imel, kira da hira ta hanyar ban mamaki ta tabbatar da yadda muka sami damar aiki tare da mutane masu ban mamaki.
Ina matukar godiya da alfahari da ku duka a matsayin abokan aiki da ba zan iya bayyana su da kalmomi ba.
A makon da ya gabata, wani mutum ya yaba mini da aikinmu.
Ya tunatar da ni game da yadda yake da muhimmanci a kawo wa duniya Wikipedia a wannan lokaci, da kuma yadda yake da iko wajen tabbatar da cewa wannan muhimmin kayan aiki yana samuwa ga kowa da kowa a kan layi.
Aikinku ne ke sa hakan ya yiwu, ko kuna kula da shafukan yanar gizo ko kuma ku kasance tushen albashi ga abokan aikinmu ko kuma ku kiyaye al'ummominmu.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, kuma yanzu tana bukatar hakan fiye da kowa.
Wannan lokaci ne da aikinmu da kuma yadda muke yi zai yi tasiri sosai a duniya.
Saboda muhimmancin wannan manufa, da kuma rawar da kuke takawa a ciki, za mu yi wasu canje -canje masu ban mamaki a yadda muke aiki tare da mu a wannan makon mai zuwa.
Canje-canje a ayyukanmu da kuma jadawalinmu
Kamar yadda Robin ya fada a baya, kungiyar C ta gana a daren jiya don tattauna tsarinmu da kuma tsara jadawalin kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna yadda muke tunani game da yanayin da muke ciki, da kuma yadda za mu ci gaba da kasancewa cikin ƙungiyar a wannan lokacin.
Mun kasance cikin damuwa kuma muna so mu kawar da damuwa kuma mu ba da haɗin kai ga aikinmu na dogon lokaci.
Idan kana bukatar ka rage yawan aikinka, babu wani laifi.
Ga dukkan ma'aikata, kwangilar, da ma'aikatan kwangilar:
Muna sa ran yin aiki na yau da kullum na kimanin sa'o'i 4 a rana, ko kuma 20 a mako har sai an ba mu ƙarin bayani.
Ba mu sanar da hutu ba - idan kana iya yin aiki fiye da sa'o'i na yau da kullum, aikin yana bukatar taimakonka.
Duk da haka, a wannan lokacin, duniya ba ta da kyau, kuma ko kuna kula da ƙaunatattunku, ko ku kawo kayan almubazzaranci, ko ku je wurin likita, ƙwarewarku ita ce fifiko.
Ba mu kula da lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba lallai ba ne mu ce hakan, amma muna yin hakan.
Babu buƙatar izinin rashin lafiya ko PTO - kawai gaya wa manajanka kuma ka taimaki ƙungiyarka ta gyara kalandar da jadawalin don tabbatar da cewa babu wanda ya lura da babban aikin.
(Idan an tabbatar da cewa kana da COVID-19, ka sanar da Brian na T&amp;C Ops don T&amp;C ya taimaka maka kuma ya tabbatar da cewa an kula da yanayin ka yadda ya kamata.)
Ma'aikatan da ke aiki a awa daya za su samu cikakken albashin su.
Mun riga mun faɗi haka, kuma muna sake tabbatar da alƙawarinmu ga masu kwangila da ma'aikatanmu na tsawon lokaci don cika alkawarinmu.
Kowane mutum zai sami albashi bisa ga sa'o'in aikinsa na yau da kullum a lokacin yanayi na yau da kullum.
Idan kana rashin lafiya kuma ba za ka iya aiki ba, za ka samu albashi.
Idan kana son yin aiki, muna tare da kai.
Mutane da yawa suna amfani da aikinsu don su sami hanyar fita daga damuwa da ke kewaye da su.
Abin da za mu iya yi zai iya zama da gamsarwa sosai, musamman a irin wannan lokacin.
Bugu da ƙari, kula da kanka ne mafi muhimmanci.
Abin da muke gaya muku shi ne ku yi magana da manajanku don mu san abin da za mu yi tsammani, kuma mu yi canje -canje bisa ga abin da muka yi.
Wasu ayyuka suna da muhimmanci.
Akwai abubuwa da ba za mu iya barin su tsaya ba.
SRE, HR ops, Trust & Safety, da kuma kungiyoyin karbar tallafi (da sauransu) suna yin ayyuka masu matukar muhimmanci da zasu iya bukatar karin taimako.
Don mu tantance manufofin da muke da su a yanzu kuma mu mai da hankali kan hada kai da abubuwan da suka dace da aikinmu, za mu fara aiki tare da dukkan sassan.
Dukanmu muna da abubuwa da yawa da za mu yi, za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka rage saurinmu yanzu, za mu iya guje wa rauni a baya.
Babu wani shiri na ninka lokacinmu na biyan bukatunmu bayan an shafe annobar.
Ba za a sa ran ku yi aiki na karin sa'o'i ba don cika iyakokin da suka wuce gaskiyar.
Mun yi imanin cewa yanayi ya canza, kuma za mu yi aiki wajen kafa sabbin manufofi da kuma takaddun lokaci a inda ya dace.
Me zai faru da APP?
Don daidaitawa da sabon gaskiyarmu da tsammanin awanni na yau da kullun, muna son sake daidaitawa cikin lokacin aiwatar da shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce mu gabatar da wani tsawo na shirinmu na 2019-2020 wanda zai ba mu karin lokaci don tsara kasafin kudi, don ma'aikata su fi fifiko ga aikin su na musamman, kula da kansu, da kula da ƙaunatattun su, kuma su daidaita waɗanda suke bukatar ko so su yi aiki a kan jadawalin da aka rage na makonni masu zuwa.
Wannan tsawaita lokaci zai kawo raguwa mai yawa a cikin nauyin aiki da matsin lamba na shirinmu na yanzu a cikin dukan ƙungiyar.
Za mu gabatar da shawarwarinmu a gaban Hukumar a mako mai zuwa kuma da zarar mun samu tabbaci za mu sanar da wakilan da kungiyoyin game da matakai na gaba.
Na gode wa tawagar APP don jagorancinku a cikin wannan.
Yanayin ofis, sadarwa, da kuma tsabtace
A makon da ya gabata, mun gano cewa wani abokin aikinmu a SF na iya kamuwa da cutar COVID-19.
Duk da haka, muna da matukar kulawa, mun sanya ma'aikatan tsabtace rigakafi don kashe cutar a duk fadin ofishin San Francisco.
Ta kwantar da hankali daga maganin rigakafin cutar da ke asibiti, ta kwantar da hankali daga kowane farfajiyar, zuwa lobby, da kuma daga bankin lif da ke zuwa bene.
Ana aiwatar da tsarin kula da kansa ta hanyar amfani da kayayyakin da ke taimakawa kare lafiyar mazaunan ginin.
Muna da tabbacin cewa a lokacin da muka dawo, ofishin zai kasance a shirye.
Ofishinmu na DC yana cikin WeWork wanda ya raba yarjejeniyar COVID-19 da mu da kuma dukkan ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya yi amfani da tsarin nesa gaba daya, daidai da jagororin da muka raba daga San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, ana tattaunawa game da haya a Brooklyn.
Ana ci gaba da tattaunawa, amma za a iya jinkirta.
Wasu abokan aikinmu suna aiki daga gida/ nesa a karon farko.
Abokan aikinmu da suka daɗe suna aiki daga gida sun san cewa hakan zai bukaci gyara, kuma suna so su ba ka shawara:
Ka rage lokacin taro zuwa karin sa'a daya ko biyu.
Idan kana bukatar ƙarin zaman, ka yi la'akari da raba su zuwa kwanaki da yawa.
Ka bayyana tarurruka a fili, ka shirya jadawalin taro, kuma ka aika da abubuwan da za ka karanta a gaba.
Ka sa bidiyon ya zama zaɓi na farko da kake amfani da su ta amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙa haɗin kai da haɗin kai.
Ka ɗauki matakai don sauƙaƙa kowane taro, mutum ɗaya ya lura da hira don tambayoyi da lissafin jerin masu magana, kuma mutum ɗaya ya taimaka wajen yin rubutu (ko yin rubutu tare da juna)
Idan kana son wani na'urar kai mai dadi, ka aika wa goyon bayan fasaha ta imel.
Ka yi amfani da kudinka na kiwon lafiya don yin amfani da shi a cikin ɗan gajeren lokaci.
Ka shiga tashar #remoties a Slack don yin magana da abokan aikinka game da aikin da aka rarraba.
HR Operations Team na nazarin jagorar aiki na yanar gizo don taimakawa wajen haɓaka aikin da aka rarraba a duk faɗin Foundation.
A makon da ya gabata, mun nemi duk masu karbar tallafin al'umma su soke ayyukan jama'a da Wikimedia ke tallafawa, kamar su Editathon, har sai WHO ta sanar da cewa annobar ta ƙare.
Mun gaya musu cewa mun fahimci cewa buƙatunmu na sokewa da sauran takunkumi na iya sa ba zai yiwu ba a cika ayyukan tallafin da suka amince da juna, kuma cewa ba za a hukunta kowa ba don jinkirta ko gyara waɗannan manufofin.
A wannan makon mai zuwa za mu bi shi da ƙarin jagora game da Wikimedia da sauran taron yanki da na al'umma.
Wannan matsalar ta haifar da rashin jin daɗi a cikin dukan al'ummar duniya, amma kuma ta kawo sauƙi ga su da kuma samun damar yin tunani a kan al'ummomin su, Wikimedia da kuma sauran al'ummomin.
A gaba, CRT na aiki don tsara shafi a kan Mat-Wiki don samar da wuri ga al'umma don lura da tasiri da kuma bin hanyoyinmu na sadarwa tare da su.
Ci gaba da tuntuɓar juna game da al'amuran COVID-19
Za mu aika da gayyatar zuwa taron ma'aikata na musamman a cikin kalandarku a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokaci don samar da ƙarin sabuntawa, amsa tambayoyinku, da kuma ciyar da ɗan lokaci a haɗa kai.
Muna tare a cikin wannan yanayi kuma muna nan don taimakawa duk yadda za mu iya.
A halin yanzu, za ka iya ci gaba da neman bayanai daga wannan imel a kan Ofishin Wiki, da kuma duk sauran bayanan da ake bukata game da COVID-19.
CRT za ta sabunta waɗannan shafuka kuma za ta adana duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatan da ke zaune a ƙasashen da ke fama da mummunan tasiri a wannan lokacin.
Idan kana da wasu tambayoyi game da tafiya, shirye-shirye, wani babban aiki, ko kalubale game da ɗaukar hoto, ko kana buƙatar taimako game da wani abu, don Allah kada ka yi shakka ka sanar da CRT kuma ka yi aiki tare da shi.
Muna nan don taimakawa da kuma kafa dangantaka idan ana bukata.
Idan lamarinka na sirri ne ko kuma yana da mahimmanci, don Allah ka aika da imel zuwa Brian Juden, Darakta na Ayyukan Duniya na HR International.
Babu wani daga cikin wadannan canje -canje da ya kamata a yi la'akari da shi a matsayin watsi da ayyukanmu da kuma alhakinmu.
Maimakon haka, sun fahimci cewa a wannan lokacin, muna bukatar mu daidaita ayyukanmu da kuma alhakinmu yadda ba mu taɓa yi ba a baya.
Mun yi imanin cewa wadannan matakai suna da muhimmanci domin mu taimaka wa juna, domin mu iya aiki, mu samar da ayyukanmu tare da goyon bayan da suke bukata, kuma mu ci gaba da samar da sabis ɗin da duniya ke dogara da shi.
Lokacin da lokaci ya zo, aikin da muke shirin yi zai kasance yana jiran mu.
A yanzu, lokaci ya yi da za mu taimaka wa juna, kuma mu samar da wuri don muhimman ayyuka a makonni masu zuwa da kuma watannin da za su zo.
Don mu iya yin hakan, muna bukatar ku duka, kuma shi ya sa muke so ku kula da kanku da iyalanku, domin ku kasance a mafi kyawun matsayi a duk lokacin da ake bukata.
Yanzu, don Allah ka wanke hannunka kuma kada ka taɓa fuskarka!
Catherine, CRT (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jamie V, Joel L, Lynette L, Ryan M, da Tony S), da sauran shugabannin kungiyar (Grant I, Heather W, Jamie V, Janine U, Lisa S, Robin A, Ryan M, da Toby N).
Angiotensin-transforming enzyme 2 (ACE2) wani enzyme ne wanda yake da alaƙa da farfajiyar ƙwayoyin halitta (shells) a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana daidaita aikin da ake yi na maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar.
An fi sani da kwayar halitta ta ɗan adam da hACE2.
Angiotensin-transforming enzyme 2 shine zinc-containing metaloenzyme wanda yake a cikin ciki da kuma saman sauran kwayoyin.
Protein ACE2 yana da yankin N-terminal peptide M2 da kuma yankin C-terminal electrin renal amino acid transporter.
ACE2 wani furotin ne mai nau ' i na membrane wanda ya wuce lokaci guda tare da wani yanki mai aiki mai aiki wanda ba a bayyana shi ba a saman sel a cikin huhu da sauran kayan.
Wani enzyme mai suna Shades ya lalata yankin ACE2 daga cikin kwayoyin halitta, kuma sakamakon haka, furotin mai narkewa da aka yi ya saki cikin jini kuma a ƙarshe ya fito cikin fitsari.
ACE2 yana cikin mafi yawan gabobin: ACE2 yana da alaƙa da ƙwayoyin cuta na huhu na nau'in II, ƙwayoyin ƙwayoyin cuta na ƙananan hanji, ƙwayoyin ƙwayoyin cuta da jijiyoyin jini da ƙwayoyin ƙwayoyin ƙwayoyin cuta na jijiyoyin jini a mafi yawan gabobin.
Ana samun ACE2 mRNA a cikin kwakwalwar kwakwalwa, stratum, hypothalamus da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine ya zama mai karɓar ACE.
ACE yana rage hormone angiotensin I zuwa angiotensin II mai hana jijiyoyi.
ACE2 ya kuma narkar da carboxylic-terminal amino acid phenylaelanin daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) zuwa cikin ruwa zuwa angiotensin (1-7), wanda ke da karfin jini (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 [des-Arg9]-na iya lalata wasu wasu peptides da dama, ciki har da bredicaine, epelin, neurotensin, dinorphine A da ghrelin.
Hakanan ACE2 yana sarrafa jigilar membrane na mai ɗaukar amino acid SLC6A19 wanda aka bayyana a cikin cutar Hartonap.
A matsayin furotin, yana aiki a matsayin babban hanyar shiga cikin kwayoyin halitta don wasu coronavirus, ciki har da ACE2, HCoV-NL63; SARS-CoV (virus mai haifar da SARS); da kuma SARS-CoV-2 (virus mai haifar da COVID-19).
Musamman, haɗuwa da ƙwayoyin halitta na ƙwayoyin halitta na ƙwayoyin cuta na SARS-CoV da SARS-CoV2 zuwa ƙwayoyin halitta na ƙwayoyin halitta na ƙwayoyin halitta na ACE2 yana haifar da canja wurin ƙwayoyin cuta da ƙwayoyin cuta zuwa endocytosis da kuma endosomes a cikin ƙwayoyin halitta.
Wannan tsari na shiga yana bukatar kuma TMPRSS2 ya kunna furotin S, wanda ake iya hana shi a matsayin magani na yanzu. Saboda haka, wasu mutane sun yi zaton cewa rage matakan ACE2 a cikin kwayoyin zai iya taimakawa wajen yaki da kamuwa da cuta.
Koyaya, yawancin hukumomi da hukumomi sun ba da shawarar ci gaba da maganin ACE mai hanawa da ARB.
A cikin bita da kuma nazarin da aka yi a kan hanyoyin da aka buga a ranar 11 ga Yuli, 2012, an gano cewa "ana amfani da ACE inhibitors wajen rage hadarin kamuwa da cutar ta pneumonia da kashi 34% idan aka kwatanta da na masu kula".
Bugu da kari, "mazauna da aka yi musu magani da masu hana ACE sun rage hadarin kamuwa da cutar ta huhu, wadanda ke da hadarin kamuwa da cutar ta huhu, musamman wadanda ke fama da bugun jini da kuma rashin karfin zuciya.
Amfani da masu hana ACEs ya kuma shafi rage yawan mutuwar da ke tattare da cutar huhu, ko da yake sakamakon ya kasance mai tsanani fiye da hadarin cutar huhu gaba ɗaya".
Ana ganin cewa maganin mai sake haɗuwa da mutum ACE2 (rhACE2) sabon magani ne ga mummunan lalacewar huhu, kuma an nuna yana inganta haemodynamics na huhu da kuma iskar oxygen a cikin jarirai da ke fama da cutar shan numfashi mai tsanani da ke haifar da lipolipolysaccharide.
RHACE2 yana da rabin rai na kimanin sa 'o'i 10 a cikin mutum kuma yana da lokacin farawa na minti 30 tare da tsarin aiki na sa 'o'i 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai kyau ga mutanen da ke da rashin haƙuri ga RAS inhibitors (Rainine-angiotensin system inhibitors) masu kyau ko kuma cututtuka da ke haifar da karuwa a cikin angiotensin II. An kimanta rhACE2 a cikin gwaji na asibiti don magance mawuyacin yanayin numfashi.
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu waɗanda aka ƙirƙira su don taimakawa cikin bin diddigin lamba, wato, aiwatar da gano mutane ("lambobi") waɗanda zasu iya kasancewa cikin haɗuwa da mutumin da ke da cutar ta 2019-20 Coronavirus.
A wasu yankuna da kuma yankunan shari'a, an ci gaba da samar da aikace -aikace da dama tare da taimakon gwamnati.
An kirkiro wasu tsare -tsarke don gina aikace -aikacen gano lamba.
An yi magana game da damuwa game da sirrin sirri, musamman game da tsarin da ke dogara da bin diddigin yanayin masu amfani da app.
Zaɓin da ya fi dacewa da lokaci-lokaci ya ƙunshi amfani da siginar Bluetooth don yin rajistar kusanci daga wayar hannu ta mai amfani.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan kai tsaye don tallafawa irin waɗannan ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'u da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'u da ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa ƙa
A kasar Sin, gwamnatin kasar Sin ta yi amfani da wani app a hade da Alipay, wanda zai baiwa 'yan kasar damar duba idan sun kasance suna hulɗa da mutanen da ke dauke da COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin. A Singapore, ana amfani da wani app mai suna TraceTogether.
An samar da app din ne daga cikin al'ummar IT na yankin, wanda aka saki a matsayin bude tushen kuma za'a mika shi ga gwamnati. Arewacin Macedonia ta kaddamar da app din Bluetooth mai suna "StopKorona!" don gano hulda da wadanda ke da cutar da kuma ba da amsa mai sauri ga hukumomin lafiya.
Ma'aikatar Sadarwa da Fasaha da kuma Ma'aikatar Lafiya ne suka kirkiro wannan app din.
A ranar 14 ga Afrilu, 2020, app din yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga watan Afrilu, gwamnatin ta ce, app din na tuntuba yana cikin wani mataki na ci gaba, kuma zai kasance a shirye don tsarawa cikin makonni. An yi amfani da irin wannan app ("StopCovid") a Ireland da Faransa.
Australia da New Zealand suna la'akari da aikace-aikacen TraceTogether na Singapore da kuma aikace-aikacen da ke dogara da yarjejeniyar BlueTrace. Rasha na son gabatar da aikace-aikacen geofencing ga marasa lafiya da aka gano COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa a fannin tsaro a jami'ar Cambridge, ya lissafa matsaloli masu yawa da za su iya faruwa tare da tsarin da ke dogara da aikace-aikace, ciki har da rashin inganci idan ana amfani da app ɗin ga ƙananan ƙananan ɓangaren jama'a.
Da yake magance damuwar game da yaduwar "Coronavirus" apps masu ɓatarwa ko cutarwa, Apple ya iyakance ga "masu hukuma" ko kuma wasu kungiyoyi masu daraja kawai, yana ƙayyade irin kungiyoyin da za su iya haɗa da aikace-aikacen da suka shafi coronavirus a cikin App Store.
Google da Amazon sun sanya irin wannan takunkumi.
Masu fafutukar tsare sirri sun nuna damuwa game da tasirin saka idanu mai yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a lalata kayan aikin saka idanu da aka gina don magance cutar coronavirus bayan wannan barazanar ta wuce.
Amnesty International da fiye da kungiyoyi 100 sun fitar da wata sanarwa kan iyakokin irin wannan sa ido.
Kungiyoyi sun bayyana sharuɗɗa guda takwas a kan ayyukan gwamnati:
Dole ne a yi sa ido a kan "doka, dole, kuma a daidaita";
Dole ne a sami sashe na ƙarshe don ƙarin bayani game da kulawa da kulawa;
Dole ne a iyakance amfani da bayanai ga dalilai na COVID-19;
Dole ne a kiyaye tsaro da kuma rashin sani na bayanai kuma a nuna su a matsayin masu kariya bisa ga shaidar.
Dole ne a guji inganta nuna bambanci da rashin ikon yin amfani da sa ido kan dijital;
Duk wani raba bayanai tare da wasu kamfanoni ya kamata a ayyana shi a cikin doka;
Dole ne a yi matakan kare hakkin 'yan kasa don magance cin zarafi da kuma yin amfani da shi;
"Sanarwar masu ruwa da tsaki" da ke da alaƙa da wannan, har da masu ba da izini ba, za su bukaci "samarwa mai ma'ana" daga dukkan "masu ruwa da tsaki", har da masu ba da izini ba, har da masu ba da izini ba.
Manufar shirin Google / Apple da aka gabatar shine magance matsalar sa ido a kai a kai ta hanyar cire tsarin ganowa daga tsarin aiki na na'urar su lokacin da ba a buƙata ba.
Wasu ƙasashe sun yi amfani da bin diddigin wuri na cibiyar sadarwa maimakon aikace -aikace, suna kawar da buƙatar saukar da aikace -aikace da kuma yiwuwar guje wa bin diddigin.
A Isra'ila, an amince da bin diddigin da ke tattare da cibiyar sadarwa.
Maganin da ke kan hanyar sadarwa wanda ke da damar samun bayanai na wuri ba tare da inganci ba yana da mahimman matsalolin sirri.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwa ba ne ke buƙatar samun damar zuwa bayanan wuri na mutum; an kirkiro tsarin kare sirrin da yawa wanda ke amfani da cibiyar sadarwa kawai don sadarwa (duba sashe na ƙasa).
An yi amfani da tsarin da ba na app ba don gano hanyoyin sadarwa a Koriya ta Kudu.
Maimakon amfani da ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'
Baya ga amfani da wannan bayanin don faɗakar da masu iya tuntuɓar, gwamnati ta ba da bayanan wurin a fili saboda canje -canje masu yawa a cikin dokokin sirrin bayanai bayan barkewar cutar MERS a wannan ƙasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar aikace -aikace da kuma shafukan yanar gizo. Kasashe da dama, ciki har da Jamus, sun yi la'akari da amfani da tsarin tsare sirri da tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a fitar da waɗannan bayanan ba tukuna.
Bayanin bayanan sirri tare da babban rukuni na wallafe-wallafen bincike ya kasance mai kyau tun daga aƙalla 2013. Kamar yadda aka yi a ranar 7 ga Afrilu, 2020, fiye da rukuni na masana sun kasance suna aiki a kan hanyoyin da za su iya magance matsalar sirri, kamar amfani da Bluetooth low energy (BLE) don yin rajistar kusanci daga wayar hannu ta mai amfani.
Duk da haka, PEPP-PT wani aiki ne na daidaitawa wanda ya ƙunshi hanyoyin da aka ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci.
A cikin waɗannan yarjejeniyoyi, bayanan sirri da za a iya ganowa ba su taɓa fita daga na'urar ba, kuma duk abubuwan da suka dace suna kan na'urar.
The Privacy Group a MIT Media Lab na ci gaba da SafePaths, dandamali don amfani da fasahohin kare sirrin yayin tattarawa da amfani da bayanan wuri ko hanyar shiga don bin diddigin yaduwar COVID-19.
Wannan ya dogara ne akan binciken da aka yi a cikin wata takarda mai suna "Apps Gone Rogue: Maintaining Personal Privacy in the Epidemic", wadda aka fitar a watan Maris na 2020. Irin wannan yunƙurin shi ne SafeTrace na kamfanin Enigma MPC wanda ke bunkasa fasahar tsare sirri, wanda aka kafa a MIT Media Lab.
SafeTrace yana amfani da fasahar tsaro ta kayan aiki, wanda ke ba masu amfani damar raba bayanan wuri da lafiyar masu mahimmanci tare da sauran masu amfani da hukumomi ba tare da yin jayayya da sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa kungiyar Global TCN Alliance ta kungiyoyi da suka hada kai a cikin sharuddan irin wannan ra'ayi da kuma irin wannan yarjejeniyar da aka yi da yawa, da nufin rage rarrabuwa, da kuma ba da damar hulɗa ta duniya ta hanyar ganowa da kuma gargadi, wanda ya kasance muhimmin abu don cimma ingantaccen aiki.
A ranar 9 ga Afrilu, 2020, Gwamnatin Singapore ta sanar da cewa ta bude tushen yarjejeniyar BlueTrace da aka yi amfani da ita ta hanyar aikace -aikacen ta na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da wani shiri don gano hanyoyin sadarwa, wanda suka yi ikirarin cewa wannan Bluetooth zai kare sirrin dangane da haɗin fasahar low energy da kuma sirrin sirrin sirrin sirrin sirrin.
Ya kuma buga takamaiman fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, ana nufin a samar da tsarin a matakai uku:
Bayar da kayan aiki don bawa gwamnatoci damar ƙirƙirar ƙa'idodin ɓoye-ɓoye na COVID-19
Wannan aikin yana aiki kai tsaye a cikin iOS da Android
Sake amfani da magani (wanda aka fi sani da sake amfani da magani, sake amfani da magani, sake amfani da magani ko kuma sauyawar magani) shine sake amfani da magani da aka amince da shi don magance wata cuta ko yanayin likita daban da wanda aka fara samar dashi.
Wannan tsarin bincike ne na kimiyya wanda ake amfani dashi a halin yanzu don haɓaka ingantaccen magani na COVID-19.
Sauran umarnin bincike sun hada da ci gaban rigakafin COVID-19 da kuma samar da maganin plasma da ya shafi lafiyar. SARS-CoV-2 yana da kusan 66 masu amfani da sunadarai, kowannensu yana da wurare masu yawa na ligand.
Binciken wuraren da aka ɗaure ya ba da kyakkyawan shiri na haɓaka ingantaccen maganin rigakafi don karewa daga furotin COVID-19.
Muhimman sunadarai na SARS-CoV-2 sune proteases masu kama da papane, RNA dependent RNA polymerases, helicases, S proteins da ADP ribophosphate.
Hussain da sauransu sun yi nazarin wasu magungunan masu neman shiga, sannan suka yi amfani da su kuma suka bincika su don daidaita tsarin su da magungunan da aka fi yarda da su don hanzarta ci gaban ingantaccen maganin SARS-CoV-2 a cikin binciken da aka ba da shawarar a cikin tsarin binciken asibiti.
Chlorokine magani ne na yaki da zazzabin cizon sauro wanda ake amfani da shi don kare kansa daga wasu cututtukan rigakafi.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da related hydroxychloroquine, za su kasance daga cikin magunguna hudu da za a yi nazari a matsayin wani ɓangare na gwajin gwaji na Solidarity.
Gwamnan New York, Andrew Cuomo, ya sanar da cewa gwajin chloroquine da hydroxychloroquine na jihar New York zai fara ne daga ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chlorophyll phosphate a ƙarƙashin Hukumar Amfani da Gaggawa (EUA).
Ba a amince da maganin ba ta hanyar FDA ta hanyar gwajin gwaji kuma an ba da izini ne kawai a ƙarƙashin EUA a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya waɗanda ke asibiti amma ba su iya samun magani a cikin gwajin gwaji ba.
CDC ta ce "Ba a kafa amfani, sashi ko tsawon hydroxychloroquine ba don rigakafi ko magani na kamuwa da cutar SARS-CoV-2".
Likitoci sun ce suna amfani da miyagun ƙwayoyi ne a lokacin da "babu wani zaɓi".
Wani rukuni na bincike na Turkiyya a Istanbul na gudanar da karamin bincike kan amfani da chloroquine a hade da zinc, bitamin A, bitamin C da bitamin D.
Akwai manyan karatu a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar likitancin NYU Langon tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine.
Gwaje -gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa Favipiravir ya nuna "a bayyane yake" yana da tasiri.
A cikin Shenzhen, 35 sun samu gwajin rashin lafiya a matsakaita na kwanaki 4, yayin da tsawon cutar ya kasance kwanaki 11 a cikin 45 marasa lafiya da ba su samu ba.
A cikin wani bincike da aka gudanar a Wuhan a kan mutane 240 da ke fama da cutar huhu, rabin marasa lafiya sun karɓi favipiravir da kuma rabin sun karɓi omefenovir.
Hukumar kula da magunguna ta Italiya ta tunatar da jama'a cewa akwai karancin shaidu da suka nuna cewa maganin yana da kyau.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don adana su, kuma za ta yi amfani da sojojin don isar da magunguna zuwa asibitocin jami'a, inda za a yi amfani da magungunan don magance marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya aika da shawarwari ga gwamnatin Trump game da sayen magani. Wannan magani na iya zama da tasiri a cikin matsanancin yanayin cutar, inda cutar ta riga ta ninka.
Ba za a iya amfani da shi ba ga mata masu ciki ko mata masu ƙoƙarin yin ciki.
Wani bincike na maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar cutar cutar cutar cutar cutar (alama da ake kira don maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar (AR cutar cutar cutar cutar cutar ta hanyar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar ta cutar cutar cutar cutar cutar cutar ta cutar ta cutar cutar cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar
An tsara magunguna don hana kwayar cutar HIV ta hanyar ɗaure ta da protease.
Wata ƙungiyar masu bincike daga Jami'ar Colorado na kokarin gyara magunguna don gano wani fili wanda zai danganta da protease na SARS-CoV-2. Akwai zargi a cikin al'umma na kimiyya game da tura albarkatu don sake amfani da magunguna da ake ci gaba da amfani da su musamman don HIV / AIDS.
WHO ta hada da Lopinavir/Ritonavir a cikin gwajin hadin kai na kasa da kasa.
Gilead Sciences ta kirkiro kuma ta ci gaba da yin amfani da Remdesivir a matsayin magani ga cutar Ebola da kuma kamuwa da cutar Marburg. Gilead Sciences ta gano cewa Remdesivir yana da aikin maganin rigakafi na artificial environmental don kare kansa daga yawancin philo-, pneumocytes-, paramix- da kuma coronavirus-virus.
Wata matsala da ake samu a maganin rigakafi ita ce ci gaban juriya ta hanyar mutants wanda zai iya haifar da cutar da kuma kamuwa da cutar.
Wasu karatun da aka fara yi kafin a yi gwaji sun nuna cewa Remdesivir na iya haifar da babban rashin daidaito na kwayoyin halitta ga juriya. Akwai gwaje -gwaje masu yawa da ake gudanarwa, ciki har da gwaje -gwaje biyu da asibitin Jami'ar Cleveland ke gudanarwa; ɗaya ga mutanen da ke da matsakaiciyar cuta kuma ɗayan ga waɗanda ke da cutar mai tsanani.
Akwai gwaje -gwaje guda uku na asibiti na intravenous vitamin C a kan masu asibiti da marasa lafiya masu tsanani da COVID-19; biyu placebo-controlled (a China, Kanada) da kuma daya ba tare da wani iko (a Italiya).
Jihar New York ta fara gwaji don maganin rigakafi azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) tana shirin yin gwaji na asibiti don maganin cutar ta coronavirus, wani corticosteroid mai shan numfashi don asma, Tighins alvesco (cyclosodine), don magance marasa lafiya da ke da alamun cutar.
Wani gwaji na mataki na II na enzyme mai canza angiotensin 2 yana gudana tare da marasa lafiya 200 da ke karbar magani daga cikin mawuyacin hali, asibitoci a Denmark, Jamus da Austria don tantance tasirin magani.
Masu bincike daga Cibiyar Zuciyar Montreal a Kanada a halin yanzu suna nazarin rawar Colchicine wajen rage kumburi da cututtukan huhu a cikin marasa lafiya da ke fama da bayyanar cututtuka masu sauƙi na COVID-19.
A cikin binciken da ake kira COLCORONA, ana daukar manya 6000 masu shekaru 40 zuwa sama da suka kamu da COVID-19 kuma suna fuskantar bayyanar cututtuka masu sauki, wanda ba ya bukatar asibiti.
Matan da suke da ciki ko suna shayarwa ko kuma ba sa amfani da wata hanyar hana haihuwa mai tasiri ba su cancanci.
Ana gwada wasu masu hana cutar a Italiya.
Ana amfani da Heparin mai ƙarancin nauyin kwayoyin halitta don magance marasa lafiya, wanda ya sa Hukumar Kula da Magunguna ta Italiya ta wallafa jagororin amfani da shi.
An sanar da wani bincike mai zurfi a kan marasa lafiya 300 da ke yin bincike kan amfani da anoxaparin sodium a allurai masu hana cututtuka da magani a Italiya a ranar 14 ga Afrilu.
Tunda SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai ga sake amfani da magungunan rigakafin cutar da aka amince da su, wanda aka haɓaka don barkewar cutar ta MERS, SARS da West Nile.
Ribararin: An bada shawarar ribarinin don maganin COVID-19 bisa ga jagororin juyin juya halin kasar Sin na 7.
Umfenovir: An bada shawarar Umfenovir don maganin COVID-19 bisa ga jagororin juyin juya halin 7 na kasar Sin
Wasu maganin rigakafi da aka gano a matsayin yiwuwar sake amfani da su a matsayin maganin COVID-19 sune:
Tocilizumab (mai karɓar maganin IL-6): An amince da shi a kasar Sin.
Hakanan an gwada su a Italiya da China.
Allurar rigakafin COVID-19 allurar rigakafi ce da aka yi zato don kare mutum daga cutar Coronavirus Disease 2019 (COVID-19).
Ko da yake babu wani magani da ya kammala gwajin asibiti, duk da haka ana yin ƙoƙari da yawa don haɓaka irin wannan maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta sa ran samun allurar rigakafi a cikin watanni 18 ba don kare kanta daga SARS-CoV-2, cutar da ke haifar da cutar.
Masu neman rigakafin guda biyar sun shiga binciken tsaro na farko a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020 an samu babban barkewar cutar a duniya, wanda ya haifar da babban zuba jari da bincike don bunkasa rigakafi.
Kungiyoyi da dama suna amfani da bayanan da aka wallafa don samar da alluran rigakafi don kare kansu daga SARS-CoV-2.
A watan Afrilu, an bayyana cewa, abubuwan da ke da muhimmanci ga CEPI don bunkasa allurar rigakafi sune saurin aiki, samar da kayayyaki, tsarawa mai yawa da kuma samun damar duniya.
A watan Afrilu, masana kimiyyar CEPI sun sanar da cewa, a farkon shekarar 2020 akwai dandamali daban-daban 10 na fasaha da ke karkashin bincike da ci gaba don samar da ingantaccen allurar rigakafi don karewa daga COVID-19.
Mataki na farko na nazarin tsaro ya hada da manyan manufofin dandamali:
Nucleic acid (DNA da RNA) (mataki na farko na ci gaba da kuma takarar allurar rigakafi: Moderna, mRNA-1273)
Maganin Viral (mataki na farko mai tasowa da kuma mai neman allurar rigakafi: CanSino Biologics, Adenovirus Type 5 vector)
Kamar yadda masana kimiyyar CEPI suka sanar a watan Afrilu, jimillar masu neman allurar rigakafi 115 suna cikin matakai na farko na ci gaba, 78 daga cikinsu an tabbatar da su a matsayin ayyukan aiki (a cewar Cibiyar Milken 79) da kuma 37 da aka bayyana, amma akwai karancin bayanan jama'a (wanda ake tsarawa ko kuma ake zato a cikin shiri).
Gwajin farko na aminci da rigakafi a cikin gwajin I-II na farko, ana gudanar da shi a wurare da yawa, wanda aka yi a bazuwar, placebo-controlled, da kuma a wurare da yawa, yana ƙayyade ƙarin daidai, ingantattun sashi.
Gwaje -gwaje na III na gaba suna yawanci sun haɗa da ƙarin mahalarta, tare da ƙungiyar kulawa da ke lura da tasirin illa ga mafi kyawun sashi, da kuma gwada tasirin allurar don hana cutar.
Daga cikin masu neman allurar rigakafi 79 a ci gaba mai aiki (wanda aka tabbatar a farkon watan Afrilu na 2020), 74 har yanzu ba su cikin kimantawar mutum ba (har yanzu suna cikin binciken "preclinical").
A ranar 24 ga Janairu, 2020, Jami'ar Queensland ta Australia ta sanar da cewa tana nazarin yiwuwar allurar kwayar cuta ta kwayar cuta, wadda za ta yi gyare-gyare ga furotin na kwayar cuta don motsa amsawar rigakafi.
A ranar 24 ga Janairu, 2020, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan a Kanada ta sanar da fara aiki kan allurar rigakafi da nufin fara gwajin mutum a 2021.
A ranar 26 ga Janairu, 2020, an sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin da kuma a ranar 28 ga Janairu, a Jami'ar Hong Kong.
A ranar 29 ga Janairu, 2020, kamfanin Yansen Pharmaceutical, wanda Hanneke Shutemaker ke jagorantar, ya sanar da cewa ya fara aiki kan samar da allurar rigakafi.
Yancen yana ci gaba da samar da allurar baki tare da abokin aikinsa na biotechnology, Vaxart.
A ranar 18 ga Maris, 2020, Emergent Biosolutions ta sanar da haɗin gwiwar masana'antu don haɓaka allurar rigakafi tare da Waxart.
A ranar 8 ga Fabrairu, 2020, Laboratory Oncogene a Romania ta wallafa takarda kan tsara maganin da ya yi kama da na maganin da ake amfani da shi wajen maganin cutar kansa.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa ya kammala hada-hadar allurar kuma ya fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani kamfanin mallakar Generex, NuGenerex Immuno-Oncology ya sanar da cewa suna fara aikin yin allurar rigakafi don samar da allurar peptide mai laushi don kare daga COVID-19.
Sun so su samar da takardar neman rigakafi da za a iya gwadawa a cikin mutane "a cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula
A ranar 10 ga watan Maris na shekarar 2020, Emergent Biosolutions ta sanar da cewa za ta ci gaba da bunkasa da kuma samar da allurar rigakafi.
Za mu yi aiki tare da Novavax Inc.
Abokan hulɗa sun sanar da shirye-shirye don gwajin gwaji na farko da kuma gwajin gwaji na farko har zuwa Yuli 2020.
A ranar 12 ga watan Maris na shekarar 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa tana aiki da masu samar da allurar rigakafi guda 11, kuma cewa za a dauki a kalla shekaru biyu da rabi kafin a samar da allurar rigakafi a hanya mai sauri.
A ranar 12 ga watan Maris na shekarar 2020, wani kamfanin kere kere a birnin Quebec, Quebec, ya ruwaito cewa an samu wani kwayar cutar coronavirus a karkashin wani tallafi daga Cibiyar Nazarin Lafiya ta Kanada.
Mai neman allurar rigakafi yana cikin binciken dakin gwaje -gwaje wanda ake shirin gwadawa a jikin mutum a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da "babban kuɗi don musamman gano COVID-19 allurar rigakafi" ga Kurvac, wanda gwamnatin Jamus ta yi hamayya da shi.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin Biotech na Jamus don haɓaka allurar mRNA.
BNT162 wanda ya dace da allurar rigakafi ta mRNA, a halin yanzu yana cikin gwajin gwaji, wanda ana sa ran fara gwajin gwaji a watan Afrilu na 2020.
A ranar 17 ga Maris, 2020, a Italiya, kamfanin fasaha na zamani na Italiya, Tacis Biotech, ya sanar da cewa za su samu sakamakon gwajin gwaji a watan Afrilu na 2020 kuma za a iya fara gwajin su a kan dan takararsu ta karshe a cikin kaka.
A ranar 19 ga Maris, 2020, a Faransa, Kungiyar ta Coalition for Epidemic Preparedness Innovation (CEPI) ta sanar da zuba jari na dala miliyan 4.9 a kungiyar binciken allurar rigakafin COVID-19, wanda ya hada da Institute Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh, wanda ke zuba jari na dala miliyan 29 na CEPI a cikin bunkasa allurar rigakafin COVID-19.
Sauran abokan cinikin CEPI don haɓaka allurar COVID-19 sune Moderna, Curevac, Inovaio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na 'yan takarar rigakafi guda shida.
Masu bincike daga Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da rigakafin RNA mai karfafa kai don COVID-19.
An samar da wannan allurar ne cikin kwanaki 14 bayan samun tsari daga kasar Sin.
A karshen watan Maris, gwamnatin Kanada ta sanar da kudade na dala miliyan 275 don samar da bincike kan ayyukan bincike 96 kan hanyoyin da za a iya amfani da su wajen kare mutane daga COVID-19, wanda ya hada da masu neman allurar rigakafi daga kamfanoni da jami'o'i a Kanada, kamar su Mediciago da Jami'ar Saskatchewan.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da dala miliyan 192 don samar da wani sabon allurar COVID-19 musamman, tare da shirin kafa "bank na alluran rigakafi" na kasa na sabbin alluran rigakafi da za a iya amfani da su yayin da sauran annobar coronavirus ke barkewa.
A ranar 2 ga Afrilu, 2020, masu bincike daga Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoto kan gwajin PittCoVacc, wani yaduwar COVID-19 a cikin beraye, inda suka ce " alluran SARS-CoV-2 S1 subunit da aka bayar na MNA sun haifar da maganin antigen-specific antibody responses [a cikin beraye], wanda ya bayyana a fili ya fara makonni 2 bayan an yi allurar".
A ranar 16 ga Afrilu, 2020, Makarantar Magunguna ta Jami'ar Waterloo a Kanada ta sanar da zane na mai neman allurar rigakafi ta DNA a matsayin mai yiwuwa nasal spray.
Ta amfani da bacteriophages, za a tsara DNA don yin kwayar halitta a cikin kwayar mutum don samar da kwayoyin cutar-kamar cutar, wanda zai iya motsa tsarin rigakafi don samar da rigakafi don kare kansa daga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun hada kayan aiki da kayan aikin girgije daga kamfanin Hewlett Packard Enterprise, Amazon, Microsoft da Google, don samun damar yin amfani da su daga IBM zuwa manyan kwamfutoci.
Wasu magungunan suna da sakamako mai ban mamaki, wanda ake kira sakamako mara kyau.
Wannan yana nufin cewa suna iya samun ƙarin fa'idodi daga cutar da suke hanawa.
Wani gwaji na bazuwar a Ostiraliya yana neman ma'aikatan kiwon lafiya 4,170 su shiga.
Yana yiwuwa cewa alluran rigakafi ba za su kasance masu aminci ko tasiri ba a ci gaba.
Binciken farko na samfurin dabbobi na COVID-19, kamar su ACE2-transgenic mice, da sauran dabbobi na dakin gwaje-gwaje da kuma wadanda ba na mutum ba, don tantance tasirin rigakafin, ya nuna bukatar matakan kariya na matakin 3 na biosafety don magance kwayar cutar da ke rayuwa da kuma daidaitaccen tsari na tsaro na duniya don tabbatar da daidaito.
An gwada alluran rigakafi daga SARS da MERS a cikin samfurin dabba ba na mutum ba.
A shekarar 2020, babu magani ko rigakafin rigakafi ga SARS wanda aka tabbatar da cewa yana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya na jama'a a duniya.
Lokacin da cutar ta MERS ta zama gama gari, an yi imanin cewa binciken SARS na yanzu zai iya samar da wani tsari mai amfani don samar da alluran rigakafi da magunguna don karewa daga kamuwa da cutar MERS-CoV.
A watan Maris na shekarar 2020, akwai allurar rigakafin MERS guda daya da ta kammala gwajin gwaji na farko a cikin mutane, kuma akwai wasu uku da ke ci gaba, dukkansu alluran rigakafin da ke dauke da kwayar cutar, biyu sune adenoviral vectored (ChAdOx1-MERS, BVRS-GamVac), da kuma daya MVA vectored (MVA-MERS-S).
Shafukan sada zumunta sun inganta wata makirci, suna da'awar cewa an san game da cutar da ke haifar da COVID-19 kuma riga an sami allurar rigakafi.
Patents da aka ambata ta hanyar shafukan sada zumunta daban-daban suna nufin patents na yanzu don jerin kwayoyin halitta da kuma alluran rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa wacce ta haifar da cutar ta Coronavirus ta 2 (SARS-CoV-2) mai tsanani.
Alamun bayyanar cututtuka sun hada da zazzabi, tari, da kuma numfashi.
Sauran alamun na iya kasancewa gajiya, ciwon tsoka, asphyxia, rashin jin daɗi a cikin wuya, rashin jin ƙanshi da ciwon ciki.
Lokaci daga bayyanar cutar zuwa bayyanar cututtuka yana ɗaukar kimanin kwanaki biyar amma yana iya ɗaukar kwanaki biyu zuwa goma sha huɗu.
Ko da yake a mafi yawan lokuta bayyanar cututtuka suna da sauƙi, a wasu lokuta ana samun cutar huhu ta hanyar ƙwayar cuta da rashin ƙarfi na gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gab
A ranar 17 ga Afrilu, 2020, an samu karin shari'o'i miliyan 2.24 a kasashe da yankuna 210 da suka haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yaduwa tsakanin mutane ne a lokacin da suka yi hulɗa da juna, galibi ta hanyar ƙarancin saukad da ke fitowa daga tari, cizon yatsa ko magana.
Ko da yake waɗannan saukad da sukan faru ne lokacin da suke numfashi, suna yawan fadawa ƙasa ko farfajiya maimakon su zama masu yaduwa a nesa.
Mutane za su iya kamuwa da cutar ta hanyar taɓa wani fili mai datti kuma daga baya su taɓa idanunsu, hancinsu ko bakinsu.
Kwayar cutar na iya rayuwa har zuwa awanni 72 a saman ƙasa.
Yana da matukar yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake zai yiwu a samu yaduwar cututtuka kafin bayyanar cututtuka da kuma bayan cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da suka yi shakkar cewa suna da cutar da kuma masu kula da su.
Shawarwarin amfani da abin rufe fuska ta jama'a sun bambanta, wasu hukumomi sun ba da shawarar kada a yi amfani da su, wasu sun ba da shawarar yin amfani da su, wasu kuma sun sa amfani da su ya zama dole.
A halin yanzu, babu allurar rigakafi ko maganin riga-kafi na musamman don COVID-19.
Yawancin ƙasashe a duk yankunan WHO guda shida sun sami watsawar cutar ta gida.
Mutane da suka kamu da cutar na iya zama marasa lafiya ko kuma suna da alamun irin na mura kamar zazzabi, tari, gajiya da numfashi.
Alamun gaggawa sun hada da wahalar numfashi, ciwon kirji ko matsa lamba, rikicewa, wahalar farkawa da kuma fuska ko lebe mai launin shuɗi; ana ba da shawarar samun kulawa ta likita nan take idan waɗannan alamun sun bayyana.
A mafi yawan lokuta, ana iya ganin alamun hanyar numfashi ta sama kamar su yin tawaye, numfashi ko kuma ƙwanƙwasawa a cikin makogwaro.
Alamun cututtukan gastrointestinal kamar naƙuda, vomiting da kuma asphyxiation an lura da su a cikin kashi daban -daban.
A wasu lokutan a kasar Sin, a farkon an lura da tsaurin kai da kuma saurin bugun jini.
A wasu lokuta, cutar tana iya haifar da ciwon huhu, rashin aiki da gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin
Wannan shi ne lokacin da aka haife shi.
Lokacin bayyanar COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya zama daga kwana biyu zuwa 14.
97.5% na mutanen da suka kamu da cututtuka sun sami cututtuka a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk mutanen da suka kamu da cutar suka samu cututtuka ba.
Ba a san cikakken matsayin waɗannan masu ɗaukar hoto a cikin watsawa ba tukuna; duk da haka, shaidar farko ta nuna cewa suna iya taimakawa wajen yaduwar cutar.
Ba a san adadin mutanen da suka kamu da cutar ba da alamun cutar ba a halin yanzu kuma ana nazarin su, cibiyar kula da cututtuka ta Koriya (KCDC) ta ruwaito cewa kashi 20% na duk maganganun da aka tabbatar sun kasance marasa lokaci yayin da suke asibiti.
Hukumar Lafiya ta kasar Sin ta fara hada da cututtuka marasa lokaci a cikin al'amuranta na yau da kullum a ranar 1 ga Afrilu; daga cikin cututtuka 166 da aka samu a wannan rana, 130 (78%) sun kasance marasa lokaci a lokacin gwaji.
A cikin barkono da barkono, ana iya samun adadin ƙwayoyin cuta.
Magana da babbar murya tana haifar da ƙarin saukad da fiye da magana da murya ta al'ada.
Wani bincike a Singapore ya gano cewa, tari da ba a rufe su ba zai iya kaiwa ga mita 4.5 (15 ft) daga tari.
Ko da yake wannan kwayar cutar ba ta da iska, amma, a cewar National Academy of Sciences, ana iya samun yaduwar kwayoyin halitta kuma ana iya samun RNA mai kyau daga samfurori na iska a cikin hanyoyin da ke waje da ɗakunan mutane.
Wasu hanyoyin magani kamar su hoses da cututtukan zuciya da huhu (CPR) na iya haifar da iskar numfashi ta haifar da iskar gas ta hanyar iska.
Ko da yake akwai damuwa cewa cutar za ta iya yaduwa ta hanyar fitsari, ana ganin cewa haɗarin ya rage. Wannan kwayar cutar tana da matukar yaduwa lokacin da mutane ke da alamun bayyanar cututtuka; ko da yake yana yiwuwa a yada kafin bayyanar cututtuka, amma haɗarin ya rage.
Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC) ta ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Wannan kwayar cutar tana rayuwa a farfajiya na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano cewa cutar tana iya ganowa a rana ɗaya a kan kwali, kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), da kuma awanni hudu a kan 99% jan ƙarfe.
Duk da haka, yanayin zafi da zafin jiki sun bambanta.
Sabulu da kuma masu cirewa suna da tasiri idan aka yi amfani da su yadda ya kamata; samfurori na sabulu suna kashe su ta hanyar lalata kayan kariya na kwayoyin cuta, da kuma cire su daga fata da sauran farfajiyar.
Sauran maganin, kamar benzalkonium chloride da chlorhexidine gluconate (mai kashe kwayoyin cutar kan tiyata), ba su da tasiri sosai. A cikin wani binciken da aka yi a Hong Kong, an ɗauki samfurori na larura a matsakaici kwanaki biyu bayan an fara asibiti.
A cikin mutum biyar cikin shida, samfurin farko ya nuna mafi yawan adadin kwayar cutar, kuma mutum na shida ya nuna mafi yawan kwayar cutar a rana ta biyu ta gwaji.
Cutar ta numfashi mai tsanani Coronavirus 2 (SARS-CoV-2) sabon cuta ce ta numfashi mai tsanani wanda aka fara warewa daga mutane uku da ke fama da cutar huhu da ke tattare da cutar ta numfashi mai tsanani a Wuhan.
Dukkanin halayen cutar SARS-CoV-2 ana samun su a cikin coronavirus masu alaƙa da yanayi.
A waje da jikin mutum, ana lalata kwayar cutar da sabulu na gida, wanda ke karya murfin kariya. SARS-CoV-2 yana da alaƙa da kusa da asalin SARS-CoV.
Fuskokin su ne sassan da suka fi fama da cutar COVID-19 saboda kwayar cutar ta kai ga kwayoyin abinci mai gina jiki ta hanyar enzyme angiotensin-transforming enzyme 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin huhu na nau'in II.
Kwayar cutar tana amfani da wani nau'in glycoprotein na musamman mai suna "Peploomer" don yin aiki tare da ACE2 kuma ya shiga cikin kwayoyin abinci mai gina jiki.
Kashi 12 cikin 100 na mutanen da suka kamu da cutar da cutar da suka shiga asibiti a birnin Wuhan, China sun kamu da mummunan rauni na zuciya kuma wannan ya fi kowa a cikin cututtukan da suka shafi cututtukan zuciya.
A yayin ciwon, yawan cututtukan zuciya suna da yawa saboda rashin lafiyar jiki da kuma rashin lafiyar jiki, amma mummunan rauni na myocardial zai iya kasancewa tare da masu karɓar ACE2 a zuciya.
ACE2 yana da yawa a zuciya kuma yana da hannu a cikin aikin zuciya.
A cikin ICU da ke da kamuwa da COVID-19, an gano yawan cututtukan thrombosis (31%) da kuma venous thromboembolism (25%) wanda zai iya kasancewa da alaƙa da rashin lafiya. Binciken gawawwakin mutanen da suka mutu daga COVID-19 sun gano cutar da ke haifar da cutar ta iska (DAD) da kuma abubuwa na waje masu samar da lymphocytes a cikin huhu.
Ko da yake SARS-COV-2 yana da bi na ACE2 na sassan huhu na hanyar numfashi, marasa lafiya da ke fama da COVID-19 suna da alamun cutar ta jiki.
Musamman, an nuna cewa kwayoyin halitta na GM-CSF-sabout T-cell suna da alaƙa da zabin kwayoyin halitta na IL-6-sabout monocytes a cikin marasa lafiya na COVID-19 da kuma mummunan cutar huhu.
An kuma nuna cewa akwai wasu abubuwa masu dauke da cutar lymphocytic a cikin gwajin.
WHO ta wallafa wasu takardun gwaji don cutar.
Hanyar gwajin da aka saba amfani da ita ita ce ta hanyar yin amfani da real-time reverse transcription polymerase chain reaction (rRT-PCR).
Ana gwada shi ne a kan samfurori na numfashi da aka samu ta hanyar hancin hanci; duk da haka, ana iya amfani da samfurin hanci ko hanci.
Sakamakon yakan kasance cikin sa'o'i kadan zuwa kwana biyu.
Ana iya yin amfani da gwajin jini, amma ana buƙatar ɗaukar samfurin jini biyu a cikin mako biyu kuma sakamakon yana da ƙimar gaggawa.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'in coronavirus da kuma wallafa jerin kwayoyin halitta don haka dakunan gwaje -gwaje a duk duniya zasu iya bunkasa gwajin polymerase chain reaction (PCR) da kansa don gano kamuwa da cutar.
Kamar yadda aka yi a ranar 4 ga Afrilu 2020, gwajin rigakafi (wanda zai iya gano kamuwa da cutar da ke aiki da kuma ko mutum ya kamu da cutar a baya) yana ci gaba, amma har yanzu ba a yi amfani da shi sosai ba.
Gwajin da aka yi a kasar Sin ya nuna cewa tsarki ya kai kashi 60 zuwa 70 cikin 100.
FDA a Amurka ta amince da gwajin farko na kulawa-da-gidanka don amfani a ƙarshen wannan watan a ranar 21 ga Maris, 2020. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya fitar sun bayyana hanyoyin gano kamuwa da cuta dangane da wuraren bincike da haɗarin annobar.
Abubuwan da ke faruwa a farkon juyin halitta sune rashin daidaito na ƙasa-glass na biyu tare da rarraba ta gefe, rashin daidaito da baya.
Sa'ad da cutar ta yi girma, za a iya nuna rinjaye na subplural, ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ.
Akwai karancin kididdiga game da cututtukan COVID-19 da kuma yanayin jiki.
Babban binciken da aka samu daga binciken gawawwakin shi ne:
Macroscopy: Shaggy a cikin huhu, pericarditis, ƙarancin huhu da kuma bugun huhu
Ana iya ganin nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau' na nau'ikan nau'ikan nau'ikan nau'ikan nau' na nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau' na nau'ikan nau' na nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau' na nau'ikan nau' na
Rashin ƙwayar huhu: ƙwayar huhu, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Rashin ƙwayar cuta mai tsanani: Rashin ƙwayar cuta mai tsanani (DAD) tare da radiationic airway leakage.
DAD yana haifar da rikicin numfashi mai tsanani (ARDS) da kuma rashin iskar oxygen mai tsanani.
Maganin cutar huhu: gudanar da zubar da jini da kuma zubar da jini a cikin huhu
Jini: Ana yin bincike na jini (DIC);
Matakan rigakafi don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da ke da jama'a, wanke hannuwanku da sabulu da ruwa akai -akai kuma aƙalla na tsawon dakika 20, kula da tsabtace numfashi mai kyau da kuma guje wa taɓa idanu, hanci ko bakinka ba tare da hannuwan da aka wanke ba.
CDC ta ba da shawarar rufe bakinka da hancinka da wani abu a kan tari ko cizon sauro kuma idan babu wani abu a ciki, ka yi amfani da ɓangaren gwiwoyin.
Ana ƙarfafa tsabtace hannu bayan tari ko tsatsa.
CDC ta ba da shawarar yin amfani da suturar rufe fuska a cikin tsarin jama'a don iyakance watsawa ta hanyar mutane marasa hankali. Dabarun samar da nesa na zamantakewa suna nufin rage haɗuwa da mutane masu kamuwa da cuta tare da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, hana tafiya da soke manyan taron jama'a.
Ka'idodin nesa sun hada da kiyaye mutane aƙalla 6 feet (1.8 m) nesa.
Tun da babu wani magani da aka sani da zai iya zama tasiri wajen hana COVID-19. Tun da ba a tsammanin samun allurar rigakafi aƙalla ba har zuwa 2021, wani muhimmin ɓangare na gudanar da COVID-19 shine ƙoƙarin rage mawuyacin cutar, wanda ake kira "ragewa".
CDC ta kuma ba da shawarar cewa mutum ya wanke hannayensa da sabulu da ruwa a kai a kai na akalla dakika 20, musamman bayan ya je bayan gida ko kuma idan hannayensa sun zama marasa tsabta, kafin ya ci abinci da kuma bayan ya yayyafa hanci, ya yi tari ko ya yi tsatsa.
Bugu da kari, yana ba da shawarar yin amfani da wanke hannu mai tushen giya wanda ya ƙunshi aƙalla kashi 60% na giya, amma kawai idan sabulu da ruwa ba su da sauƙi. Wadancan yankuna inda wanke hannu na kasuwanci ba su da sauƙi, WHO tana ba da tsari biyu don samar da gida.
A cikin waɗannan tsari, ana haifar da maganin antimicrobial daga ethanol ko isopropenol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da kwayoyin cuta a cikin giya; ba "abu ne mai aiki ba don hana hannu".
Ana haɗa glycerol a matsayin mai danshi.
Ana kula da mutane tare da kulawa mai taimako, wanda zai iya haɗawa da taimakon likitanci, taimakon oxygen da kuma sauran mahimman gabobin da aka shafa.
CDC ta bada shawarar cewa mutanen da ake zaton suna dauke da cutar su sa abin rufe fuska na yau da kullum.
Ana amfani da Oxygenation of Extracorporeal Membrane (ECMO) don magance matsalar rashin numfashi, amma amfanin sa har yanzu yana cikin tambaya.
Ana ba da shawarar tsabtace mutum da salon rayuwa mai kyau da abinci don inganta rigakafi.
Maganin taimako na iya zama da amfani ga mutanen da ke da alamun bayyanar cututtuka a farkon matakin kamuwa da cuta. WHO da Hukumar Lafiya ta Kasa ta kasar Sin sun wallafa shawarwari don kula da mutanen da ke asibiti tare da COVID-19.
Masu binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cuttukan
A watan Afrilu na shekarar 2020, babu wani takamaiman magani ga COVID-19.
Don bayyanar cututtuka, wasu ma'aikatan kiwon lafiya suna ba da shawarar yin amfani da paracetamol (acetaminophen) maimakon ibuprofen don amfani na farko.
Ya kamata a dauki matakan tsaro don rage haɗarin watsa kwayar cutar, musamman a cikin tsarin kula da lafiya, lokacin da ake aiwatar da ayyukan samar da aerosol kamar shigar da bututu ko kuma daukar hoto ta hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutanen da ke dauke da COVID-19, CDC ta ba da shawarar sanya mutum a cikin dakin keɓewa na kamuwa da cutar ta iska (AIIR) ban da yin amfani da daidaitattun matakan tsaro, matakan tuntuɓar da kuma matakan iska. CDC ta tsara jagororin don amfani da kayan kariya na mutum (PPE) a lokacin annobar.
Kayan aikin da aka ba da shawarar su ne: PPE chonga, na'urar numfashi ko mask na fuska, na'urar kariya ta ido, da safofin hannu na likita. Idan akwai, ana ba da fifiko ga na'urorin numfashi (maimakon na fuska).
An amince da N95 respirators don tsarin masana'antu, amma FDA ta ba da izinin amfani da masks a ƙarƙashin Hukumar Amfani da Gaggawa (EUA).
An tsara su don kare su daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancin su ga wani takamaiman mai aiki da kwayoyin ba don gwaje -gwaje marasa inganci.
Idan babu masks, CDC ta ba da shawarar yin amfani da takalman fuska ko, a matsayin mataki na ƙarshe, abin rufe fuska na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani sosai da za su buƙaci a yi musu maganin inji ko wasu zaɓuɓɓuka, amma a cikin wasu kashi na shari'o'in, ana buƙatar su.
Ana nazarin nau'in taimakon numfashi ga mutanen da ke fama da rashin numfashi da ke da alaƙa da COVID-19 don waɗanda ke asibiti, tare da wasu shaidu cewa za a iya kauce wa shigar da bututu tare da shigar da hanci mai yawa ko matsin lamba mai kyau na iska mai ƙarfi.
Ba a san ko kowanne daga cikin waɗannan abubuwa biyu zai iya ba da amfanin da ya dace ga waɗanda suke da ciwon zuciya ba.
Wasu likitoci suna son yin amfani da shigarwa ta hanyar shigarwa idan akwai saboda wannan fasaha ta iyakance yaduwar kwayoyin aerosol fiye da shigarwar hanci mai zurfi. Matsalar mai tsanani ta fi kowa a cikin tsofaffi (mafi shekaru 60 da haihuwa, musamman ma sama da shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isasshen asibiti a kowace mutum, wanda ke iyakance ikon tsarin kiwon lafiya don magance karuwar kwatsam na adadin mummunan COVID-19 da ke sa yin asibiti ya zama dole.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na mutanen da ke cikin ICU, kashi 2.3 cikin 100 na mutanen da ke bukatar taimako na inji don yin aiki, kuma kashi 1.4 cikin 100 sun mutu.
A kasar Sin, kusan kashi 30 cikin dari na mutanen da suka shiga asibiti da COVID-19 sun shiga ICU.
Hanyar aiki ta zama da rikitarwa yayin da COVID-19 ya haifar da rikicin numfashi mai tsanani (ARDS) da kuma samun wahalar samar da iskar oxygen.
Ana buƙatar tsarin kula da matsa lamba da masu ƙarfin PEEP don haɓaka isar da iskar oxygen yayin rage lalacewar huhu da haɗarin pneumothorax.
Ba za a iya samun PEEP mai girma a kan tsofaffin iska ba.
Bincike kan yiwuwar warkarwa ya fara ne a watan Janairun 2020, kuma ana gudanar da gwaji na asibiti kan kwayoyin riga - riga da yawa.
Remdesivir ya fi nuna tabbaci.
Ko da yake ana iya samar da sababbin magunguna ta hanyar 2021, yawancin magunguna da ake gwadawa sun riga an amince da su don wasu amfani ko kuma suna cikin gwaji mai ci gaba.
Ana iya yin ƙoƙari don ba da maganin rigakafi ga mutanen da ke da mummunan cuta.
WHO ta ba da shawarar cewa masu aikin sa kai su halarci gwaje -gwajen inganci da aminci na yiwuwar magunguna. FDA ta ba da izinin wucin gadi ga plasmas masu amfani da lafiya a matsayin magani na gwaji a lokuta inda rayuwar mutum ke cikin haɗari mai tsanani ko gaggawa.
Babu binciken asibiti da ya dace da wannan don nuna cewa yana da lafiya da tasiri ga cutar.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani app na wayar hannu don magance cutar.
Ana tambayar masu amfani su shigar da sunayensu da lambar ID.
Wannan app yana iya gano yiwuwar kamuwa da cutar ta hanyar gano 'ƙusoshi' ta amfani da bayanan sa ido.
Kowane mai amfani zai iya duba matsayin wasu masu amfani guda uku.
Idan aka gano yiwuwar haɗari, app ɗin ba kawai yana ba da shawarar keɓance kai ba, amma yana kuma faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da manyan bayanan bayanai don bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da kuma ilimin kere-kere don bin diddigin waɗanda suka kamu da cutar da waɗanda suka tuntube su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta bai wa hukumomin tsaro damar bin diddigin wayar salula na mutanen da ake zargi da cutar.
Wannan matakin ya kasance ne don aiwatar da killacewa da kuma kare mutanen da suka hadu da wadanda ke dauke da cutar.
Bugu da kari, a watan Maris na shekarar 2020, Deutsche Telecom ta raba bayanan wuri na waya tare da Cibiyar Robert Koch, hukumar gwamnatin tarayya ta Jamus don hana yaduwar cutar da bincike.
Rasha ta yi amfani da fasahar fuska don gano masu keta dokar killacewa.
Kwamishinan lafiya na yankin Italiya, Julio Gallerà, ya ce an sanar da shi daga masu amfani da wayoyin hannu cewa "kashi 40% na mutane suna yin wasu motsi".
Gwamnatin Jamus ta shirya taron na tsawon sa'o'i 48 na karshen mako tare da masu halarta sama da 42,000.
Bugu da kari, shugaban Estonia, Kerst Kaljulad ya yi kira ga duniya da za ta nemi hanyoyin samar da ingantattun hanyoyin magance yaduwar cutar.
Mutane na iya fuskantar matsala ta hanyar yin rigakafi, hana tafiya, illa na magani ko tsoron kamuwa da cutar da kansu.
BBC ta ruwaito Rory O'Connor cewa, "kara yawan warewar zamantakewa, kadaici, damuwa game da lafiya, damuwa da kuma koma bayan tattalin arziki, babban hadari ne da ke damun lafiyar mutum da kuma yadda yake rayuwa".
Wannan cuta na iya faruwa tare da ko ba tare da wasu alamun bayyanar cututtuka ba kamar sauran cututtukan cututtukan sama na sama na sama.
A cikin lokuta masu sauki, sau da yawa ana warkar da su cikin makonni biyu, yayin da a cikin lokuta masu tsanani ko matsananciyar cuta, ana iya ɗaukar makonni uku zuwa shida don warkewa.
Bisa ga bayanai daga wasu irin wannan ƙwayoyin cuta kamar SARS da MERS, mata masu ciki na iya samun haɗarin kamuwa da COVID-19 mai tsanani, amma akwai ƙarancin bayanai don COVID-19. A cikin wasu mutane, COVID-19 na iya haifar da cutar huhu ta hanyar shafar huhu.
A cikin mutanen da suka fi fama da cutar, COVID-19 na iya haifar da ciwon hanzari na numfashi mai tsanani (ARDS), wanda zai iya haifar da rashin numfashi, bugun jini ko rashin ƙarfi na gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin gabobin
Rikicin da ke tattare da COVID-19 ya hada da rashin lafiya, rashin jin daɗi, da kuma cutar zuciya, koda da hanta.
An ruwaito rashin daidaito na scanning, musamman karuwar lokaci na prothrombin, a cikin 6% na mutanen da aka kwantar da su asibiti tare da COVID-19, yayin da 4% na wannan rukuni suka sami aikin koda mara kyau.
Kimanin kashi 20-30 cikin dari na mutanen da suka kamu da COVID-19 suna nuna karuwar enzymes na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin da aka samu tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 10, daga cikinsu akwai kwanaki biyar da aka yi a asibiti.
Koyaya, marasa lafiya da aka sauya zuwa ICU suna da matsakaicin lokaci na kwanaki bakwai tsakanin shiga asibiti da mutuwa.
A cikin wani binciken da aka yi na farkon kamuwa da cutar, an yi matsakaicin kwanaki 14 daga bayyanar cututtukan farko zuwa mutuwa, tare da cikakken iyaka daga kwanaki shida zuwa 41.
A cikin wani binciken da hukumar lafiya ta kasar Sin ta gudanar, mace-mace a maza sun kai kashi 2.8 cikin dari, amma mata sun kai kashi 1.7 cikin dari.
Gwajin kwayar halitta na samfurori na huhu na gawa ya nuna lalacewar iska ta iska tare da ɓarkewar fibromycoside a cikin huhu biyu.
An lura da canje -canje a cikin ƙwayar cuta na ƙwayar cuta a cikin ƙwayoyin cuta.
Hoton huhu ya yi kama da na rikicin numfashi mai tsanani (ARDS).
A cikin mutuwar 11.8% da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya ta hanyar yawan matakan troponin ko kuma dakatar da bugun zuciya.
A cewar bayanan watan Maris na Amurka, kashi 89 cikin dari na mutanen da aka kwantar da su asibiti suna da yanayin da suka gabata.
Yawan mutuwar da ake samu daga yanayin ya bambanta saboda bambance -bambance na yankin da kuma matsalolin da suka shafi tsarin.
Saboda karancin adadin wadanda suka kamu da cutar, ana iya yin karin kimantawa a kan mutuwar.
Koyaya, gaskiyar cewa mutuwar ta kasance sakamakon abubuwan da suka faru a baya na iya nufin cewa an rage yawan mutuwar yanzu.
Masu shan sigari sun kasance sau 1.4 mafi kusantar samun alamun COVID-19 mai tsanani fiye da waɗanda ba sa shan sigari kuma sun kasance kusan sau 2.4 mafi kusantar buƙatar kulawa mai zurfi ko mutuwa.
Hukumar asibitin Hong Kong ta gano raguwar makamashi na huhu na kashi 20 zuwa 30% a cikin wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar sassan.
Wannan zai iya haifar da ciwon ciwon bayan kulawa mai tsanani bayan ya warke.
Har zuwa watan Maris na shekarar 2020, ba a san ko kamuwa da cutar ta baya ta samar da tasiri da rigakafi na dogon lokaci ga mutanen da suka warke daga cutar ba.
Ana ganin rigakafi a matsayin mai yuwuwa dangane da halayyar sauran coronaviruses, amma an bayar da rahoton gwajin tabbatacce ga coronavirus a kwanan wata bayan dawowa daga COVID-19.
Ana ganin cewa wadannan lokuta sun fi muni da kamuwa da cutar da ba a warke ba maimakon sake kamuwa da ita.
Ana ganin cewa kwayar cutar ta fito ne daga dabba, wanda ke yaduwa ta hanyar yaduwa daga dabba zuwa mutum.
Ba a san ainihin asalin cutar ba, amma har zuwa Disamba 2019 kamuwa da cutar ta kasance ta hanyar watsawa ta mutum zuwa mutum.
A cikin binciken da aka buga a cikin The Lancet a cikin Janairu 2020, na farkon shari'o'in COVID-19 41 da aka tabbatar, an ba da kwanan wata farko na fara bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Official WHO wallafe -wallafe sun bayyana farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da hanyoyi da yawa don tantance mutuwar.
Wadannan lambobi suna canzawa ta hanyar yanki da lokaci kuma suna shafar yawan gwaji, ingancin tsarin kula da lafiya, zaɓuɓɓukan magani, lokacin da ya wuce farkon barkewar cutar da halaye na yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambar cutar ta gaggawa ta ICD-10 U07.1 don mutuwar da aka tabbatar da cutar ta SARS-CoV-2 ta hanyar dakin gwaje-gwaje da lambar cutar ta U07.2 don mutuwar COVID-19 wanda aka gano ta hanyar asibiti ko annobar cutar ba tare da an tabbatar da SARS-CoV-2 ta hanyar dakin gwaje-gwaje ba.
Bisa ga bayanan jami'ar Johns Hopkins, adadin mutuwar da aka samu a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Yawan ya bambanta daga yanki zuwa yanki. Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano su mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR) wanda ke nuna yawan mutanen da suka kamu da cutar (masu ganowa da marasa ganowa) da suka mutu daga cutar.
Wadannan kididdigar ba su da lokaci kuma suna bin wani yanki na al'umma daga kamuwa da cuta zuwa warkewar cutar.
Ko da yake ba duk mutanen da suka kamu da cutar suke samun rigakafi ba, kasancewa da rigakafi na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, a wani karamin kauye mai yawan mutane 4,600, Castiglione d'Aeda, mutane 80 (1.7%) sun riga sun mutu.
A Gangalt, cutar ta yadu ta hanyar bukukuwan Carnival da kuma matasa, wanda ya rage yawan mutuwar, kuma ba za a iya rarraba dukkan mutuwar COVID-19 ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba ya wuce gona da iri.
A Netherlands, kimanin kashi 3 cikin 100 na iya samun rigakafi, kamar yadda aka kimanta daga masu ba da jini.
An tabbatar da mutuwar 69 (0.004% na yawan) daga COVID-19.
Sakamakon cutar da kuma mutuwar ta na bambanta ga maza da mata.
A cikin binciken da aka yi a kasar Sin da Italiya, yawan mutuwar maza ya fi girma.
Mafi yawan haɗarin ga maza suna cikin shekarunsu na 50, kuma rata tsakanin maza da mata tana raguwa ne kawai a lokacin da suka kai shekara 90.
A kasar Sin, yawan mutuwar maza ya kai kashi 2.8 cikin dari, mata kuma kashi 1.7 cikin dari.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma akwai yiwuwar cewa akwai wasu dalilai na halitta da na hali.
Bambancin rigakafi dangane da jinsi, rashin yawan shan sigari a cikin mata da kuma ci gaban yanayin rashin lafiya a cikin maza kamar hawan jini a cikin ƙarami na iya taimakawa cikin yawan mutuwar maza a cikin mata.
A Turai, kashi 57 cikin 100 na mutanen da suka kamu da cutar sun kasance maza kuma kashi 72 cikin 100 na mutanen da suka mutu daga COVID-19 sun kasance maza.
Kamar yadda na Afrilu 2020, Gwamnatin Amurka ba ta lura da bayanan jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan cuta irin su Ebola, HIV, influenza da SARS suna shafar maza da mata a hanyoyi daban -daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma ma'aikatan jinya mata ne, kuma suna da mafi kusantar kamuwa da cutar.
Hukumar lafiya ta duniya ta sanar a ranar 11 ga watan Fabrairun 2020 cewa za a yi amfani da sunan COVID-19 a matsayin sunan hukuma.
Shugaban WHO Tedros Adnanom Gabreyasus ya bayyana cewa CO na nufin Corona, VI na nufin Virus, D na nufin Cutar, kuma 19 na nufin shekarar da aka fara gano barkewar cutar wato 31 ga Disamba, 2019.
An zabi sunan ne don kauce wa nassoshi ga wani wuri na musamman (kamar China), jinsunan dabbobi ko rukuni na mutane, wanda ya dace da shawarwarin kasa da kasa don sanya suna don hana ɓata suna. Kwayar cutar da ke haifar da COVID-19 ana kiranta da cutar ta Coronavirus ta 2 (SARS-CoV-2).
WHO ta kara amfani da "COVID-19 virus" da "virus da ke da alhakin COVID-19" a cikin sadarwar jama'a.
Ana kiran cutar da kuma cutar "Coronavirus" a matsayin sanannen sanarwa.
A lokacin da aka fara bullar cutar a Wuhan, China, an san cutar da cutar da "Coronavirus" da "Wuhan Coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV a matsayin sunaye na rikitarwa don cutar ta hanyar numfashi mai tsanani da cutar, wanda ya bi ka'idodin 2015 na rashin amfani da wurare a cikin sunayen cututtuka da cutar.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakokin iyawa a cikin sarkar samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar NASIKA FAH da sassan iska.
A wani misali, lokacin da asibiti na Italiya ya bukaci kwandishan nan take, kuma mai samar da kayayyaki bai iya samar da su a cikin lokaci da ake bukata ba, wani kamfani na gida ya buga kwandishan da aka yi ta hanyar yin aikin da ya dace da kwandishan da ke bukatar kwandishan 100 a cikin dare.
Bayan barkewar cutar COVID-19, makirci, rashin gaskiya da kuma ɓatarwa game da asalin cutar, matakin cutar, rigakafi, magani da sauran bangarori sun bayyana kuma sun bazu cikin sauri akan layi.
Mutum yana iya yada kwayar cutar a wasu dabbobi.
Binciken ya kasa gano shaidar kwayar cutar a cikin alade, ducks, da kaji.
Babu magani ko allurar rigakafi da aka amince da ita don magance cutar.
Kungiyoyin gwamnati, kungiyoyin ilimi da masana'antu da masu bincike a masana'antu suna gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna a COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da "Taraitaccen Jaraba" don tantance tasirin maganin maganin maganin riga - riga guda hudu da ake tsammani za su yi tasiri.
Babu allurar rigakafi a halin yanzu, amma hukumomi daban -daban suna aiki sosai wajen samar da takarar rigakafi.
Ana amfani da aikin da aka yi a baya akan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da ACE2 graphite don shiga cikin ƙwayoyin mutum.
Ana yin bincike kan dabarun rigakafi guda uku.
Na farko, masu bincike suna da burin samar da cikakken rigakafin cutar.
Yin amfani da irin wannan kwayar cutar, ko dai ta zama mai aiki ko ta mutu, yana nufin haifar da gaggawa ga jikin mutum don amsawa ga sabon kamuwa da cutar COVID-19.
Wata dabara ta biyu, wato, allurar rigakafi, tana nufin samar da allurar rigakafi da za ta iya sa tsarin rigakafi ya zama mai saurin kamuwa da wasu sassan cutar.
A game da SARS-CoV-2, irin wannan bincike ya mai da hankali ne kan furotin S-contact wanda ke taimakawa kwayar cutar ta shiga cikin kwayar halitta ta ACE2.
Dabarar ta uku ita ce ta allurar nucleic acid (DNA ko RNA, sabuwar fasaha ta yin allurar).
Dole ne a gwada alluran gwaji na kowane ɗayan waɗannan dabarun don aminci da inganci. A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar tare da masu aikin sa kai guda huɗu a Seattle.
Alurar riga kafi tana da lambar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An bayyana karuwar dogara da antibody a matsayin wata babbar kalubale ga ci gaban allurar rigakafi don SARS-COV-2, amma wannan abu ne mai rikitarwa.
Ana gudanar da gwajin asibiti sama da 300 a cikin aiki har zuwa watan Afrilu 2020.
Gwaje -gwaje guda bakwai sun kasance suna tantance maganin da aka riga aka amince da shi don cutar malaria, wanda ya hada da nazarin hudu akan hydroxychloroquine ko chloroquine.
Da ake sa ran sanar da shi a karshen watan Afrilu, tare da gwaji na Phase III tara akan Remdesivir a kasashe da dama, ana aiki a kan magungunan rigakafin cutar da za a iya amfani da su a yawancin binciken kasar Sin.
Kamar yadda na Afrilu 2020, ana gudanar da wani bita mai zurfi na ci gaban asibiti ga masu neman rigakafi da magunguna na COVID-19. Ana tantance wasu magungunan riga-kafi na yanzu don magance COVID-19, gami da Remdesivir, Chloroquine da Hydroxychloroquine, Lopinavir/Ritonavir da Interferon Beta.
A watan Maris na shekarar 2020, akwai shaidar gwaji game da ingancin Remdesivir.
A cikin marasa lafiya da aka yi wa magani da amfani da Remdesivir ba a ba da izini ba, an ga ci gaba a cikin asibiti.
Ana gudanar da gwaji na asibiti na Phase III a Amurka, China da Italiya. An riga an yi nazarin chloroquine, wanda aka yi amfani da shi don magance cutar zazzabin cizon sauro, tare da sakamakon farko a kasar Sin a watan Fabrairun 2020.
Duk da haka, an yi kira ga a yi nazari a kan bincike.
Hukumomin kiwon lafiya na kasar Korea da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwa Kwa Kwaya, ta lura cewa, a karbar Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwaya, Kwayoyin Kwayoyin Kwaya, Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwaya, Kwayoyin Kwayoyin Kwaya, Kwayoyin Kwayoyin Kwaya, Kwayoyin Kwayoyin Kwayoyin Kwaya, Kwayoyin Kwayoyin Kwayoyin Kwa Kwa Kwa Kwaya, Kwayoyin Kwaya, Kwa Kwayoyin Kwa Kwa Kwa Kwa Kwa Kwaya, Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwaya, Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwaya, Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwa Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya Kwaya
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chloroquine a kan lamiri na likitoci da ke kula da mutane da COVID-19. Jagororin juzu'i na 7 na kasar Sin sun hada da interferon, ribavirin ko umfenovir don amfani don kariya daga COVID-19.
Bayanai na farko sun nuna cewa ana bukatar karin rigakafin ribavirin don hana cutar SARS-CoV-2 ta hanyar kwayoyin halitta.
An ba da shawarar yin nazarin nitasoxanoid a cikin kwayoyin halitta bayan sun nuna ƙananan ƙwayar cuta na SARS-CoV-2. Nazarin ya nuna cewa SARS-CoV-2 yana da mahimmanci don shigarwa ta hanyar aiki tare da farkon ƙwayoyin cuta na farko, tare da ACE2 graphite, ta hanyar shigar da proteins na transmembrane serine 2 (TMPRSS2).
Akwai manyan iyakoki ga nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba, wanda ya hana ƙungiyar likitanci karɓar waɗannan hanyoyin magani ba tare da ƙarin bincike ba. Osaltamivir ba ya hana SARS-CoV-2 na muhalli na wucin gadi kuma ba shi da wani sanannen matsayi a cikin maganin COVID-19.
Karuwar yawan sinadarin cytokine a cikin matakan COVID-19 mai tsanani na iya zama rikitarwa.
Akwai shaidu cewa hydroxychloroquine na iya ƙunsar abubuwan da ke hana karuwa a cikin sinadarin cytokine. Bayan kammala wani karamin bincike, Hukumar Lafiya ta Kasa ta kasar Sin ta haɗa tokilizumab a cikin jagororin magani.
Yana cikin gwajin gwaji na biyu a matakin kasa a Italiya bayan ya nuna sakamako mai kyau a cikin mutane masu cutar mai tsanani.
A hade da gwajin jini na serum ferritin don gano karuwar adadin cytokine, ana nufin magance irin karuwar da ake ganin ta haifar da mutuwa a wasu mutanen da suka sha wahala.
An amince da Interleukin-6 anti-inflammatory a shekara ta 2017 ta FDA bisa ga nazarin shari'ar da aka yi a baya don magance cututtukan cytokine-release syndrome na steroid-reactive steroid, wanda ya haifar da maganin CAR T cell, saboda wata dalili daban.
Har zuwa yau babu wata hujja ta bazuwar da aka sarrafa cewa Tocilizumab magani ne mai tasiri ga CRS.
Ana gudanar da bincike kan canja wurin tsarkakakken rigakafi da aka samar ta hanyar tsarin rigakafin mutanen da suka warke daga COVID-19 zuwa ga mutanen da suke bukatar su a matsayin hanyar ba da allurar rigakafi ba.
An yi amfani da wannan dabarar ne ga SARS tare da sakamako mai ban mamaki.
Hanyar da ake tsammani ta hanyar yin amfani da maganin rigakafi na cutar ta hanyar maganin rigakafi na iya taimakawa wajen kare kariya daga SARS-CoV-2.
Duk da haka, wasu hanyoyin aiki, kamar su cytotoxicity da/ ko phagocytosis na ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Sauran nau'ikan maganin antibody na rashin aiki, misali, amfani da rigakafin monoclonal da aka gina, suna ci gaba.
Za a iya ƙara samar da magani mai amfani, wanda ke dauke da ruwa a cikin jinin marasa lafiya da suka warke kuma yana da takamaiman rigakafi ga cutar, don saurin tsarawa.
Cutar Coronavirus, wata ƙungiya ta cututtukan da suka shafi kusanci
Li Wenliang, wani likita a asibitin Wuhan na tsakiya, ya kamu da COVID-19 kuma ya mutu bayan ya wayar da kan jama'a game da yaduwar cutar.
